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Introduction and outline of the thesis
Critically ill patients
Critical illness can be defined as a life-threatening condition caused by marked 
alterations in the structure and function of vital organs that can result in significant 
morbidity and mortality. In the Netherlands, each year nearly 100.000 patients are 
admitted to the intensive care unit (ICU) with a mortality rate of 15-20% (1, 2). 
Severe infections remain the most common problem encountered on the ICU (1), 
but also surgery and trauma can lead to critical illness. To save lives, continuous 
monitoring of vital organ functions in critically ill patients is crucial in order to timely 
start and evaluate therapeutic interventions. For example, sophisticated monitoring 
techniques in patients with acute respiratory failure on mechanical ventilation may 
limit development of complications associated with mechanical ventilation, such as 
lung injury and diaphragm dysfunction.
The diaphragm
The diaphragm is our main respiratory muscle and accounts for the major part 
(approximately 70%) of inspiratory work (3), hence it is called the respiratory pump. 
The diaphragm is a dome-shaped, musculotendinous partition separating the thoracic 
and abdominal cavities (Figure 1). The diaphragm is a skeletal muscle and receives 
its motor innervation via the phrenic nerve, which originates from the cervical roots 
3 to 5. During inspiration the diaphragm descends; however, only its central part 
moves because its periphery, as the fixed origin of the muscle, attaches to the inferior 
margin of the thoracic cage and the superior lumbar vertebrae.
 During inspiration, the downward movement of the diaphragm and outward 
movement of the chest wall results in a decrease in pleural pressure, i.e. the pressure 
surrounding the lung within the pleural space. Consequently pressure in the alveoli 
decreases, which creates a pressure gradient between the airway opening and the 
alveoli, leading to flow of air into the lungs. The transpulmonary pressure is the 
pressure difference between the opening to the pulmonary airway and the pleural 
surface, it represents the distending pressure of the lungs (4). In order to determine 
the contribution of the diaphragm to breathing, one can use the abdominal pressure. 
Due to the downward movement of the diaphragm, abdominal pressure increases 
during inspiration. When diaphragm function is impaired, the magnitude of increase 
in abdominal pressure is reduced and may even decrease during inspiration, this is 
clinically referred to as paradoxical chest movement. The pressure gradient over the 
diaphragm can therefore be estimated by subtracting pleural pressure from abdominal 
13
Introduction and outline of the thesis
1pressure. Gastric pressure (Pga) may represent abdominal pressure. Unfortunately, pressures within the chest cavity are difficult to measure and an estimate of pleural 
pressure is required. As the esophagus is situated inside the thoracic cavity, the 
esophageal pressure (Pes) can be used as an estimate for pleural pressure. The 
pressure gradient over the diaphragm can then be calculated as: transdiaphragmatic 
pressure (Pdi) = Pga – Pes.
Figure 1. The inner anterior surface (left) and inner posterior surface (right) of the dia-
phragm. Right: the three large apertures from top to bottom are the caval opening, the 
esophageal hiatus and the aortic hiatus. Adapted from Cluzel and colleagues (5).
Critical illness and diaphragm dysfunction
Critical illness has detrimental effects on the structure and function of the diaphragm 
(6-12). For instance, respiratory muscle strength measured by volitional maximal 
inspiratory pressure, has been shown to decrease after one week of mechanical 
ventilation and is associated with delayed extubation and prolonged ventilation (7). 
Also, non-volitional measurement of diaphragm strength, by phrenic nerve 
stimulation, revealed severe diaphragm weakness in critically ill patients (8). 
Diaphragm weakness may already be present at ICU admission and is associated 
with sepsis and disease severity (10, 13), suggesting it is an important part of 
multiorgan failure. The effects of critical illness on diaphragm function are often part 
of a more generalized phenomenon, known as ICU-acquired weakness (14). Factors 
such as systemic inflammation, drugs, electrolyte disturbances, and immobility have 
been identified in the pathogenesis of ICU-acquired skeletal muscle weakness (14). 
Besides generalized muscle weakness, there is convincing evidence that mechanical 
ventilation is an important cause of diaphragm dysfunction, so-called ventilator-
induced diaphragm dysfunction (VIDD) (15). In a landmark paper, Levine and 
colleagues demonstrated that only a few days of controlled mechanical ventilation is 
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associated with disuse atrophy of the diaphragm (6). In accordance with these data, 
Jaber and colleagues reported the functional consequences of critical illness on the 
respiratory muscles (9). They found approximately a third reduction in respiratory 
muscle function induced in the first 5-6 days of invasive mechanical ventilation, 
indicating the rapid development of diaphragm weakness. Recently, the frequent 
development of diaphragm atrophy in critically ill patients was also demonstrated 
using diaphragm ultrasound (16). Moreover, the diaphragm is more severely affected 
by critical illness and mechanical ventilation than other peripheral muscles (6, 17). 
At the time of liberation from mechanical ventilation, diaphragm dysfunction exists 
twice as frequent as limb muscle weakness and is associated with subsequent 
weaning failure and mortality (17). Therefore, there is an urgent need for tools to 
monitor diaphragm function and to develop preventive and therapeutic interventions 
to improve diaphragm function in critically ill patients. 
Mechanical ventilation and patient-ventilator interaction
For patients with acute respiratory failure mechanical ventilation is a life-saving 
intervention, which aims to reduce the work of breathing and improve gas exchange. 
Modern mechanical ventilators support or substitute the inspiratory effort of the 
diaphragm by delivering air to the lungs via positive pressure, causing an increase in 
pleural pressure. The latter is in contrast to unassisted spontaneous breathing, where 
caudal movement of the diaphragm causes a decrease in pleural pressure. Positive 
pressure ventilation can be delivered to the patient via an invasive or non-invasive 
route. Invasive mechanical ventilation requires placement of an endotracheal tube, 
whereas non-invasive mechanical ventilation is delivered via a face mask. Positive 
pressure ventilation is usually delivered with a bi-level approach. A lower pressure 
level during the expiratory phase, called positive end-expiratory pressure, and a 
higher level of assist during the inspiratory phase. Ventilator assist can be provided in 
a ‘controlled’ or ‘assisted’ mode. With controlled ventilation, duration and frequency 
of the inspiratory phase is completely regulated by the ventilator. With assisted 
ventilation, patients are required to trigger the ventilator, allowing the patient to 
time assist delivery to inspiratory effort. Triggering in conventional ventilators takes 
place by detection of the inspiratory flow or pressure generated by the patient and 
cycling-off is flow-based.
 To avoid patients ‘fighting the ventilator’ with assisted ventilation, the interaction 
between patient and ventilator is important. Ideally, the level of assist should be 
delivered in proportion to respiratory effort of the patient and in perfect synchrony 
with patient neural inspiratory time and neural expiratory time. Too high levels of 
inspiratory support may suppress output from the respiratory centers (over-assist), 
15
Introduction and outline of the thesis
1which is associated with respiratory muscle atrophy and contractile dysfunction (6, 16, 18). In opposite, too low levels of assist may result in high work of breathing 
and strenuous diaphragm efforts, which may result in the development of diaphragm 
injury and fatigue (19-21). In practice delivering synchronous and proportional 
assist is challenging with flow or pressure controlled systems (22). Patient-ventilator 
interaction depends on factors related to the ventilator and the patient. Ventilator-
related factors are the trigger sensitivity, the variable that control gas delivery, and 
the cycling-off criterion (23). Patient-related factors include the mechanics of the 
respiratory system and neural activation of the diaphragm (23). Patient-ventilator 
interaction can be classified into synchronous, dyssynchronous or asynchronous 
respiratory events (24). Dyssynchronous events refer to trigger delays and early or 
late cycling-off. Asynchronous events refer to wasted efforts, auto-triggering, and 
double-triggering. One-fourth of patients exhibit a high incidence of asynchrony 
(defined as more than 10% asynchronous events of total respiratory counts) during 
invasive assisted mechanical ventilation (25). Such a high incidence is associated with 
a prolonged duration of mechanical ventilation (25). With non-invasive ventilation, 
even 43% of patients presents with severe asynchrony (26). 
 A relatively new assisted mode of ventilation is neurally adjusted ventilatory assist 
(NAVA) (27). A mode designed to optimize patient-ventilator interaction. NAVA uses 
the electrical activity of the diaphragm to control the ventilator. Both timing and 
magnitude of assist are controlled by the patient. Clinical and physiological studies 
are needed to evaluate this new mode of ventilation. 
Weaning from mechanical ventilation
Prolonged mechanical ventilation leads to increased morbidity, including diaphragm 
dysfunction, and mortality in critically ill patients (28, 29). Therefore mechanical 
ventilation should be discontinued as soon as possible. This process is called 
weaning and it covers the entire process of liberating the patient from mechanical 
ventilation and the endotracheal tube (30). Approximately 40% of the time a patient 
is mechanically ventilated is dedicated to weaning from mechanical ventilation (31). 
An important stage in the weaning process is a spontaneous breathing trial (SBT). 
During an SBT the patient is challenged to breathe without support (a T-tube trial) for 
a certain time, usually between 30 and 120 min. An SBT is predictive for extubation 
failure or extubation success of the patient. Based on the number of SBT and the 
number of days in between until successful extubation, weaning patients can be 
classified into three groups (30). Group 1, the simple weaning group includes patient 
who successfully pass the initial SBT and are successfully extubated on the first 
attempt. This group represent the majority of weaning patients. Group 2, difficult 
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weaning, includes patients who require up to three SBT or as long as 7 days from 
the first SBT to achieve successful weaning. Group 3, prolonged weaning, includes 
patients who require more than three SBT or more than 7 days of weaning after the 
first SBT. This group is estimated to be approximately 6 - 15% of weaning patients 
(29, 30, 32). A major determinant of weaning failure is respiratory muscle dysfunction 
(7, 17). Detailed analysis of diaphragm function during an SBT might help to identify 
diaphragm dysfunction in patient who fail a trial of weaning.
Aims and outline of the thesis
This thesis focuses on diaphragm function in critically ill patients. In spite of growing 
evidence that diaphragm dysfunction develops in critically ill patients and contributes 
to prolonged mechanical ventilation and weaning failure, the respiratory muscles 
remain poorly monitored in the ICU and almost no interventions to maintain or improve 
function are available. This is in sharp contrast with the numerous options available to 
monitor and treat, for example, disorders of the heart and lungs in critically ill patients. 
Therefore, we investigated techniques to monitor diaphragm function, and preventive 
and therapeutic interventions to optimize diaphragm function.
The first part of this thesis focuses on monitoring of diaphragm function in critically 
ill patients. In chapter 2 we review the techniques available to monitor respiratory 
muscle function and discuss the possible implications of monitoring respiratory muscle 
function in the critically ill. If not monitored, diaphragm dysfunction often becomes 
apparent when a patient fails to wean from mechanical ventilation. However, the 
pathophysiology of difficult and prolonged weaning may be complex. Therefore, in 
chapter 3, we discuss in depth the differential diagnosis of difficult and prolonged 
weaning from mechanical ventilation, with emphasis on diaphragm dysfunction.
 Analysis of respiratory muscle function is an important step that is required to 
identify the primary cause for prolonged weaning from mechanical ventilation. In 
chapter 4 we performed detailed physiological analysis of inspiratory muscle activity 
and expiratory muscle activity during an SBT, in particular neuromechanical efficiency 
of the diaphragm and expiratory muscle effort were studied. Besides physiological 
measurements of the diaphragm, ultrasound could be a useful and accurate 
noninvasive bedside tool to evaluate diaphragm function (33). Currently, ultrasound 
of the diaphragm is used to quantify thickness, thickening during inspiration and 
movement of the diaphragm (34). However, correlations between physiological 
measurements, such as transdiaphragmatic pressure, and diaphragm thickening are 
low (35). Therefore in chapter 5 we evaluated the performance of speckle tracking 
imaging to quantify diaphragm function. Speckle tracking imaging is an ultrasound 
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1technique which enables angle-independent, two-dimensional quantification of muscle deformation and muscle deformation velocity during muscle contraction.
The second part of this thesis focuses on preventive and therapeutic interventions to 
optimize diaphragm function. A first approach is to prevent the development of VIDD 
by minimizing the harmful effects of mechanical ventilation on diaphragm function. 
Ideally, mechanical ventilation should exactly provide ventilatory assist proportional 
to the demands of the patient and cycle in perfect synchrony with neural respiratory 
timing of the patient. With conventional pressure support ventilation it can be 
challenging to deliver support in synchrony with the patients neural respiratory 
drive (22). NAVA is relatively new ventilator mode, controlled by electrical activity of 
diaphragm, where the patient regulates both timing and magnitude of assist (27). 
In chapter 6, we evaluated patient-ventilator interaction during different modes of 
non-invasive ventilation including NAVA. Previously it was shown in a heterogeneous 
groups of critically ill patients that non-invasive NAVA improves patient-ventilator 
interaction. Therefore, our study was performed in patients with chronic obstructive 
pulmonary disease as these patients are more likely to exhibit severe patient ventilator 
asynchrony (36). In addition, we used an automated analysis method to quantify 
patient-ventilator interaction. 
 In patients with acute respiratory distress syndrome (ARDS) the use of assisted 
mechanical ventilation over controlled mechanical ventilation is subject of debate 
(37-40). Assisted ventilation better preserves diaphragm function compared to 
controlled ventilation, but allowing spontaneous breathing efforts increases the 
risk of lung injury. It has been shown in patients with acute respiratory failure that 
increasing levels of support with NAVA unloads the respiratory muscles, but limits 
pressure increases due to down-regulation of respiratory muscle activity (41-43), 
suggesting a long-protective feedback mechanism. In chapter 7 we evaluated 
whether differences in patient control of the ventilator, affect lung protective 
ventilation, breathing pattern variability, and patient ventilator-interaction in mild to 
moderate ARDS patients. 
 After the transition from controlled mechanical ventilation to assisted mechanical 
ventilation, ARDS patients might generate high tidal volumes. To prevent lung injury 
clinicians often switch back to controlled ventilation, including high dose sedatives. 
However, this promotes diaphragm dysfunction. In chapter 8 we investigated 
whether partial neuromuscular blocking of the diaphragm can facilitate lung 
protective ventilation while maintaining diaphragm activity under assisted ventilation.
 Currently, there are no therapeutic agents available to improve diaphragm 
function. In chapter 9 we studied the effects of the calcium sensitizer levosimendan 
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on diaphragm function in healthy subjects. Previously, we have shown that 
levosimendan enhances calcium sensitivity of permeabilized muscle fibers obtained 
from the human diaphragm (44).
 As described, sepsis is strongly associated with diaphragm dysfunction (10, 13). 
In chapter 10 we aimed to develop an experimental in vivo model for diaphragm 
dysfunction during systemic inflammation. Such a model would allow testing of 
therapeutic agents to improve diaphragm dysfunction.
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Abstract
Evidence has accumulated that respiratory muscle dysfunction develops in critically 
ill patients and contributes to prolonged weaning from mechanical ventilation. 
Accordingly, it seems highly appropriate to monitor the respiratory muscles in these 
patients. Today, we are only at the beginning of routinely monitoring respiratory 
muscle function. Indeed, most clinicians do not evaluate respiratory muscle function 
in critically ill patients at all. However, practical issues and the absence of sound 
scientific data for clinical benefit should in our opinion not discourage clinicians 
for having a closer look at respiratory muscle function in critically ill patients. This 
perspective discusses the latest developments in the field of respiratory muscle 
monitoring and possible implications of monitoring respiratory muscle function in 
critically ill patients.
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Introduction
The physiological status of critically ill patients is characterized by rapidly evolving and 
frequently life-threatening derangements as well as ‘silent’ yet important alterations 
in organ function. The intensive care unit (ICU) environment is specifically equipped 
to monitor the critically ill patient. Intensivists monitor cardiac-, pulmonary-, and 
kidney function more or less continuously, and other organs or tissues, such as bone-
marrow and gastrointestinal tract are closely monitored as well.  
 In spite of growing evidence that respiratory muscle dysfunction develops in 
critically ill patients and contributes to weaning failure (1-3), the respiratory muscles 
are poorly monitored in the ICU. Therefore, diaphragm dysfunction is usually 
unrecognized in the ICU and only becomes apparent when a patient fails to wean 
from mechanical ventilation. This may be related to: 1) the limited knowledge of 
health care workers on the effects of critical illness on respiratory muscle function; 
2) the limited availability and knowledge of tools to monitor respiratory muscle 
function in critically ill patients; or 3) the perception that monitoring respiratory 
muscle function has no clinical consequences. 
 In this perspective, we discuss the latest developments in the field of respiratory 
muscle monitoring (Table 1) and possible implications of monitoring respiratory 
muscle function in the critically ill. The effects of critical illness on respiratory muscle 
function will be described briefly. 
What is the effect of critical illness on respiratory 
muscle function? 
The effects of critical illness on respiratory muscle function are often part of a more 
generalized phenomenon, known as ‘ICU acquired weakness’. It should be recognized 
that ICU weakness may result from alteration in muscle or nerve function, and in 
fact both often migrate together. Factors such as systemic inflammation, drugs, 
electrolyte disturbances, and immobility have been identified in the pathogenesis 
of ICU-acquired weakness (4). The clinical relevance of ICU-acquired weakness is 
supported by the observations that prolonged mechanical ventilation is associated 
with decreased diaphragm strength (3), and that muscle weakness is among the 
most prominent long-term complications of survivors of acute respiratory distress 
syndrome (ARDS) (5). 
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Table 1. Overview of available tools to monitor respiratory muscle function. 
diagnostic tool Parameter Comment
pressure and flow 
recordings
airway pressure/flow inspiratory muscle 
strength (PImax)
Easy to perform voluntary measurements of 
global respiratory muscle strength.  High values 
exclude respiratory muscle weakness. Low values 
may reflect poor technique or effort rather than 
respiratory muscle weakness (6).
expiratory  muscle 
strength (PEmax)
neural respiratory
drive (P0.1)
Available in most mechanical ventilators, but of 
limited value due to wide normal range (7).
transdiaphragmatic 
pressure *
diaphragm strength 
(Pdimax/ sniff Pdi)
Voluntary measures of specific diaphragm 
strength. High values exclude respiratory muscle 
weakness.  Low values may reflect poor technique 
or effort rather than respiratory muscle weakness 
(6).
Gilbert index These indices are frequently used for research 
purposes, but without dedicated software are too 
complicated for routine clinical use.
tension time index / 
pressure-time product
electromyography* neural respiratory
drive (EAdi)
Direct measure of respiratory output from the 
brainstem, no normal values available.
patient-ventilator 
synchrony
Gold standard for detection of patient-ventilator 
asynchronies.
neuro-ventilatory and 
-mechanical  efficiency
Relatively new indices still under evaluation, no 
normal values available.
phrenic nerve stimulation diaphragm strength 
(Pditw / Pmotw)
Non-voluntary evaluation of diaphragm function, 
fairly invasive and technical difficult. Should be 
performed only in experienced centers in selected 
patients.phrenic nerve conduction 
time
imaging chest x-ray diaphragm position Atelectasis, pneumonia and diaphragmatic 
eventration complicate findings of 
hemidiaphragmatic elevation. 
fluoroscopy diaphragm motion Misleading in patients with bilateral 
diaphragmatic paralysis and radiation exposure 
(8).
ultrasonography 
(B/M-mode)
diaphragm thickness / 
motion
Well characterized, noninvasive and easy to 
perform at bedside (9). M-Mode difficult to 
perform for left hemidiaphragm. Technique of 
limited value during assisted breathing.
CT / MRI diaphragm position / 
motion
Applicability for monitoring is very limited.
circulatory biomarkers troponin I The relation between plasma troponin I levels and 
functional measures in critically ill patients has not 
yet been investigated. 
Abbreviations: CT = computed tomography; EAdi = electrical activity of the diaphragm; 
MRI = magnetic resonance imaging; P
0.1 
= mouth pressure generated in the first 100 ms of 
inspiration; Pdi = transdiaphragmatic pressure; PE
max
 = maximal expiratory pressure; PI
max
 = maximal 
inspiratory pressure; Pmo = mouth pressure. * Requires placement of naso-gastric tube.
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Besides generalized weakness, there is evidence that mechanical ventilation itself 
is an important cause of diaphragm dysfunction, which is collectively referred to 
as ‘ventilator-induced diaphragm dysfunction’ (VIDD) (10). In a landmark paper, 
Levine and colleagues demonstrated that only a few days of controlled mechanical 
ventilation is associated with atrophy of the diaphragm, but not to the pectoralis major 
(11). In a recent study, Jaber and colleagues reported the functional consequences 
of critical illness on respiratory muscles (2). They found ~30% reduction in twitch 
airway pressure induced by magnetic phrenic nerve stimulation in the first 5-6 days 
of invasive mechanical ventilation, indicating the rapid development of diaphragm 
weakness. 
 The last decade the understanding of the molecular and cellular mechanisms 
underlying respiratory muscle weakness in the critically ill has been the subject 
of intensive research (extensively reviewed in (12) and (13)). To summarize, an 
imbalance between proteolysis and protein synthesis results in a loss of contractile 
proteins (11, 14). In addition, function of remaining muscle proteins may be impaired 
by enhanced oxidation and dephosphorylation (15-17). Inflammation and oxidative 
stress are the major drivers of these impairments (17). Figure 1 provides a graphic 
representation of conditions and their pathways contributing to acquired diaphragm 
weakness in critically ill patients. 
How to assess respiratory muscle function in 
critically ill patients?
A. History, symptoms and signs
A patient’s past medical history can provide information on the patient’s premorbid 
functional status and, in particular, preexistent respiratory muscle dysfunction. Weakness 
of the respiratory muscles occur in a variety of neuromuscular disorders (18), but also in 
non-myopathic chronic diseases such as chronic obstructive pulmonary disease (COPD) 
and congestive heart failure (19, 20). Other conditions that may precipitate respiratory 
and peripheral muscle dysfunction include aging (sarcopenia) and cachexia (21, 22). 
A patient’s medication history should be reviewed, since respiratory muscle function 
can be negatively affected by drugs including steroids, sedatives, analgetics (23-25).
 Clinical examination may reveal evidence of respiratory muscle weakness. Accessory 
respiratory muscle recruitment, especially the sternocleidomastoid muscle, may be 
apparent by palpation in patients where inspiratory load exceeds the capacity of the 
diaphragm (26). When the diaphragm is very weak, a supine abdominal paradox can 
be observed. 
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Figure 1. Graphic representation of conditions and their pathways contributing to acquired 
diaphragm weakness in critically ill patients. As shown, different conditions can lead to 
diaphragm atrophy via an imbalance between proteolysis and protein synthesis (11, 14), 
whereas remaining muscle proteins may be impaired by enhanced oxidation and dephos-
phorylation (15-17). Inflammation and oxidative stress are proposed to be the major driv-
ers of these impairments (17). In addition, certain drugs can impair neural drive and exci-
tation-contraction coupling. Abbreviations: NMBA = neuromuscular blocking agent.
Conversely, care must be taken in assessing abdominal wall motion in patients 
actively exhaling. Contraction of the abdominal muscles during expiration and 
subsequent relaxation as an assistance to inspiration may give the appearance of 
outward motion of the anterior abdominal wall during inspiration. Thus, activation 
of the abdominal muscles during expiration could also be regarded as a sign of 
respiratory muscle dysfunction.
B. Pressure and flow recordings
Airway pressure and flow
Although routine assessment of respiratory muscle function using airway pressures 
is common in several diseases, such as COPD, very few clinicians actually measure 
global respiratory muscle strength in the ICU. A maximal static inspiratory (Mueller 
maneuver) and expiratory maneuver can be obtained in intubated patients to evaluate 
global inspiratory (PI
max
) and expiratory (PE
max
) muscle strength. Both can be measured 
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either while the patient is connected to the ventilator or during brief disconnection 
using a handheld pressure monitoring device. Voluntary maneuvers require patient 
cooperation and are influenced by sedation level, anxiety and pain. Therefore, high 
values exclude clinically significant weakness, but low values are common and may 
reflect poor technique or effort as well (6). To obtain more reliable measurements of 
PI
max
 in ventilated and sedated patients, a 20 second end-expiratory occlusion period 
can be performed (27). A T-piece with one-way valves should be attached to the 
endotracheal tube to allow expiration, but obstruct inspiration. 
 Airway pressure (Paw) generated in the first 100 ms of inspiration (P
0.1
) has been 
used as an index of neural respiratory drive. Interpretation of P
0.1
 is limited by its 
wide normal range and dependency on lung volume and contractile properties of 
the diaphragm, nevertheless the technique remains useful when its limitations are 
recognized (7). 
Transdiaphragmatic pressure
In contrast to PI
max
, a specific measure of diaphragm muscle strength is transdiaphragmatic 
pressure (Pdi).  Pdi is the difference between abdominal and pleural pressure. In 
practice, the difference between esophageal (Pes) and gastric pressure (Pga) is used to 
calculate Pdi. Voluntary measurements of maximum Pdi can be obtained by having the 
patients inspire as forcefully as possible against a closed airway (28), or by having the 
patient sniff forcefully (29). Sniff Pdi
 
appears to be
 
more reproducible than maximum 
inspiratory Pdi
 
(29). The Gilbert index (ΔPga/ΔPdi) can be used to determine the relative 
contribution of the diaphragm to inspiration (30). The higher this index, the greater 
is the contribution of the diaphragm to total inspiratory effort. In case of a paralyzed 
diaphragm, the Gilbert index becomes negative. To estimate the energy expenditure of 
the diaphragm, the tension-time index  and pressure-time product of the diaphragm 
can be calculated using Pdi (31, 32). These indices are frequently used for research 
purposes, but without dedicated software are too complicated for routine clinical use.
Today, gastric- and esophageal balloons are extensively used for research purpose but 
not routinely in clinical care. This is probably the result of the perceived invasiveness 
of the procedure and technical difficulties. It should be noted that techniques, that 
are much more invasive and probably at least as complex (i.e. pulmonary artery 
catheter) are used to measure cardiac function in selected critically ill patients. 
Interestingly, in a recent study, esophageal pressure measurement was used to guide 
PEEP setting, indicating the applicability in clinical care (33). In fact, some of the 
modern ventilators have auxiliary ports to measure esophageal pressure, which is 
a step forward to implement measurement of esophageal pressure in clinical care. 
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However, one should keep in mind that Pdi is influenced by positive pressure of the 
mechanical ventilator and ideally should be measured during a trial of spontaneous 
breathing.
In conclusion, PI
max
 and PE
max
 can be used as a global measure for respiratory muscle 
function and possibly to monitor the response of respiratory muscle training. We 
recommend the use of esophageal catheters only for monitoring diaphragm function 
in selected ICU patients, such as with difficult weaning (34). In these patients, 
esophageal and gastric pressures could be used to closely monitor the role of the 
diaphragm in weaning failure (34). 
C. Electromyography
Electromyography (EMG) comprises the temporal and spatial summation of neural 
impulses from the brain that are translated into muscle fiber action potentials. 
Diaphragm EMG can be recorded best using an esophageal catheter with multiple 
electrodes and has already proven its use as a powerful research tool (35). Today, 
the (processed) EMG signal can be obtained rather easily and continuously in ICU 
patients, which opens windows for using this tool in patient monitoring. The 
processed signal is from here referred to as the amplitude of the electrical activity of 
the diaphragm (EAdi). EAdi may be helpful in monitoring respiratory muscle loading, 
patient-ventilator synchrony and efficiency of breathing in critically ill patients. 
Respiratory muscle loading 
An important goal of mechanical ventilation is to unload the respiratory muscles. The 
ratio of actual EAdi to maximum EAdi is a measure of the patient’s effort to breath, 
where maximum EAdi can be defined as the peak activity observed during a 20 
second inspiratory occlusion (27). A too low ratio suggests too high level of support, 
whereas a high ratio strongly suggests inadequate unloading of the respiratory 
muscles. In controlled mechanical ventilation, disuse of the diaphragm results in 
atrophy within a few days (11). High levels of pressure support may also suppress 
output from the respiratory centers by over-assistance resulting in respiratory muscle 
atrophy and contractile dysfunction  (36, 37).  In ARDS, extracorporeal membrane 
oxygenation (ECMO) improves oxygenation and carbon dioxide elimination. ECMO 
sweep gas flow can be adjusted to regulate carbon dioxide elimination. In patients 
recovering from ARDS, EAdi increases in response to decreasing ECMO sweep gas 
flow and vice versa (38). In selected cases monitoring of EAdi during ECMO allows 
titration of sweep gas flow to prevent extreme unloading of the diaphragm. Besides 
an increase in EAdi, high inspiratory loading and/or low inspiratory muscle capacity 
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Figure 2. Screenshots from a mechanical ventilator in pressure support mode, tracings 
from top to bottom: airway pressure (Paw), airway flow, tidal volume, and diaphragm elec-
trical activity (EAdi). (A) Over-assistance with pressure support ventilation leads to suppres-
sions of diaphragm activity. (B) Diaphragm electrical activity reveals severe trigger delays 
(gray shaded area) and wasted efforts (indicated by arrows).
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is also characterized by recruitment of the accessory inspiratory muscles. Data show 
that with decreasing levels of support the accessory muscle are increasingly activated 
(39). Although clinical implications of this observation are still unclear, it seems 
reasonable to assume that an increase in accessory muscle recruitment is the result 
of inadequate unloading. In the future, activity of accessory muscle may play a role 
in determining optimal ventilator settings. 
Patient-ventilator synchrony 
To date, visual inspections of flow and pressure waveforms are used to detect 
patient-ventilator asynchronies. However, it has been shown that the ability of 
ICU physicians, even experts, to do so is overall quite low and decreases at higher 
prevalence of asynchronies (40). Since EAdi is a direct measure of neural respiratory 
drive, it can be used to detect the onset and duration of neural inspiration and 
expiration. Consequently, monitoring EAdi could be considered the gold standard for 
detection of patient-ventilator asynchronies, including trigger delays, early and late 
cycling off, auto triggering, double triggering, and wasted efforts (Figure 2). 
Neuro-ventilatory and -mechanical efficiency 
Currently, new indices are evaluated for respiratory muscle function in ventilated 
patients. The ratio between tidal volume (Vt) and EAdi, represents neuro-ventilatory 
efficiency (NVE) of the diaphragm. An improved NVE indicates that a patient is able to 
generate the same Vt with lower levels of EAdi, whereas a higher EAdi suggests the 
opposite. NVE has been used to discriminate between extubation failure and success 
in patients weaning from mechanical ventilation (41). Evidently, NVE is sensitive to 
changes in diaphragm function (atrophy, fatigue and hyperinflation) as well as a 
patient’s load of breathing (airway compliance and resistance). Monitoring the ratio 
between Pdi and EAdi, represents neuro-mechanical efficiency (NME), excludes the 
influence of a patient’s load of breathing. A gradual decrease in NME over days 
indicates the development of diaphragm weakness, whereas an increase suggests 
recovery. 
Limitations
Diaphragm electromyography is feasible in routine clinical care for monitoring 
respiratory muscle fucntion. However, we still face several challenges. First, there is 
the need to identify the target level of EAdi or NVE that should be attained in the 
day-to-day management of mechanically ventilated patients. Second, it should be 
recognized that respiratory muscle activity is also suppressed by sedatives, in particular 
propofol and morphine-like analgetics (42). Third, insertion of an esophageal catheter 
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carries a (low) risk for complications, and may be an uncomfortable procedure in 
non-sedated patients. Nevertheless, most critically ill patients require a naso-gastric 
tube for feeding, which are already commercially available with EMG electrodes 
(Maquet Critical Care, Solna, Sweden). Taken together, EAdi is a rational parameter 
to monitor respiratory muscle unloading and patient-ventilator synchrony from an 
early phase of critical illness. We expect that in the near future EAdi will become an 
important tool for respiratory muscle monitoring during mechanical ventilation and 
weaning (41, 43).
D. Phrenic nerve stimulation
Magnetic phrenic nerve stimulation allows non-voluntary evaluation of diaphragm 
strength, measured as the magnitude of twitch transdiaphragmatic pressure (Pdi
tw
) 
or twitch airway pressure (Paw
tw
) (44). The integrity of the phrenic nerve, in response 
to stimulation, can be tested by recording the compound muscle action potential 
(CMAP) of the diaphragm (45). This allows calculation of phrenic nerve conduction 
time and subsequent detection of phrenic nerve injury. Phrenic nerve stimulation has 
been extensively used in research settings. The technique, however, is not applicable 
for routine bed-side monitoring because of the fairly invasive nature, technical 
difficulties, and limitations concerning patients’ condition and tolerance. Therefore, 
this technique should be restricted for diagnostic purposes to a selection of patients 
(difficult weaning from mechanical ventilation) in centers that have sufficient 
experience with this technique. 
E. Imaging 
Radiography
Conventional radiography can be used for evaluating the position (chest x-ray) and 
motion (fluoroscopy) of the diaphragm. Elevation of the hemidiaphragm may be seen 
with hemidiaphragm paralysis. The clinical utility of this finding, however, is limited 
as hemidiaphragmatic elevation can occur in the absence of paralysis, such as with 
atelectasis, pneumonia and diaphragmatic eventration. Compared to chest x-ray, 
fluoroscopy provides more dynamic information and can be used to detect unilateral 
diaphragm paralysis. However, fluoroscopy is less helpful when the hemidiaphragm is 
weak but not completely paralyzed, and it can be particularly misleading in patients 
with bilateral diaphragmatic paralysis (8). Moreover, fluoroscopy is not suitable as a 
bedside monitoring tool.
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Ultrasonography
Several recent studies have demonstrated the utility of ultrasonography for diaphragm 
muscle imaging. B-mode ultrasonography using a linear array transducer can be used 
to assess the diaphragm thickness in the zone of apposition (46, 47), an echogenic 
layer bordered by pleural and peritoneal membranes. Another promising method is 
the non-invasive evaluation of diaphragm motion with M-mode ultrasonography. 
With this mode, a phased array transducer is positioned subcostal or low intercostal 
between the midclavicular and mid-axillary lines. Procedure, reproducibility 
and normal values have been assessed recently in a large population of healthy 
subjects (9). In Figure 3, M-mode images are shown from a patient with normal 
diaphragm motion and diaphragm paralysis. Ultrasonography takes little time to 
perform, is noninvasive and can be performed at the bedside. However, diaphragm 
ultrasonography will only provide useful information during unassisted breathing 
and is therefore of limited relevance in the very early course of critical illness. 
Figure 3. Ultrasonographic M-mode images from the right hemidiaphragm. (A) Normal 
diaphragm motion, the diaphragm moves 1.8 cm cephalad during inspiration. (B) Caudal 
movement of the diaphragm in a patient with diaphragm paralysis.
More complex imaging techniques, such as magnetic resonance imaging (MRI) and 
computed tomography (CT) have been used to evaluate diaphragm function (48, 
49), but are not suitable for monitoring as these techniques are cumbersome in 
mechanically ventilated patients and should only be used for specific diagnostic 
purposes. 
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F. Circulatory biomarkers
Studies in critically ill patients and ventilated animals revealed that respiratory muscle 
weakness is associated with muscle fiber damage and loss of contractile proteins (2, 
11, 14, 16, 17). Considering the important role of plasma markers in the diagnosis 
of myocardial damage and rhabdomyolysis, it could be reasoned that the detection 
of muscle specific proteins in plasma would be a valuable tool to monitor damage 
of the respiratory muscles. Although potential candidates include classical markers 
such as creatine kinase and myoglobin, the clinical use of these markers is probably 
hampered by their large range in healthy individuals and non-specificity for structural 
damage (50). Recent experimental findings indicate that measuring serum levels of 
skeletal muscle troponin I is more sensitive to detect structural injury of respiratory 
muscles (51). However, the relation between plasma troponin I levels and functional 
measures in critically ill patients has not yet been investigated. Of note, respiratory 
muscle weakness in the critically ill is often part of generalized muscle weakness. In 
those cases, evaluation of circulatory biomarkers of skeletal muscle damage may not 
specifically reflect the functioning of respiratory muscles, but could rather represents 
overall skeletal muscle function.
How could respiratory muscle monitoring 
affect clinical care?
Given the detrimental effects of critical illness, monitoring respiratory muscle 
function is a reasonable approach, even in the absence of evidence based therapeutic 
implications. If monitoring indicates rapid loss of respiratory muscle function then 
factors that negatively affect muscle function should be restricted as much as 
possible, including disuse by over-assistance, patient-ventilator asynchrony and 
drugs associated with side effects on muscle function. In fact, this is to a certain 
extend in analogy with monitoring renal function in critically ill patients. There are no 
direct therapeutic implications in monitoring renal function, but clinicians will avoid 
certain nephrotoxic drugs when renal function is impaired. 
Monitoring in the early phase
In the early phase of critical illness, monitoring of the respiratory muscles should 
focus on minimizing the negative effects of mechanical ventilation. During this phase, 
clinicians should avoid too high (‘over-assist’) as well as too low levels of pressure 
support. Although the width of this therapeutic margin is unknown, monitoring EAdi 
might prove helpful to detect suppressed output from the respiratory centers by 
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over-assistance as well as excessive respiratory drive during inadequate unloading. A 
considerable group of mechanically ventilated patients (25%) exhibit severe patient-
ventilator asynchrony (52). Such a high incidence is associated with a prolonged 
duration of mechanical ventilation (52, 53). Hence, early detection of severe 
asynchrony by monitoring EAdi can be used to adjust ventilator settings to improve 
synchrony. For example, neutrally adjusted ventilatory assist (NAVA) has been shown 
to reduce patient-ventilator asynchrony (54). In the early phase of ARDS the use of 
neuromuscular blocking agents (NMBA) has been shown to improve outcome (55). 
Muscle paralysis prevents patient-ventilator asynchrony, thereby reducing the risk of 
baro- and volutrauma, providing an acceptable explanation for the beneficial effects 
observed in this latter study (56). If true, monitoring EAdi to detect patient-ventilator 
asynchrony, during brief interruption of NMBA, may help the clinician to decide 
when to stop further NMBA administration. Also, we use EAdi to titrate NMBA in 
selected ARDS patients. A bolus is administered when EAdi is observed, thereby 
reducing the risk of overdose. 
Monitoring during (difficult) weaning
During weaning from mechanical ventilation, short periods of unassisted breathing 
allow closer monitoring of respiratory muscle function using ultrasonography and 
respiratory pressure measurements. Using M-mode ultrasonography, diaphragm 
dysfunction was found in 29% of critically ill patients without history of diaphragm 
dysfunction (57). In a non-ICU population, it was shown that sequential measurements 
of diaphragm thickness using B-mode ultrasonography is not only useful in making 
the initial diagnosis of diaphragm weakness, but for determining subsequent recovery 
as well (58). Knowing whether or not the respiratory muscles are impaired is of major 
clinical importance. It allows development of an effective treatment plan (including 
mobilization and physiotherapy) and proper prognostic advice to the patient and 
relatives. 
Therapeutic strategies
Contrary to another vital muscle, the heart, there are currently limited strategies 
available to improve respiratory muscle function. However, data from recent pre-
clinical studies offer hope for the near future (59-61). Recently, we have shown 
that the calcium sensitizer levosimendan improves neuro-mechanical efficiency 
and contractile function of the human diaphragm in vivo. Our findings suggest a 
new therapeutic approach to improve respiratory muscle function in patients with 
respiratory failure (59). In mechanically ventilated rats, the antioxidant N-acetylcysteine 
prevented ventilation induced diaphragmatic oxidative stress and proteolysis and 
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abolished ventilation-induced diaphragmatic contractile dysfunction (60). Like any 
skeletal muscle, the diaphragm is responsive to training. In a randomized controlled 
trial, inspiratory muscle training (IMT) has been shown to improve inspiratory muscle 
strength and weaning outcome in critically ill patients (61). IMT should therefore be 
considered in difficult to wean patients with proven inspiratory muscle weakness.
 Further studies are needed to establish the effects of these new pharmacological 
interventions and to develop specific training protocols for critically ill patients. 
Adequate monitoring of respiratory muscle function is indispensible to establish the 
effects of these interventions.
Summary and future directions
A large body of evidence shows the detrimental effects of critical illness on respiratory 
muscle structure and function, which is associated with prolonged weaning from 
mechanical ventilation. While some factors related to impaired muscle function in the 
critically ill are unpreventable (e.g. sepsis), awareness of developing weakness may 
alter treatment (e.g. ventilator settings, training, drug prescription).
 As outlined, different tools are available to asses respiratory muscle function. Some 
of these tools have limited value (chest x-ray, fluoroscopy) or are not suitable for routine 
clinical care monitoring (MRI, CT, phrenic nerve stimulation). However, more promising 
tools that can be used today or in the near future for monitoring of respiratory muscle 
function are: (1) ultrasonography to evaluate diaphragm movement and thickness; 
(2) measurement of mouth and/or transdiaphragmatic pressure to monitor respiratory 
muscle strength; and (3) electromyography of the diaphragm to monitor respiratory 
muscle unloading and patient-ventilator asynchrony. Circulatory biomarkers for 
respiratory muscle injury are much needed and hopefully will appear in the next few 
years.
 There is scarce literature that directly demonstrates improved outcome with close 
monitoring (and action) of the respiratory muscles. However, over the last years 
circumstantial evidence suggests that respiratory muscle monitoring can affect clinical 
care in the ICU. 
Today, we are only at the beginning of routinely monitoring respiratory muscle function. 
However, practical issues and the absence of sound scientific data for clinical benefit 
should in our opinion not discourage clinicians for having a closer look at respiratory 
muscle function in critically ill patients. In modern ICUs, monitoring the respiratory 
muscles should be as much part of the routine as monitoring any other organ function.
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Abstract
Purpose of review: In this review, we discuss the causes for a failed weaning trial and 
specific diagnostic tests that could be conducted to identify the cause for weaning 
failure. We briefly highlight treatment strategies that may enhance the chance of 
weaning success. 
Recent findings: Impaired respiratory mechanics, respiratory muscle dysfunction, 
cardiac dysfunction, cognitive dysfunction and metabolic disorders are recognized 
causes for weaning failure. In addition, iatrogenic factors may be at play. Most 
studies have focused on respiratory muscle dysfunction and cardiac dysfunction. 
Recent studies demonstrate that both ultrasound and electromyography are valuable 
tools to evaluate respiratory muscle function in ventilated patients. Sophisticated 
ultrasound techniques and biomarkers such as BNP, are valuable tools to identify 
cardiac dysfunction as a cause for weaning failure. Once a cause for weaning failure 
has been identified specific treatment should be instituted. Concerning treatment, 
both strength training and endurance training should be considered for patients 
with respiratory muscle weakness. Inotropes and vasodilators should be considered 
in case of heart failure. 
 
Summary: Understanding the complex pathophysiology of weaning failure in 
combination with a systematic diagnostic approach allows identification of the 
primary cause of weaning failure. This will help the clinician to choose a specific 
treatment strategy and therefore may fasten liberation from mechanical ventilation.
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Introduction
Weaning from mechanical ventilation covers the entire process of liberating a patient 
from the ventilator and the endotracheal tube (1). Weaning failure is usually defined 
as an unsuccessful spontaneous breathing trial (SBT) or need for ventilator support 
(including noninvasive ventilation) within 48 hours after extubation (1). In patients 
that require more than 7 days of weaning after a first failed spontaneous breathing 
trial, mortality is significantly increased (13% versus 7% of patients that need shorter 
weaning time (2)). The pathophysiology of a failed weaning trial may be complex, 
but it is in our opinion important to understand the reason for a failed weaning 
trial. Identification of the cause of weaning failure will help the clinician to choose 
a rationale treatment strategy that improves the chances of success for the next 
weaning trial. The aim of this paper is summarize the differential diagnosis of a failed 
weaning trial and discuss recent papers that help the clinician to identify the cause 
for weaning failure. Finally, we briefly discuss new treatment strategies that may 
fasten liberation from mechanical ventilation.
Causes of weaning failure
The transition from positive inspiratory pressure during mechanical ventilation to 
negative airway pressure during spontaneous breathing challenges the patients 
physiological reserve. When an imbalance develops between the patients’ ventilatory 
needs and capacity, weaning fails. Below we will discuss the causes of weaning 
failure and the techniques that are most helpful in the diagnostic work-up.
Impaired respiratory mechanics 
The load imposed upon the respiratory muscles is determined by the resistance and 
compliance of the respiratory system and the presence of PEEPi. An increase in load 
is accompanied by an increase in work of breathing and as such may lead to weaning 
failure. Indeed airway resistance is higher in patients failing a weaning trial (3, 4). In 
the upper airways, resistance may be increased by the artificial airway and/or tracheal 
injury, including stenosis, tracheomalacia, and granulation tissue. In tracheostomized 
patients with weaning failure referred to a dedicated weaning center, endoscopy 
revealed significant tracheal stenosis (>50% of tracheal lumen) in 5% (14/288) of 
the patients (5). Ten of these 14 patients could be successfully decannulated after 
removal of granulation tissue.
 The presence of elevated small airway resistance is obvious in patients with COPD 
or asthma, but in acute respiratory distress syndrome (ARDS) airway resistance may 
be increased as well due to edema of the bronchial wall. As a result of increased 
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airway resistance, expiratory flow is limited and consequently intrinsic positive 
end-expiratory pressure (PEEPi) may develop. PEEPi elevates work of breathing 
via hyperinflation and by acting as a threshold for generation of inspiratory flow. 
Under dynamic conditions, PEEPi can be determined only by using an esophageal 
balloon. Although these balloons are widely available, positioning of the catheter 
and interpretation of the signal is subject to pitfalls (6). 
 The compliance of the respiratory system is determined by the elastic properties 
of both the lungs and the chest wall. In a population of ARDS patients, compliance 
was found to be lower in the failure group compared to successful weaning (4). 
Lung compliance may be reduced due to alveolar filling (edema or pus), atelectasis, 
interstitial lung disease, pulmonary fibrosis, and hyperinflation. Pleural effusion, 
edema, obesity and elevated abdominal pressure decrease chest wall compliance. 
Measurement of esophageal pressure (Pes) is required to differentiate lung compliance 
from chest wall compliance. However, in clinical practice when total respiratory 
compliance is decreased clinical and / or radiological work up will generally identify 
the cause of reduced compliance.
Respiratory muscle dysfunction 
Critical illness has profound effects on respiratory muscle structure and function 
(7), Rapid development of diaphragm weakness, indicated by approximately a third 
reduction in diaphragm force, was found in the first 5-6 days of invasive mechanical 
ventilation in a small group of critically ill patients (8). Diaphragm muscle fiber cross-
sectional area is reduced by ±25% in critically ill patients ventilated for ±7 days 
compared to patients referred for elective surgery (9). In addition, in-vitro force 
generation of these fibers was severely reduced compared to controls. Goligher and 
colleagues (10) found that in 44% of the ventilated ICU patients diaphragm thickness, 
as assessed by ultrasound, decreased by more than 10% in the first week on the 
ventilator. The reduction in diaphragm thickness was associated with weakness (10).
 Clinical evaluation of respiratory muscle function in ventilated critically ill patients 
is a challenge. Previously, we discussed the available techniques in detail (11, 12). 
Here, we will briefly discuss clinically relevant and feasible techniques. Maximal 
inspiratory pressure (MIP) and maximal expiratory pressure (MEP) are tests of global 
respiratory muscle strength and can be measured using a handheld device connected 
to the artificial airway. A MIP above 30 cmH
2
O is associated with a shorter time 
to successful extubation (13). Simultaneous recording of Pes and gastric pressure 
(Pga) using dedicated balloons allows calculation of transdiaphragmatic pressure 
(Pdi = Pga - Pes), a specific measure of diaphragm contractility. The latter is useful 
for close monitoring and evaluation of diaphragm function in difficult-to-wean 
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patients (Table 1). However, as mentioned before, acquisition and interpretation of 
Pes, Pga and their derived measures, such as work of breathing, requires expertise.
 Diaphragm ultrasonography is a practical and non-invasive tool for assessment of 
diaphragm thickness, thickening fraction and displacement (Figure 1). Using M-mode 
ultrasonography, diaphragmatic dysfunction (vertical excursion < 1 cm or paradoxic 
movements) was found in 24 of 82 patients who met criteria for an SBT (14).
 Using M-mode ultrasonography, diaphragmatic dysfunction (vertical excursion 
< 1 cm or paradoxic movements) was found in 24 of 82 patients who met criteria 
for an SBT (14). These patients showed frequent early and delayed weaning failures. 
DiNino and colleagues found in 63 mechanically ventilated patients that diaphragm 
thickening fraction above 30% predicts extubation success with a sensitivity and 
specificity of 88% and 71%, respectively (15). Very recently, it was proposed that 
thickening fraction of the diaphragm as assessed with ultrasound could be used 
to detect dysfunction (10). Future fields of ultrasonography application may be 
detection of patient-ventilator asynchrony (16), and assessment of respiratory 
workload (17, 18) .
 Diaphragm electromyography (EMG) reflects neural respiratory drive to the 
diaphragm. The (processed) EMG signal can be obtained continuously using 
commercially available multi-electrode esophageal catheters required for neurally 
adjusted ventilatory assist (NAVA) ventilator mode (Maquet, Solna, Sweden). The ratio 
between diaphragm EMG and tidal volume is called the neuro-ventilatory efficiency 
(NVE). NVE has been shown to identify weaning failure in multiple studies (19-22). 
Evidently, NVE is sensitive to changes in diaphragm function as well as a patient’s 
load of breathing. Diaphragm EMG may also be used to monitor respiratory muscle 
unloading (23) patient-ventilator interaction (24) and the effect of residual sedation 
on respiratory drive (25). In a preliminary observation, it was reported that diaphragm 
EMG can be used to detect development of fatigue after extubation (26). 
Cardiac dysfunction 
The lungs and heart are functionally and anatomically coupled and therefore 
transition of assisted breathing to unassisted breathing has profound cardiovascular 
effects that may induce weaning failure. First, during positive pressure ventilation 
the intra-thoracic pressure (ITP) increases during inspiration, whereas during 
unassisted breathing ITP decreases during inspiration as a result of activation of 
the inspiratory muscles. The decrease in ITP during a weaning trial will enhance 
venous return by reducing right atrial pressure, end diastolic RV volume and such 
in patients with normal cardiac function increase RV and LV output, but may result 
in heart failure in patients with compromised cardiac function. Second, increased 
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sympathic tone (emotional stress, hypercapnia, hypoxemia) may further increase LV 
afterload. Finally, the transition to unassisted breathing puts an elevated load on 
the respiratory muscles, which increases oxygen consumption and such is a stress to 
the heart. The final effects of unassisted breathing on the cardiovascular system are 
much more complex. We refer to recent papers for review (27, 28). Table 2 shows 
the cardiovascular effects of a successful prolonged spontaneous breathing trail in a 
typical ICU patient.
 As an alternative to the pulmonary artery catheter, less invasive techniques 
are currently used to identify cardiac failure during a weaning trial. Transthoracic 
echocardiography during an SBT can identify both systolic and diastolic dysfunction 
(29). With tissue Doppler imaging, myocardial relaxation can be quantified by 
measuring the early diastolic mitral annulus velocity (Ea). In combination with 
transmitral early diastolic filling velocity (E), measured by conventional pulsed wave 
Figure 1. Normal diaphragm ultrasonography. From left-to-right, top-to-bottom: B-mode 
diaphragm thickness during expiration, B-mode diaphragm thickness during inspiration, 
M-mode diaphragm displacement during normal inspiration, measurements obtained from 
images. Abbreviations: Dia = diaphragm; exp = expiration; ICS = intercostals muscles; insp 
= inspiration; SC = subcutis. 
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Doppler, the resulting E/Ea ratio closely correlates with left ventricular filling pressure 
(30). Moschietto and colleagues found in a non-selected population of 68 patients, 
performing an SBT, that the E/Ea ratio before and during the SBT was higher in the 
failure group than in the successful group (29). In this study, an E/Ea ratio during the 
SBT of 14.5 predicted weaning failure with a sensitivity of 75% and a specificity of 
95.8%. It should be recognized that performing ultrasound at the time of weaning 
failure might be a quite challenge. 
 B-type natriuretic peptide (BNP) and N-terminal (NT)-proBNP are cardiac 
biomarkers secreted by ventricular cardiomyocytes in response to increased 
ventricular wall stress. Increases in BNP and NT-proBNP levels during the SBT are 
consistent with weaning failure of cardiac origin, in which BNP performs better than 
NT-proBNP (31, 32). An increase in BNP levels by more than 12% allowed diagnosing 
weaning failure from cardiac origin with a sensitivity of 76% and a specificity of 
78%, with the pulmonary artery catheter as a reference method (32). Mekontso 
Dessap and colleagues showed that a BNP-guided fluid management strategy was 
associated with a shorter duration of mechanical ventilation, especially in patients 
with left ventricular systolic dysfunction (33). In conclusion, changes in BNP levels 
are a reliable and feasible alternative to the pulmonary artery catheter for diagnosing 
weaning-induced pulmonary edema. A passive leg raising before the SBT has also 
been suggested to identify weaning failure patients related to cardiac dysfunction 
(34). Recently, Dres and colleagues developed an algorithm for management of 
weaning failure from cardiac origin (27).
Table 1. Respiratory effects of a spontaneous breathing trial.
Resp rate
(/min)
Vt 
(ml)
Edi
(µV)
ΔPes
(cmH2O)
ΔPga
(cmH2O)
ΔPdi
(cmH2O)
PEEPi
(cmH2O)
WOB
(J/L)
PaO2
(mmHg)
PaCO2
(mmHg)
PS * 34 211 20 12 1 13 5 1.0 75 56
5 min 36 246 48 25 1 26 10 2.1 61 56
10 min 37 260 43 24 2 26 9 2.0
60 min 23 352 52 30 2 32 10 2.6 70 57
Successful spontaneous breathing trial in a COPD patient despite an increase in PEEPi and 
WOB. Abbreviations: Edi = electrical activity of the diaphragm; PaCO
2 
 = arterial carbondi-
oxide partial pressure;  PaO
2
 = arterial oxygen partial pressure; Pdi = transdiaphragmatic 
pressure; PEEPi = intrinisic positive end-expiratory pressure; Pes = esophageal pressure; Pga 
= gastric pressure; Resp rate = respiratory rate; Vt = tidal volume; WOB = work of breathing. 
* PS = 5 cmH
2
O, PEEP = 10 cmH
2
O
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Table 2. Cardiovascular effects of a spontaneous breathing trial. 
SvO2
(%)
PCWP
(mmHg)
PAP
(mmHg)
ABP
(mmHg)
CVP
(mmHg)
HR
(/min)
SpO2
(%)
PaO2
(mmHg)
CO
(L/min)
BNP
(pg/mL)
Lactate
(mmol/L)
PS * 64 22 27/45 (35) 59/124 (79) 15 63 94 75 5.3 1358 1.0
5 min 62 23 27/40 (33) 67/158 (97) 11 68 92 61 6.4
60 min 65 25 25/42 (34) 70/163 (100) 10 70 94 70 6.3 1450 1.1
Succesfull spontaneous breathing trial in a COPD patient with a normal cardiavasular re-
sponse. Abbreviations: ABP = arterial blood pressure; BNP = B-type natriuretic peptide; CO 
= cardiac output; CVP = central venous pressure; HR = heart rate; PaO
2
 = arterial oxygen 
partial pressure; PAP = pulmonary artery pressure; PCWP = pulmonary capillary wedge pres-
sure; SvO
2
 = mixed venous oxygen saturation. * PS = 5 cmH
2
O, PEEP = 10 cmH
2
O 
Cognitive dysfunction 
A serious and frequent psycho-organic disorder in critically ill patients is delirium. 
Critically ill patients with a delirium have a 7 times higher risk of prolonged mechan-
ical ventilation (35). Moreover, it was found that delirium was associated with more 
respiratory and neurologic complications and a reduced probability of successful 
extubation (36). The CAM-ICU is a validated tool to detect delirium (37). Besides 
delirium other psychological factors may play a role in weaning failure. It should 
be recognized that the inability to communicate physical and emotional needs, and 
ventilator-dependence cause mental stress and contribute to weaning failure (38). 
Depressive disorders are associated with weaning failure as well (39). Consultation of 
a psychiatrist is reasonable when a psychological disorder is suspected.
Endocrine and metabolic disorders
The role of endocrine dysfunction in weaning failure has never been systematically 
evaluated, but is most likely of limited importance. Hypothyroidism and adrenal 
insufficiency should be excluded in case of clinical suspicion, as treatment options are 
available. Malnutrition frequently occurs in critically ill patients and is associated with 
higher mortality (40), but also with reduced muscle mass and as such contributes to 
difficult weaning, as discussed above. 
Iatrogenic factors
The role of the clinician in weaning is crucial, in particular the assessment whether the 
patient still requires ventilator support. In patients with unplanned extubation only 
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44% required reintubation (41). When unplanned extubation occurred during the 
weaning phase, only 30% required reintubation. Patients with successful unplanned 
extubation during weaning phase spent less time on weaning the ventilator (41). In 
a large clinical trial comparing weaning methods performed in a long-term weaning 
facility (42), 32% of the patients passed the initial screening weaning trial. This 
indicates that these patients were already weaned upon arrival in this weaning 
facility, although this was unrecognized by the referring ICU team. These studies 
stress the importance to screen patients for readiness for weaning and extubation. 
Appropriate tests for weaning readiness have recently been reviewed elsewhere (43). 
Under certain conditions there may be a role for automated weaning (44). 
 Asynchrony between the patient and ventilator is associated with increased 
duration of weaning (45) and even mortality (46). Although it is reasonable to aim 
for optimal patient-ventilator interaction, no studies have been performed to study 
the effect on weaning outcome. 
Therapeutic consequences
Once a specific reason for weaning failure has been identified, the clinician should 
develop a strategy that increases the chances of successful weaning. 
Respiratory mechanics
In patients with elevated airway resistance bronchodilators should be administered. 
Under certain conditions (malpositioning, granulation tissue) the tracheostomy 
can enhance airway resistance (47). Specifically adapted tubes may be required. In 
patients with impaired respiratory compliance it is often obvious how mechanics 
can be improved, such as evacuation of pleural fluid or ascites, diuretics to achieve 
negative fluid balance in case of chest-wall or pulmonary edema (48). 
Respiratory muscle dysfunction 
Disuse is a prominent risk factor for the development of respiratory muscle weakness 
as pointed out above. Therefore, it is reasonable to limit the duration of respiratory 
muscle inactivity, by using assisted modes for ventilation. Future studies should 
determine the optimum time point for initiation of assisted ventilation and the level 
of unloading of the inspiratory muscles. 
 Respiratory muscle strength training seems as a reasonable intervention in weak 
patients. Most experience for respiratory muscle training has been obtained in 
patients with COPD. For instance in a randomized controlled trial (N=33; not on 
the ventilator) inspiratory muscle strength training improved respiratory muscle 
strength, 6-minute walking distance and reduces dyspnea sensation, compared to 
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sham training (49). Very few studies have been performed in ventilated patients. 
The best evidence up to now comes from Martin and colleagues, demonstrating 
that inspiratory muscle training in long-term ventilated patients improves muscle 
strength and the chances of successful weaning (50). Although many questions 
remain concerning optimal timing and protocol (51), initiation of inspiratory muscle 
training appears reasonable in weak ventilated ICU patients difficult to wean from 
the ventilator. 
 In contrast to cardiac muscle dysfunction, no drug is approved to optimize 
respiratory muscle function. However, some small pilot studies demonstrate 
that respiratory muscle contractility can be enhanced pharmacologically (52). 
Levosimendan is a relatively novel cardiac inotrope that improves calcium sensitivity 
of the contractile proteins. In healthy subjects levosimendan improves contractile 
efficiency of the respiratory muscles (53). A clinical trial in difficult to wean patients 
is currently conducted (NCT01721434). Anabolic hormones that directly enhance 
contractile protein synthesis are another potentially interesting strategy to enhance 
respiratory muscle function. In a randomized controlled trial Schols demonstrated 
that nandrolone together with high caloric feeding enhances respiratory muscle 
strength in patients with COPD participating in a rehabilitation program (54). The 
effect of anabolic steroids on peripheral or respiratory muscle strength in difficult to 
wean ICU patients has not been investigated and the routine use is not recommended 
today.
Cardiac dysfunction 
Routsi evaluated the effects of nitroglycerin infusion on hemodynamics and weaning 
outcome in difficult to wean patients with COPD and arterial hypertension (55). 
In these patients, nitroglycerin had beneficial hemodynamic effects during a 
spontaneous breathing trial, including reduction in pulmonary capillary wedge 
pressure, right ventricular stroke work index and improved venous oxygen saturation. 
Moreover, whereas all patients (12) failed a weaning trial under control conditions, 
92% successfully completed the SBT under nitroglycerin infusion. In patients with 
overt heart failure inotropes could be considered, despite the absence of strong 
evidence. Levosimendan has been shown to improve cardiac output and reduce 
pulmonary capillary wedge pressure and clinical outcome in patients with acute heart 
failure (56, 57). The effects of levosimendan on weaning outcome was evaluated in 
a small pilot study, including 12 patients with systolic heart failure (left ventricular 
ejection fraction 28% ± 5%) (58). After levosimendan infusion 7 of the 12 patients 
were weaned from mechanical ventilation within 51 hours of treatment. Although 
there is a strong rationale for inotropes in patients with heart failure that are difficult 
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to wean from the ventilator, clinical studies should confirm the favorable effect on 
outcome. 
Cognitive dysfunction 
Reducing the level of sedation has been shown to reduce duration of mechanical 
ventilation (59). More recently, in a propensity score analysis Lonardo demonstrated 
that the use of propofol instead of benzodiazepines reduced duration of mechanical 
ventilation and mortality in a heterogeneous group of patients (60). Among 
other factors, it should be recognized that benzodiazepines are associated with 
the development of delirium (61). In addition, benzodiazepines adversely affect 
sleep architecture as assessed by polysomnography in weaning patients (62). In 
patients with confirmed depressive disorder that affect weaning, treatment with 
psychostimulants may be considered (63). 
Endocrine and metabolic disorders
The role of thyroid hormone replacement therapy in difficult to wean patients 
has not been systemically evaluated. However, suppletion of thyroid hormone in 
patients with proven hypothyroidism is reasonable (64). Huang and colleagues have 
demonstrated that in patients with confirmed adrenal insufficiency treatment with 
hydrocortisone fastens weaning from the ventilator (65). No specific nutritional 
therapy has been shown to improve weaning outcome. 
Conclusion
The pathophysiology of weaning failure is complex and requires a systematic 
differential diagnostic approach to identify the primary cause for weaning failure. 
Several tools and techniques are available to discriminate between these causes. 
Identification of the cause of weaning failure allows specific treatment and thereby 
may fasten liberation from mechanical ventilation.
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Abstract
Background: Respiratory muscle dysfunction is an important cause for difficult 
weaning from mechanical ventilation. Today, several studies have evaluated 
inspiratory muscle function in weaning patients. Although the expiratory muscles 
play an important role in breathing, in particular in patients with inspiratory muscle 
weakness or high breathing effort, the role of the expiratory muscles during weaning 
in ICU patients has not been studied in detail. The current physiological study aims 
to compare the recruitment of the inspiratory muscles and expiratory muscles during 
weaning. 
Methods: Twenty-one adult patients receiving pressure support ventilation underwent 
a spontaneous breathing trial (T-tube with supplemental oxygen) of maximal 1 hour. 
During the trial flow, gastric pressure, esophageal pressure and diaphragm electrical 
activity were recorded continuously. Transdiaphragmatic pressure, neuromechanical 
efficiency of the diaphragm, pressure-time product of the inspiratory muscles and 
expiratory muscles were calculated.
Results: Ten patients failed the spontaneous breathing trial. In the weaning failure 
group diaphragm electrical activity was higher (71 %; p<0.05) and neuro-mechanical 
efficiency of the diaphragm was lower (41 %; p<0.05). In the failure group the 
contribution of the expiratory muscles to total respiratory muscle effort increased 
up to 26±4 % during spontaneous breathing compared to 10±3 % in the weaning 
success group (p<0.05).
Conclusions: The expiratory muscles significantly contribute to respiratory muscle 
effort in critically ill patients who fail a trial of spontaneous breathing. In addition, 
our findings confirm that impaired pressure-generating capacity of the diaphragm, 
regardless of its origin, plays a central role in failure to wean from mechanical 
ventilation.
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Introduction 
Prolonged weaning from mechanical ventilation is associated with increased 
morbidity and mortality (1-3), and therefore, successful extubation is a crucial step 
for critically ill patients. However, approximately 6-15% of mechanically ventilated 
patients experience prolonged weaning (1-4). A major determinant of weaning 
failure is respiratory muscle dysfunction (5, 6). The respiratory muscles, in particular 
the diaphragm, are profoundly affected by critical illness and mechanical ventilation 
(7-13). Only a few days of controlled mechanical ventilation is associated with a 
decline in diaphragmatic pressure generating capacity (10). In particular with 
increased respiratory load, diaphragm weakness may result in failure to wean from 
mechanical ventilation (14). 
 Detailed analysis of diaphragm function by recording diaphragm electromyography 
(EMGdi) and transdiaphragmatic pressure (Pdi) during a spontaneous breathing trial 
(SBT) may help to understand the role of diaphragm dysfunction in patients who 
fail to wean from mechanical ventilation. These measurements allow calculation of 
the so-called neuromechanical efficiency (NME) of the diaphragm, i.e. the ability 
of the diaphragm to convert neural input into mechanical output (15). Recordings 
of esophageal pressure (Pes) also allows in depth analysis of respiratory mechanics 
and muscle effort (16, 17). Gastric pressure (Pga) is used to calculate Pdi and also 
the recruitment of the abdominal muscles during expiration. Expiratory muscle 
recruitment may be a mechanism for offsetting the effects of increased load on a 
weak diaphragm and to decrease end-expiratory lung volume to limit hyperinflation 
(18). In patients with chronic obstructive pulmonary disease (COPD) expiratory muscle 
recruitment has been demonstrated during weaning failure (19, 20). However, it 
is unknown to what extent expiratory muscle recruitment contributes to total 
respiratory muscle effort in weaning patients.
 Accordingly, the aim of the current physiological study was to compare the 
recruitment of the inspiratory muscles and expiratory muscles in weaning success 
and weaning failure. Additionally, we performed detailed analysis of respiratory 
mechanics in these patients. 
Methods 
Study design and population
This cross-sectional physiological study was conducted in the intensive care unit 
(ICU) of the Radboud university medical center Nijmegen, the Netherlands. Twenty-
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one adult patients receiving invasive mechanical ventilation for at least 3 days and 
considered ready for a spontaneous breathing trial were recruited. The decision to 
extubate or resume mechanical ventilation was made solely by the clinical team, 
who were blinded to the study data. Exclusion criteria were a medical history of 
neuromuscular disorders, upper airway or esophageal pathology (e.g. recent surgery, 
esophageal varices, diaphragmatic hernia) and recent (< 1 month) nasal bleeding.
 The protocol was approved by the local ethics review committee (approval 
number: 2010-058) and conducted in accordance with the Declaration of Helsinki 
and its later amendments. Written informed consent was obtained from patients 
who did not have a multi-electrode esophageal catheter with two balloons in situ 
prior to the start of the study.
Study protocol
All patients were ventilated with the Servo-i ventilator (Maquet Critical Care, Sölna, 
Sweden). If not already in situ, a multi-electrode esophageal catheter with two 
balloons (NeuroVent Research Inc, Toronto, Canada) was inserted nasally. Catheter 
characteristics and positioning techniques have been described previously (15, 21, 
22). Next, 10 minutes of pressure support ventilation (PSV) was recorded with an 
inspiratory support level of 8 cmH
2
O and a positive end-expiratory pressure (PEEP) 
level of 5 cmH
2
O. Subsequently, a spontaneous breathing trial, using a T-tube 
with supplemental oxygen, was performed for up to 60 minutes, according to our 
clinical protocol. The criteria for weaning failure were tachypnea (> 35 breaths 
/ min), low arterial oxygen saturation (< 90%), tachycardia (> 140 beats / min), 
hypertension (systole > 180 mmHg), hypotension (systole < 90 mmHg), agitation, 
diaphoresis, and anxiety during the SBT. Patients were extubated after a successful 
SBT. Weaning failure was defined as a unsuccessful SBT, or reintubation within 48 
hours after extubation. Arterial blood samples were collected before disconnection 
from the ventilator and at the end of the SBT before reinstitution of ventilator 
support.
Data acquisition 
Flow was measured with a Fleisch pneumotachograph (Hans Rudolph, Kansas City, 
MO, USA) placed at the endotracheal tube or cannula. The pneumotachograph was 
connected to a differential pressure transducer (range ± 50 kPa, Freescale, Tempe, AR).
 Esophageal pressure (Pes) and gastric pressure (Pga) were obtained using two thin-
walled balloons filled with air attached on the esophageal catheter. The balloons 
were connected to two differential pressure transducers (range ± 50 kPa, Freescale, 
Tempe, AR). Pressure signals from the transducers were digitized (Porti 16, 22 bits, 
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1.4 µV/least significant bit, TMSi; The Netherlands) at a sampling frequency of 100 
Hz. Pdi was calculated as Pes subtracted from Pga. 
 EMGdi signals recorded from the electrodes on the esophageal catheter were 
amplified and digitized (Porti 16, 22 bits, 71.5 nV/least significant bit, TMSi; the 
Netherlands) at a sampling frequency of 2 kHz. EMGdi signal processing from 
the multiple electrodes was performed according to the method of Sinderby and 
colleagues (23-25). 
 Flow, Pes, Pga and EMGdi were acquired synchronously using dedicated software 
(NeuroVent Research Inc, Toronto, Canada) and stored on a hard disk for offline analysis 
in a software routine developed for Matlab (R2014b, The Mathworks, Natick, MA).
Physiological measurements
Inspiratory time (Ti), expiratory time (Te), total respiratory cycle time (Ttot) and 
respiratory rate were derived from the flow signal. Tidal volume (Vt) was calculated 
as the integral of inspiratory flow.
 ΔPes was calculated as the difference between the start of decrease in Pes and the 
negative peak value of Pes during inspiration. ΔPga was calculated as the difference 
between the start of increase in Pga and the positive peak value of Pga during 
inspiration. ΔPdi was calculated as the difference between the start of increase 
in Pdi and the positive peak value of Pdi during inspiration. ΔPes and ΔPga were 
corrected for the rise in expiratory gastric pressure (ΔPga
exp
)  in the preceding breath, 
as described previously (20). ΔPga
exp
 was calculated as the rise in gastric pressure 
from end-inspiration to the start of decrease in Pes (i.e. start of inspiration). PEEPi 
was calculated as the rise in Pdi until start of inspiratory flow and thus corrected 
for a drop in gastric pressure at start of inspiration. The Gilbert index, a measure 
of relative contribution of the diaphragm to inspiratory pressure, was calculated as 
ΔPga / ΔPdi. Dynamic lung compliance (Cdyn
L
) and inspiratory resistance of the lung 
and airways (Rinsp) were calculated as described previously (26).
 ΔEMGdi, an estimation of neural respiratory drive, was calculated as the peak 
root-mean-square of the EMGdi during inspiration. Center frequency of the EMGdi 
(CFdi), a measure of contractile fatigue of the diaphragm (27), was calculated using 
spectral analysis of the EMGdi. A detailed description of calculation of EMGdi and 
CFdi can be found in the work by Sinderby and colleagues (23-25, 28). NME was 
computed as  ΔPdi/ΔEMGdi.
 Effort of the inspiratory muscles was quantified by calculating the esophageal 
pressure-time product (PTPes) and work of breathing (WOB) during inspiration. PTPes 
was calculated as the time integral of the difference between Pes and the recoil 
pressure of the chest wall, as described previously (29, 30). WOB was calculated 
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as the integral of the product of Vt and Pes (i.e. the Campbell diagram) (31). PTP 
was partitioned in resistive, elastic and PEEPi components. A calculated theoretical 
value was used for the recoil pressure of the chest wall, as described previously (32). 
Effort of the expiratory muscles was quantified by calculating the gastric pressure-
time product (PTPga) during expiration. PTPga was calculated as the time integral of 
the rise in gastric pressure during expiration. Total PTP (PTPtot) for the respiratory 
muscles was calculated as PTPes + PTPga.
Data analysis
Data were analyzed on a breath-by-breath basis. For the period of mechanical 
ventilation, a 2-min period at the end was selected for analysis. The duration of the 
SBT differed per patient. Therefore, data were analyzed at seven points in time: the 
first and last minute and five periods of at least 1 min taken at equal time intervals 
in between.
 Statistical analyses were performed using IBM SPSS Statistics version 22 (IBM 
Corp., Armonk, New York, USA). First, to analyze the effect of removing ventilator 
assist, a paired student t-test (PSV vs. first minute of the SBT) was performed for the 
different physiological variables per group (weaning failure and weaning success). 
Second, we used a linear mixed model design and applied restricted maximum 
likelihood estimation to analyze the effect of SBT duration (seven points from minute 
one to the last minute) and SBT group (weaning failure and weaning success). Linear 
mixed models are well suited for the analysis of repeated measures. In contrast to 
repeated measures two-way ANOVA it preserves more information contained in the 
data, they account for correlations between the repeated measurements within each 
subject and they can handle missing data (33). Full-factorial models were built with 
duration and group treated as fixed effects and subjects as a random effect. The 
model was run using the compound symmetry covariance type for the repeatedly 
measured outcomes. Bonferroni corrected pairwise comparisons based on the 
estimated marginal means were used as post-hoc tests. To analyze the effect of the 
SBT on blood gas values and hemodynamics a repeated measures two-way ANOVA 
was performed. For all tests, a two-tailed p < 0.05 was considered significant. Data 
are described as mean ± SEM, except as stated otherwise. 
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Results
Ten patients met the criteria for weaning failure, six patients failed the SBT  after 30 ± 
6.5 minutes (range 13 – 60 minutes) and four were reintubated within 48 hours after 
extubation. Eleven patients successfully completed the 60 minute SBT and remained 
extubated for at least 48 hours. Patient characteristics and ventilator settings at study 
inclusion are presented in Table 1. ΔEMGdi, CFdi and ΔPdi of one patient in the 
weaning success group were excluded from analysis due to dislocation of the catheter 
during SBT. From another patient in the failure group ΔEMGdi and CFdi were excluded 
from analysis due to electrode artefacts detected during offline signal analysis.
Table 1. Patient characteristics
Diagnosis Age
(yr)
BMI
(kg/m2)
Sex Days 
MV
PSV level 
(cmH2O)
NAVA level
(cmH2O/µV)
PEEP level 
(cmH2O)
FiO2 PaO2/FiO2
(mmHg)
Failure group
1 Cardiac arrest 88 24 F 24 - 2.3 6 0.40 268
2 Pneumonia 64 22 F 49 10 - 6 0.30 328
3 Postoperative, CABG 72 27 F 83 10 - 8 0.40 194
4 Multitrauma 45 28 M 4 10 - 5 0.30 318
5 Exacerbation COPD 58 25 M 14 8 - 10 0.30 405
6 Postoperative, CABG 67 29 F 8 0 - 8 0.40 214
7 Postoperative, AAA 63 27 M 7 4 - 8 0.40 199
8 Postoperative, 
papillary muscle rupture
80 24 M 8 0 - 8 0.45 132
9 Guillain Barre 64 23 M 153 10 - 8 0.25 *
10 Cardiogenic shock 76 23 M 21 - 0.4 10 0.30 228
Success group
1 Tracheal stenosis (COPD) 69 25 M 7 14 - 3 0.45 190
2 Postoperative, aortoenteric 
fistula (COPD)
71 26 M 8 5 - 6 0.40 *
3 Sepsis 58 26 F 7 0 - 6 0.35 330
4 Postoperative, CABG 73 29 M 14 10 - 10 - *
5 Cardiac arrest 76 29 F 17 6 - 6 0.45 248
6 Postoperative, AAA 82 28 M 5 9 - 5 0.45 258
7 Sepsis 73 29 M 24 8 - 6 0.25 306
8 Multitrauma 46 25 M 9 0 - 5 0.30 *
9 Sepsis 63 24 F 7 0 - 8 0.30 *
10 Pneumonia 60 21 M 12 6 - 6 0.35 291
11 Postoperative, CABG 78 30 M 3 4 - 10 0.40 358
* patient without arterial line. AAA, abdominal aortic aneurysm; CABG, coronary artery 
bypass graft; COPD, chronic obstructive pulmonary disease; F, female; M, male; MV, me-
chanical ventilation.
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Ventilation, respiratory timing and mechanics
Variables of ventilation and respiratory time are listed in Table 2. Directly after the 
transition from PSV to spontaneous breathing there was a drop in V
T
 in both groups, 
thereafter V
T
 remained stable during the SBT. In both groups respiratory frequency 
and the ratio between respiratory frequency and V
T
 (i.e. an index of rapid shallow 
breathing) increased after removal of ventilator assist. However, in the failure group 
there was a further increase in respiratory frequency and rapid shallow breathing 
during the SBT whereas this was not observed in the success group. There were no 
significant differences in V
E
 over time and between groups.
 Values of PEEPi, Cdyn
L
 and Rinsp are listed in Table 2. In the failure group 
PEEPi increased after removal of ventilator assist, but during the SBT there were 
no differences between both groups. Directly after the transition from PSV to 
spontaneous breathing Cdyn
L
 decreased in the failure group, whereas it remained 
stable in the success group. Removal of ventilator assist resulted in an increase in 
Rinsp in both groups. During the SBT no changes in or differences between groups 
for both Cdyn
L
 and Rinsp were found.
Respiratory muscle activity
Figure 1 shows the activity of the inspiratory muscle and expiratory muscles for both 
the weaning success and weaning failure group. Removal of ventilator assist caused 
an immediate increase in ΔPdi, ΔPes and ΔEMGdi in both groups, whereas ΔPga
exp
 
and NME of the diaphragm did not change in the first minute after the removal of 
inspiratory support. 
 During spontaneous breathing, no significant interactions were seen between SBT 
duration and group for ΔPdi, ΔPes,  ΔEMGdi and NME. However, due to a higher 
ΔEMGdi, NME was lower in the weaning failure group compared to successfully 
extubated patients (Figure 1, panel D). In the failure group the activity of the expiratory 
muscles increased during spontaneous breathing, whereas it remained equal in the 
success group (Figure 1, panel E). The Gilbert index (ΔPga / ΔPdi) was higher in de 
success group compared to the failure group, indicating a greater contribution of the 
diaphragm to respiration.
 CFdi, a measure of muscle fiber conduction velocity, decreased during the SBT in 
both the success group and failure group (significant main effect duration, p = 0.002) 
from 89 ± 4 Hz to 81 ± 5 Hz and from 93 ± 2 Hz to 88 ± 2 Hz, respectively. There was 
no significant interaction between the main effects of duration and group on CFdi 
(p = 0.874).
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Table 2. Variables of ventilation, respiratory timing and mechanics during PSV and the SBT 
for the failure group and success group
PSV SBT start SBT end p value
main effect
duration 
p value
main effect
group
p value
interaction 
duration * group
VT 
(ml)
F 522 ± 49 * 367 ± 57 388 ± 65 0.866 0.715 0.424
S 486 ± 70 * 414 ± 62 413 ± 52
Peak insp. flow
(ml/s)
F 768 ± 72 * 619 ± 69 792 ± 106 < 0.001 0.444 0.002
S 714 ± 74 * 637 ± 81 650 ± 78
Freq. 
(breaths/min)
F 21.8 ± 2.8 * 26.2 ± 2.6 30.8 ± 2.6 0.007 0.772 0.012
S 24.9 ± 2.5 * 27.6 ± 2.8 28.0 ± 2.7
VE 
(L/min)
F 10.9 ± 1.3 9.3 ± 1.5 11.5 ± 1.9 0.039 0.836 0.297
S 11.5 ± 1.5 11.1 ± 1.6 11.6 ± 1.4
Ti
(s)
F 0.99 ± 0.11 0.87 ± 0.08 0.70 ± 0.06 < 0.001 0.101 < 0.001
S 0.95 ± 0.07 0.96 ± 0.08 0.96 ± 0.10
Te 
(s)
F 2.23 ± 0.36 * 1.78 ± 0.27 1.49 ± 0.18 0.122 0.679 0.099
S 1.76 ± 0.24 * 1.48 ± 0.19 1.47 ± 0.16
Ttot 
(s)
F 3.22 ± 0.45 * 2.65 ± 0.32 2.19 ± 0.23 0.024 0.814 0.020
S  2.71 ± 0.29 * 2.44 ± 0.25 2.43 ± 0.24
Ti/Ttot F 0.32 ± 0.02 0.35 ± 0.02 0.33 ± 0.02 0.375 0.029 0.727
S 0.37 ± 0.02 * 0.41 ± 0.02 0.40 ± 0.02
Freq./VT
(breaths/min/L)
F 46 ± 9 * 84 ± 13 101 ± 17 0.016 0.395 0.001
S 61 ± 9 * 78 ±10 78 ± 10
PEEPi
(cmH2O)
F 2.3 ± 0.9 * 4.6 ± 1.2 5.0 ± 1.5 0.654 0.250 0.802
S 2.0 ± 0.5 2.8 ± 0.8 3.4 ± 0.9
CdynL 
(ml/cmH2O)
F 48.9 ± 8.0 * 33.6 ± 5.3 31.7 ± 7.6 0.508 0.664 0.691
S 41.8 ± 4.9 40.8 ± 9.0 35.9 ± 7.4
Rinsp
(cmH2O/L/s)
F 8.2 ± 2.5 * 15.3 ± 3.0 16.0 ± 2.7 0.926 0.909 0.545
S 7.3 ± 1.1 * 14.4 ± 2.5 15.9 ± 3.3
Note that only data at start and end of the SBT is shown and not the time intervals in be-
tween. * p < 0.05 PSV vs. SBT start (student t-test). p
 
values in table reflect results during 
the SBT (linear mixed model). Cdyn
L
, dynamic lung compliance; PEEPi, positive end-expirato-
ry pressure; PSV, pressure support ventilation; F, weaning failure group; S, weaning success 
group; Rinsp, inspiratory resistance ;SBT, spontaneous breathing trial; Te, expiratory time; Ti, 
inspiratory time; Ttot; total respiratory cycle time; V
E
, minute ventilation; V
T
, tidal volume. 
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Figure 1. ΔPdi, ΔPes, ΔEMGdi, NME, ΔPga
exp
 and the Gilbert index during PSV and the SBT for 
the weaning success and weaning failure group. After removal of ventilator assist ΔPdi, ΔPes 
and ΔEMGdi
 
increased in both groups (* p < 0.05 PSV vs. start SBT). During the SBT there was 
a significant main effect of duration (p = 0.047) on ΔPes (panel B) , a significant main effect of 
duration (p = 0.039) and group (p = 0.047) on ΔEMGdi (panel C), a significant main effect of 
group (p = 0.033) on NME (panel D), a significant main effect of duration (p = 0.013) on ΔPga
exp
 
(panel E) and a significant main effect of group (p = 0.020) on the Gilbert index (panel F). # 
p < 0.05 Bonferroni corrected pairwise post-hoc comparisons. EMGdi, diaphragm electromy-
ography; NME, neuromechanical efficiency; Pdi, transdiaphragmatic pressure; Pes, esophageal 
pressure; Pga, gastric pressure; ΔPga
exp
, expiratory rise in gastric pressure; PSV, pressure support 
ventilation; SBT, spontaneous breathing trial. 
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Respiratory muscle effort
Figure 2 (panel A) shows the inspiratory muscle effort. PTPes was equal during PSV 
for both groups. There was initial and parallel significant increase in PTPes in both 
groups after removal of ventilator assist. During the SBT there were no effects of 
duration or group on PTPes. In addition, there were no differences between the 
PEEPi, elastic and resistive components of PTPes. 
 Figure 2 (panel B) shows the expiratory muscle effort. The transition from PSV to 
spontaneous breathing had no effect on PTPga. However, during the SBT there was 
an significant interaction between duration of the SBT and group, indicating that the 
increase in PTPga in the failure group was significantly higher than in the success 
group. Figure 3 shows an representative example of increasing expiratory rise in 
Pga during the SBT. Moreover, as can be seen in Figure 4, in the failure group the 
contribution of the expiratory muscles to total respiratory muscle effort increased 
from 15 ± 4 % to 26 ± 4 % during spontaneous breathing, whereas there were no 
changes in the success group. 
Figure 2. Inspiratory muscle effort 
(panel A) and expiratory muscle effort 
(panel B) during PSV and SBT for the 
weaning success and weaning failure 
group. After removal of ventilator as-
sist PTPes increased in both groups (* 
p < 0.05 PSV vs. start SBT). During the 
SBT there were no effects of duration 
and group on PTPes. For PTPga, how-
ever, there was a significant main ef-
fect of duration (p = 0.012) and the 
interaction between the effects of 
duration and group (p = 0.044). # p 
< 0.05 Bonferroni corrected pairwise 
post-hoc comparison. Note that only 
data at start and end of the SBT is 
shown and not the time intervals in 
between. PEEPi, positive end-expira-
tory pressure; PSV, pressure support 
ventilation; PTPes, esophageal pres-
sure-time product; PTPga, gastric 
pressure-time product; SBT, sponta-
neous breathing trial.
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 Inspiratory WOB during PSV was 9.8 ± 2.7 J/min in the success group and 8.8 ± 
2.4 J/min in the failure group, which increased to 14.4 ± 3.3 J/min (p = 0.003) and 
15.7 ± 3.9 J/min (p < 0.001 ), respectively, after removal of ventilator assist. Although 
WOB at the end of the SBT was 17.1 ± 3.8 J/min for the success group and 23.7 ± 
9.5 J/min for the failure group, these differences did not reach statistical significance. 
Arterial blood gas measurements
In Table 3, the blood gas values are presented. There were significant main effects of 
time point and group on PaCO
2
, such that PaCO
2 
increased over time during the SBT 
and was higher in the failure group. However, the interaction between the effects of 
time point and group was not significant, indicating that the increase in PaCO
2 
was 
not different between both groups. 
Table 3. Blood gas values and hemodynamic variables before and after the SBT for the 
failure group and the success group.
PSV SBT end p value
main effect
time point
p value
main effect
group
p value
interaction 
time point * group
PaO2 (mmHg) F 95 ± 9 103 ± 16 0.735 0.930 0.522
S 102 ± 7 99 ± 9
PaCO2 (mmHg) F 46 ± 3 50 ± 4 0.021 0.046 0.187
S 38 ± 1 40 ± 2
pH F 7.42 ± 0.02 7.40 ± 0.02 0.013 0.228 0.471
S 7.45 ± 0.01 7.44 ± 0.01 
MAP (mmHg) F 87 ± 7 89 ± 8 0.903 0.579 0.281
S 96 ± 10 94 ± 9
Heart rate F 84 ± 6 87 ± 8 0.228 0.571 0.505
S 81 ± 4 82 ± 3
MAP, mean arterial pressure; PSV, pressure support ventilation; F, weaning failure; S, wean-
ing success; SBT, spontaneous breathing trial. 
Discussion
The present study is the first that provides an in depth analysis of the recruitment and 
effort of respiratory muscles during inspiration and expiration in a heterogeneous 
group of weaning patients. We found that after removal of ventilator assist, patients 
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Figure 3. Individual example of increasing expiratory rise in Pga during the SBT. Note that 
the increase in gastric pressure during expiration caused by the expiratory muscle exceeds 
the increase in gastric pressure during inspiration caused by the diaphragm. PSV, pres-
sure support ventilation; Pes, esophageal pressure; Pga, gastric pressure; SBT, spontaneous 
breathing trial.
Figure 4. The contribution of the expiratory muscles to total respiratory muscle effort 
during PSV and the SBT for the weaning success and weaning failure group. During the SBT 
there was a significant main effect of duration (p = 0.011) and group (p = 0.038) and a sig-
nificant interaction between the effects of duration and group (p = 0.028) on PTPga/PTPtot. 
# p < 0.05 Bonferroni corrected pairwise post-hoc comparison. PTPga, gastric pressure-time 
product; PTPtot, total pressure-time product; SBT, spontaneous breathing trial.
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who fail a trial of spontaneous breathing progressively developed an increase in 
expiratory muscle effort up to 26% of total respiratory muscle effort at the end 
of the trial, while expiratory muscle effort in the success group remained stable. 
Furthermore, the failure group has a lower neuro-mechanical efficiency of the 
diaphragm on PSV and during SBT compared to successful weaning patients. 
Expiratory muscle effort
Respiratory muscle effort during the breathing cycle can be quantified using the 
pressure-time product, i.e. the time integral of the difference between esophageal 
pressure and the recoil pressure of the chest wall (29, 30). In experimental studies, 
changes in PTPes have been shown to reflect a comparable change in diaphragmatic 
energy expenditure (34, 35). After removal of ventilator assist we found an increase 
in PTPes, but no differences were found between the success group and failure 
group. However, under conditions of increased loading and/or impaired diaphragm 
function, expiratory muscles may be recruited during expiration (18). Indeed, in the 
present study expiratory muscle activity, as indicated by an expiratory rise in Pga, 
increased in the failure group during the SBT. This is consistent with previous findings 
in patients with COPD (19, 20). Expiratory muscle recruitment will increase the 
energy expenditure of respiration. Notably, in healthy subjects, it was demonstrated 
that expiratory pressure generation is a significant contributor to the perception of 
dyspnoea during exercise (36). Therefore, the expiratory component should be taken 
into account when calculating total respiratory muscle effort. In the present study, 
we introduce the expiratory pressure-time product, i.e. the time integral of the rise 
in gastric pressure during expiration and calculated the contribution of the expiratory 
muscles to total respiratory muscle effort. Remarkably, in the weaning failure group, 
the contribution of the expiratory muscles to total respiratory muscle effort increased 
up to 26%, whereas it remained stable in successfully extubated patients. 
 It has been reasoned that the goal of expiratory muscle recruitment is to assist 
the inspiratory muscles by decreasing end-expiratory lung volume (18, 37). However, 
PEEPi (corrected for the expiratory rise in Pga) in the current study, a surrogate of 
end-expiratory lung volume, was not lower in the failure group compared to the 
success group. On the contrary, PEEPi tended to be higher in the failure group. In 
addition, there were no improvements in NME of the diaphragm during the SBT in the 
failure group that would support a beneficial effect of expiratory muscle recruitment 
on inspiratory muscle function. In COPD patients it has also been demonstrated 
that phasic contraction of the expiratory muscles does not increase NME of the 
diaphragm (37). Our findings raise the possibility that expiratory muscle recruitment 
might not support the inspiratory muscles, but instead contributed to weaning 
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failure. However, one could also argue that NME and PEEPi would have been worse 
at the end of the SBT in the failure group if expiratory muscles would not have 
recruited. Whether increased expiratory muscle effort contributes to weaning failure 
or prevents higher inspiratory muscle effort should be investigated in subsequent 
studies. 
Neuromechanical efficiency of the diaphragm 
As expected, after removal of ventilator assist both ΔPdi and ΔEMGdi increased in 
the success group and the failure group. There was no difference between groups 
for the increase in ΔPdi and ΔEMGdi, but there was a clear baseline difference 
in ΔEMGdi before and during the SBT. Consequently, NME of the diaphragm was 
constantly lower in patients who failed a trial of spontaneous breathing (± 0.4 cmH
2
O/
µV) compared to the success group (± 0.7 cmH
2
O/µV). In healthy subjects NME is 
approximately 1.4 cmH
2
O/µV (15), thus NME is approximately 30 % and 50 % of 
normal in patients who fail a SBT and successfully extubated patients, respectively. To 
our knowledge, there are no other studies that continuously measured NME during a 
T-tube trial using Pdi and EMGdi. Previously, NME has been calculated intermittently 
during a 30-minute weaning trial as the decrease in airway pressure divided by 
ΔEMGdi during an inspiratory occlusion (38). In the latter study, the weaning trial 
was performed with 5 cm H
2
O of continuous positive airway pressure (CPAP). The 
addition of 5 cm H
2
O of PEEP can decrease work of breathing by as much as 40% in 
ventilated patients (30). Despite different methods of weaning trials and calculation 
of NME, the finding of reduced ability of the diaphragm to convert neural respiratory 
drive into inspiratory pressure is consistent in patients who fail a weaning trial.
 Undoubtedly the reduced NME we found in both groups is partly due to weakness 
of the diaphragm. Over the last years evidence of diaphragm weakness in critically ill 
patients has accumulated (7, 9-13). However, the pressure-generating capacity of the 
diaphragm also depends on muscle fatigue, and the force-velocity and force-length 
relations. These factors may play an important role during a spontaneous breathing 
trial. We did not find any evidence for short-lasting fatigue of the diaphragm, as 
expressed by center frequency of the diaphragm EMG. In addition, previously it was 
demonstrated that a one hour SBT did not cause long-lasting fatigue of the diaphragm 
(39). Increased end-expiratory lung volume may have placed the diaphragm in a 
less favourable length-tension curve. An increase in lung volume from functional 
residual capacity to total lung capacity reduces Pdi by 60% for a given ΔEMGdi (40). 
Although we did not measure end-expiratory lung volume, corrected PEEPi was not 
significantly higher in the failure group, suggesting no major differences in lung 
volume. Overall, the reduced neuromechanically efficiency in the failure group may 
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largely be explained by diaphragmatic weakness, but we cannot completely rule out 
impaired respiratory mechanics. 
In the present study, increased respiratory muscle effort (including expiratory muscle 
effort) and reduced neuromechanical efficiency of the diaphragm appear to play a role 
in failure to wean from mechanical ventilation. However, it is important to note that 
reduced respiratory muscle capacity and increased respiratory load are not the only 
causes of failure to wean from mechanical ventilation. Cardiac dysfunction, cognitive 
dysfunction and metabolic disorders are recognized causes for weaning failure as well 
(5, 6) and may have contributed to weaning failure in the current study.
Limitations
In the present study, raw EMGdi signals were recorded from multiple esophageal 
electrodes and processed according to the method of Sinderby and colleagues using 
an in-house developed algorithm (21, 23-25). Today many studies record electrical 
activity of the diaphragm not in its raw format (EMGdi), but as a processed signal via 
the neurally adjusted ventilatory assist module of the Servo-i ventilator. Differences 
between algorithms to process EMGdi can lead to differences in absolute ΔEMGdi. 
Therefore, values of ΔEMGdi (and NME) obtained in our study cannot be directly 
compared to values obtained with recordings of electrical activity of the diaphragm 
from the Servo-I ventilator. 
 We did not record EMG of the abdominal muscles in the current study to detect 
expiratory muscle recruitment. However a high correlation has been demonstrated 
between the increase in gastric pressure during expiration and electrical activity of 
the abdominal wall muscles (41).
In conclusion, the expiratory muscles significantly contribute to respiratory muscle 
effort in a mixed group of critically ill patients who fail a trial of spontaneous 
breathing. Therefore, the expiratory pressure-time product should be measured 
when estimating energy expenditure of the respiratory muscles during weaning from 
mechanical ventilation. In addition, our findings confirm that impaired pressure-
generating capacity of the diaphragm, regardless of its origin, plays a role in failure 
to wean from mechanical ventilation.
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Abstract
Background: Assessment of diaphragmatic effort is challenging especially in critically 
ill patients in the phase of weaning. Fractional thickening during inspiration assessed 
by ultrasound has been used to estimate diaphragm effort. It is unknown whether 
more sophisticated ultrasound techniques such as speckle tracking are superior in 
the quantification of inspiratory effort. This study evaluates the validity of speckle 
tracking ultrasound to quantify diaphragm contractility.
Methods: Thirteen healthy volunteers underwent a randomized stepwise threshold 
loading protocol of 0 to 50% of the maximal inspiratory pressure. Electric activity of 
the diaphragm and transdiaphragmatic pressures were recorded. Speckle tracking 
ultrasound was used to assess strain and strain rate as measures of diaphragm 
tissue deformation and deformation velocity, respectively. Fractional thickening 
was assessed by measurement of diaphragm thickness at end-inspiration and end-
expiration. 
Results: Strain and strain rate increased with progressive loading of the diaphragm. 
Both strain and strain rate were highly correlated to transdiaphragmatic pressure 
(strain R2=0.72; strain rate R2=0.80) and diaphragm electric activity (strain R2=0.60; 
strain rate R2=0.66). 
Conclusion: Speckle tracking ultrasound is superior to conventional ultrasound 
techniques to estimate diaphragm contractility under inspiratory threshold loading.
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Introduction
Under physiological conditions, the pressure developed by the inspiratory muscles 
is only ±5% of maximum inspiratory pressure (1). However, under pathological 
conditions, such as an acute exacerbation of chronic obstructive pulmonary disease 
or a failed trial of weaning from mechanical ventilation, the load imposed on the 
respiratory muscles increases considerably (2, 3). Excessive inspiratory muscle 
loading may result in fatigue or injury of the diaphragm (4-6). Accordingly, in 
selected patients evaluating respiratory muscle effort may be of clinical relevance (7, 
8). Today, measurement of transdiaphragmatic pressure (Pdi) using esophageal and 
gastric balloons is the gold standard to assess effort of the diaphragm. However, this 
technique is invasive, requires expertise and interpretation may be complex (7, 9). 
Diaphragmatic function has been studied by B-mode and M-mode ultrasound (10-
12). Fractional thickening (FT) of the diaphragm has been used in previous studies 
to quantify effort of the diaphragm (11, 13, 14). However, Goligher et al. reported 
low correlations (R2=0.28) in healthy subjects between Pdi versus diaphragmatic 
thickening fraction (15), indicating limited validity of FT to quantify diaphragm effort. 
Two-dimensional deformation ultrasound or speckle tracking (ST) ultrasound is an 
innovative ultrasound technique enabling distinct assessment of muscle function (16). 
The grey value pattern in ultrasound images remains relatively constant for any small 
region in muscle tissue, this is called a speckle. In the speckle tracking technique, a 
defined cluster of speckles is tracked from one frame to another during a contractile 
cycle. This enables the angle-independent, two-dimensional quantification of the 
percentage of deformation (strain, %) and deformation velocity (strain rate, sec-1). 
For readers with additional interest in basic deformation imaging methodology we 
may humbly refer to the references of Collier et al and Smiseth et al (17, 18).
 Speckle tracking echocardiography has become a popular tool for both research 
and clinical purposes (16, 19-21). Previously, we have demonstrated the feasibility 
of ST of the diaphragm during respiratory muscle unloading with non-invasive 
ventilation (22). ST has not been validated as a measure of diaphragm contractility 
using Pdi as a gold standard. We hypothesize that strain and strain rate, obtained 
by ST, can be used to quantify diaphragm contractility during inspiratory loading and 
this study aims to investigate the validity of these parameters. Part of this work has 
previously been presented at the international conference of the European Respiratory 
Society (23).
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Materials and methods
Subjects
We enrolled 15 healthy volunteers with a body mass index less than 25 kg/m2. The 
study was conducted at the Radboud university medical center and the protocol 
was approved by the local ethics review committee and conducted in accordance 
with the Declaration of Helsinki and its later amendments. All subjects gave their 
written informed consent. Pre-existent neuromuscular disorders or lung diseases 
were defined as exclusion criteria.
Measurements
A multi-electrode esophageal catheter with two balloons (NeuroVent Research Inc, 
Toronto, Canada) was inserted and the balloons were inflated with air as described 
previously (24, 25). The flow, electric activity of the diaphragm (EAdi), esophageal 
pressure (Pes), and gastric pressure (Pga) were recorded continuously (25). EAdi 
signals were amplified and digitized (Porti 16, 22 bits, 71.5 nV/least significant bit, 
TMSi; The Netherlands) at a sampling frequency of 2 kHz. Pressure signals and flow 
were digitized (Porti 16, 22 bits, 1.4 µV/least significant bit, TMSi; The Netherlands) 
at a sampling frequency of 2 kHz. Data were stored and buffered on an external 
drive for offline analysis. Transdiaphragmatic pressure (Pdi) was calculated as Pes 
subtracted from Pga. Tidal volume (V
T
) was obtained by digital integration of the flow 
signal. Diaphragm ultrasound was performed using a 9 MHz linear transducer with 
a Vivid E 9TM ultrasound machine (General Electric Healthcare, Horton, Norway).
Study protocol
The protocol starts with the measurement of maximum inspiratory pressure (MIP). 
The mean mouth pressure (Pmo) during sustained maximum inspiration for 1 second 
as recommended by the ATS/ERS statement on respiratory muscle testing (9) against 
a closed valve at functional residual capacity is defined as the MIP. The maneuver 
is repeated at least five times, until three reproducible efforts, with less than 10% 
variance, are obtained. Subjects were seated in upright position. 
Inspiratory loading
An in-house developed inspiratory threshold apparatus, modified from Chen et al. 
(26) was used to perform negative pressure threshold loading. In short, the device 
consisted of a cylindrical adjustable pressure chamber, which was connected to a non-
rebreathing valve. The negative pressure was generated by a powerful commercially 
available vacuum cleaner. Pressure in the chamber was measured continuously using 
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a differential pressure transducer (range ± 375 mmHg; Freescale, USA). The dead 
space of the device can be estimated around 600 ml. Subjects were seated in upright 
position with uncast abdomen, breathing through a mouthpiece while wearing a 
nose clip. Inspiratory loading of 0 , 10, 20, 30, 40 and 50% of MIP was applied 
in random order. Every loading task was applied for 3 minutes, alternated with 5 
minutes of unloaded breathing. During the loading tasks, EAdi, Pes, Pga, Pmo and 
flow were recorded continuously (Figure 1). 
Ultrasound recording
The ultrasound transducer was positioned in the right anterior axillary line longitudinal 
to the body axis (between the 9th-11th intercostal space) (Figure 2 upper panel). We 
chose the strongly longitudinal approach versus the individual intercostal space to 
reduce angle-dependence of the measurements. The hemi-diaphragm is thereby 
displayed above the liver as a central less-echogenic layer between the peritoneal 
and pleural echogenic layer (Figure 2 upper panel). The region of interest (ROI) was 
positioned as described below during the offline data analysis (Figure 2 lower panel). 
This probe position was marked on the skin for the purpose of standardization (14). 
Ultrasound recordings of the diaphragm were made at the final minute of every 
inspiratory loading task. A 10 second recording with the highest possible frame rate 
was used for offline analysis. Strain describes the relative change in length between 
an initial reference state (L
0
) and compressed/shortened state (L). The conventional 
strain is defined as: ɛ = (L-L
0
)/L
0
. Positive strain means stretching, whereas negative 
strain means shortening. An increase of strain, as described in the following data 
presentation, refers to a more negative value of strain, thus an increase of shortening; 
e.g. -10 to -15 % corresponds to an increase of strain (or shortening). 
 Strain rate indicates the rate of deformation as follows: ɛ´ = dɛ/dt. Strain rate is an 
instantaneous measurement not requiring a relation to a reference state. 
Data analysis
EAdi, Pes, Pga, Pdi, Pmo and flow were analyzed offline using algorithms developed 
in Matlab R2013a (The Mathworks, Natick, MA). EAdi refers to a method using a 
standard electrode, acquisition, and analysis system to overcome signal filtering and 
processing effects when quantifying the diaphragm, as described previously (25). 
Pes at end-expiration was calculated as a measure of lung volume, and corrected for 
active expiration (27). The recorded ultrasound data were analyzed offline with the 
speckle tracking technique using the 2D – Strain modality of EchoPac®’s Q-analysis 
tool (software version BT 12, General Electric Healthcare, Horton, Norway). 
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Figure 1. The figure shows a representative tracing of EAdi, flow, Pdi, Pes, Pga and Pmo 
during inspiratory threshold loading (20% of maximal inspiratory pressure, random subject). 
Shaded areas are inspiration. EAdi, electrical activity of the diaphragm; Pdi, transdiaphrag-
matic pressure; Pes, esophageal pressure; Pga, gastric pressure; Pmo, mouth pressure.
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Figure 2. Upper panel (A): B-mode picture of a scanned diaphragm area between chest 
wall and liver. The arrows indicate the diaphragm between to hyperechoic lines, which are 
the equivalent to the border between diaphragm/pleura and peritoneum. Note the grey 
“dots” inside the diaphragm (“speckles”). Lower panel (B): region of interest tracked by the 
software.
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Although the GE software is designed to trigger by the ECG signal by default, the cine-
loops were adjusted to one entire breathing cycle based upon simultaneous recorded 
respiratory curves. The software allows for manually moving the loop to the desired 
cycle resulting in an adequate measurement, independant of the cardiac cycle. The 
ROI was placed at the lower echogenic line (peritoneal line) to the upper echogenic 
line (pleural line) starting at the right side of the sector (cranial) and ending at the left 
sector side (caudal) with approximately 5 to 7 points (Figure 2 lower panel). In some 
loops, especially in the higher loading steps (40% and 50 % MIP), several attempts of 
ROI placement were necessary to achieve proper tracking. Here, fewer points with a 
narrower ROI had to be selected to allow adequate tracking. In general, these offline 
measurements can be finished in several minutes. 
 FT was also calculated from the ultrasound images. In the 2D image, 
diaphragmatic thickness at end-expiration and end-inspiration was measured at 
the same point following the longitudinal downward motion of the respective 
location. FT was measured at minimum in three different breaths and calculated 
by the following equation: (thickness at inspiration - thickness at expiration)/
thickness at expiration. The quality of the recorded loops varied in some volunteers 
depending on the load and general movement of the thorax especially in high 
loading steps. Loops were discarded from the analysis if no sufficient border 
tracking could be developed.
Statistical analysis
Values are presented as mean ± SD, and p<0.05 was considered significant. Statistical 
analyses were performed with SPSS 21.0 (SPSS, Chicago, IL). Repeated measures 
one-way ANOVA was used to test the effect of inspiratory loading on EAdi, Pes at 
end-expiration, Pdi, strain, strain rate and FT. Correlations between EAdi, Pdi, FT and 
strain and strain rate were assessed using repeated observations correlation (28, 29). 
This method accounts for multiple measurements within subjects, by removing the 
differences between subjects and looking only at changes within subjects.
Results
Subjects
All included subjects (baseline characteristics: male/female, 7/8; age, 21.3 ±2.3 yr; 
21.6 ±1.7 kg/m2) completed the protocol without adverse effects. Two data sets 
were lost from analysis due to technical issues (file damage). Mean MIP value for the 
group was 100 ± 32 cmH
2
O.
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Physiological measurements
Mean mouth pressure for all subjects was -1.2 ±0.4, -13.7 ±4.6, -26.3 ±7.6, -37.9 
±11.7, -49.9 ±14.3 and -59.7 ±16.9 cmH
2
O for 0 to 50% inspiratory loading 
respectively. The stepwise increase of inspiratory loading resulted in an increase 
in both Pdi and EAdi (Figure 3). Pdi increased from 14.3 ±5.9 cmH
2
O at unloaded 
breathing via the mouthpiece to 60.8 ±24.4 cmH
2
O at 50% loading. Likewise, EAdi 
increased from 20.3 ±11.3 µV at zero loading to 66 ±23.2 µV at 50% loading. Pes at 
end-expiration decreased from -3.7 ± 3.7 cmH
2
O at zero loading to -6.0 ±5.3 cmH
2
O 
at 50% loading (p=0.03). There were no changes in V
T
 and respiratory frequency 
during the different inspiratory loading steps (Table 1).
Table 1. Response in tidal volume and respiratory frequency to the different loading steps. 
Data are shown as means and standard deviation for all subjects. P-value is given of repeat-
ed measures one-way ANOVA.
Inspiratory loading (% MIP)
0 10 20 30 40 50 p-value
VT (ml) 1076 ± 350 1183 ± 427 1147 ± 425 1053 ± 346 1049 ± 418 936 ± 329 0.161
Resp. frequency (breaths/min) 13.5 ± 4.2 15.3 ± 4.4 15.6 ± 5.4 16.7 ± 6.1 16.1 ± 5.7 17.3 ± 5.7 0.133
 
MIP, maximal inspiratory pressure; V
T
, tidal volume
Table 2. Thickness of the diaphragm at end-expiration, end-inspiration and thickening frac-
tion. Data are shown as means and standard deviation for all subjects. The bottom line 
shows the values for the repeatability coefficient of the measurements.
Inspiratory loading
(% MIP)
End-expiration 
thickness (mm)
End-inspiration 
thickness (mm)
Thickening 
fraction (%) 
0 2.4 ± 0.7 3.8 ± 1.2 59.9 ± 32.1
10 2.4 ± 0.6 4.0 ± 1.5 67.9 ± 35.0
20 2.6 ± 0.5 4.1 ± 1.7 55.0 ± 39.2
30 2.6 ± 0.7 3.9 ± 1.8 48.9 ± 34.7
40 2.5 ± 0.6 4.0 ± 1.4 61.5± 48.1
50 2.4 ± 0.7 3.6 ± 1.4 50.6± 46.7
Repeatability coefficient 1.07 mm 2.54 mm 85.2%
MIP, maximal inspiratory pressure
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Figure 3. Upper 4 panels: mean with SD of EAdi, Pdi, strain and strain rate as function of 
inspiratory loading (%MIP) for all subjects. Repeated measures one-way ANOVA showed a 
significant effect of increased loading on all variables (p<0.001). Lower 2 panels: individual 
data of all subjects, strain and strain rate as function of inspiratory loading (%MIP). EAdi, 
electrical activity of the diaphragm; MIP, maximal inspiratory pressure; Pdi, transdiaphrag-
matic pressure.
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Ultrasound assessment
In all assessable datasets, a ROI could be tracked in the offline ultrasound analysis 
during diaphragm contraction and relaxation. Table 2 shows the thickness of the 
diaphragm at end-expiration, end-inspiration and thickening fraction, as well as the 
repeatability coefficients. Repeated measures one-way ANOVA showed that with 
increasing load both strain and strain rate increased (p<0.001). Strain increased from 
-22 ±7.6% at zero loading to -41.5 ±10.1 at 50% loading. Consistent with strain, 
strain rate increased from -0.48 ±0.2 s-1 at zero loading to -1.5 ±0.7 s-1 at 50% 
loading (Figure 3). 
 Strain and strain rate were both significantly correlated with EAdi and Pdi. Strain 
versus EAdi showed a correlation of R2=0.60 (p<0.0001), while strain versus Pdi data 
showed a correlation of R2=0.72 (p<0.0001). Correlations between strain rate and 
Pdi (R2=0.80, p<0.0001) and between strain rate and EAdi (R2=0.66, p<0.0001) were 
even higher than reported for strain (Figure 4). 
Figure 4. Correlation of Pdi and EAdi vs. strain and strain rate for all subjects during inspira-
tory loading from 0-50%. EAdi, electrical activity of the diaphragm; Pdi, trandiaphragmatic 
pressure.
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 Diaphragm thickness during zero loading was 2.4 ±0.7 mm and 3.8 ±1.2 mm 
during end-expiration and end-inspiration, respectively, and did not change during 
inspiratory loading (Table 2). Consequently, FT was not affected by incremental 
inspiratory loading (p=0.70). Also, no significant correlations between EAdi and 
FT (p=0.790) and between Pdi and FT (p=0.495) as well as between FT and strain 
(p=0.654) and strain rate (p=0.364) were found.
Discussion
The present study is the first to evaluate speckle tracking ultrasound of the diaphragm 
during inspiratory muscle loading. We found that the ST parameters strain and 
strain-rate are highly correlated with Pdi, the gold standard for diaphragmatic 
contractility, and also with EAdi. Strain rate had the highest correlation with Pdi and 
EAdi. Furthermore, ST proved to be superior to diaphragm fractional thickening as 
assessed by conventional ultrasound to quantify diaphragmatic effort. 
Validation of the physiological model
Two methods for loading of the diaphragm have been described in the literature: 
inspiratory threshold loading and inspiratory resistive loading. The load imposed 
by the latter method is highly dependent on the inspiratory flow generated by the 
subject; low flow will result in minimal loading. We used a threshold load, as this 
may best reflect loading in intensive care patients where elastic properties of the 
respiratory system are increased due to pulmonary edema, chest-wall edema and 
pleural fluid. Our set up for inspiratory threshold loading was modified from Chen 
et al (26). Figure 1 shows a representative example of one subject at loading of 
10% of MIP. It should be noted that at 0% inspiratory loading Pdi, EAdi, V
T
 and TF 
were higher than expected for a healthy subject (25). This is most likely the result of 
the additional resistance and instrumental dead space imposed by the experimental 
device. As expected, increasing the inspiratory load as a percentage of MIP, resulted 
in an increase in Pdi (Figure 3). 
Speckle tracking ultrasound of the diaphragm
Tracking of unique greyscale scatter patterns, ‘speckles’, is one of the most useful tools 
in cardiac imaging, to assess cardiac function and is closely correlated to contractile 
myocardial function and outcome (16, 21, 30, 31). These speckle patterns are the 
ultrasonic correlate of interferences of ultrasound inside the tissue, i.e. different tissue 
patterns (muscle fibers, epimysium, etc.) and their movement towards each other. 
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Movement of speckle patterns reflects myofibrils/muscle tissue during its contraction, 
although speckles do not represent specific single myofibrils. It is important to mention 
that strain and strain rate approximate contractile function, but are not equal to 
contraction (32, 33). 
 Software tools to derive deformation data out of 2- or 3-dimensional ultrasonic cine 
loops are usually designed to track speckles in between endomyocard and epimyocard as 
hyperechoic leading structures. The parameters strain and strain rate define different, but 
load dependent variables: muscle deformation (strain) and deformation velocity (strain 
rate) can be inferred. Importantly, in contrast to conventional ultrasound techniques 
this measure is probe angle independent, which is of fundamental importance if the 
diaphragm is investigated. An important advantage of ST is, compared to conventional 
ultrasound, that the ST software recognizes the same region of the diaphragm. A 
limitation is that defining ROIs and the software calculations are based on an algorithm 
patented by GE, which is not open to the public.
 Within the current study, we did not assess intra- and interobserver variability. This 
has been extensively evaluated by Orde et al (34). That study demonstrated that ST of 
the right diaphragm is feasible and reproducible (34). Diaphragm images were recorded 
from the end of expiration through the end of inspiration at 60% maximal inspiratory 
capacity. The current study is the first to demonstrate that diaphragm strain and strain 
rate are highly correlated with Pdi, the gold standard for diaphragm effort. In addition, 
a high correlation was found between these two ST measures and EAdi.
Fractional thickening during inspiratory loading
Diaphragm FT during inspiration as a measure for loading has been studied previously 
(15, 35-37). Umbrello et al. found that diaphragm thickening is a reliable indicator 
of respiratory effort (35) and Vivier et al. found as well a parallel decrease in TF and 
the diaphragmatic pressure-time product per breath during noninvasive ventilation 
with increasing levels of support (37). Goligher et al. (15) reported a rather low but 
significant correlation (R2 0.3; P<0.01) for FT versus both Pdi and EAdi in healthy 
subjects (N=5) (15). In the current study no significant correlation between FT and Pdi 
or EAdi was found. To evaluate if insufficient ultrasound training in our investigators 
contributed to this discrepancy, the repeatability coefficient of thickness at end-
expiration was calculated, as this measure is unaffected by our loading protocol (Table 
2). This demonstrates that the relatively high variation in FT in the present study is 
mainly due to the variation in thickness at end-inspiration, but also the repeatability at 
end-expiration in our study was relatively high compared to the study by Goligher et 
al. (15) (1.07 mm vs. 0.2 mm in the current study and the Goligher study respectively).
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 Another possible explanation for the apparent discrepancy with Golighers study 
is the difference in inspiratory loading protocol used. In their study, thickness was 
measured at different lung volumes, whereas in our study, inspiratory threshold 
loading was imposed, while volume was kept more or less constant (Table 1) which 
may have important implications. Lastly, the current study is  a single point study 
and not a follow-up study where patients are ventilated; our population consists of 
healthy, not ventilated subjects, which also may account for the discrepancy with 
Golighers study. In a study by Cohn (38) healthy subjects were instructed to target 
specific lung volumes up to total lung capacity. A non-linear relationship was found 
for FT versus lung volume (polynomial equation was calculated with a R2 of 0.99). As 
subjects were instructed to keep the glottis open, the diaphragm was active at the 
targeted lung volumes, thus changes in diaphragm thickness resulted from changes 
in volume and pressure. When thickness is measured at different lung volumes with 
closed glottis (diaphragm relaxed), volume affects diaphragm thickness only at lung 
volume >50% of vital capacity (15). Finally, Ueki (39) measured diaphragm during 
maximal inspiratory effort against a closed valve (isovolumetric). They reported a 
strong correlation between maximum inspiratory pressure and diaphragm FT (R2 
= 0.67). The relationship between isometric inspiratory pressure and FT was not 
systematically studied. 
 Apparently, the relationship between diaphragm thickness and effort (Pdi, EAdi), 
is complex and depends among possible other factors on the pressure developed, 
lung volume and thoracic cage configuration (15, 38, 39), which may explain the 
poor or absent correlation between FT and Pdi in the studies discussed. Because 
chest cage configuration was not controlled in this study, we can however not derive 
any conclusions about the influence of the chest cage configuration on the relation 
between diaphragm thickness and effort.
 The strong correlation between Pdi and strain as well as strain rate in the current 
study indicates that speckle tracking ultrasound derived parameters may provide 
good estimation of diaphragm effort, at least under inspiratory threshold loading. 
The performance of speckle tracking ultrasound under different loading conditions 
(isometric contractions, high inspiratory volume) remains to be evaluated. 
Future perspectives and clinical implications
Regarding deformation analysis of the diaphragm, the software deriving the ST data 
has to be adapted to diaphragmatic ultrasonic morphology allowing quick, easy 
and reproducible analysis, preferably on-site. The offline setting of the actual data 
analysis is currently the only way to ensure proper data analysis, which hampers its 
use as bedside tool. In echocardiography most vendors provide a simplified software 
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tool for ST allowing measurements on site. 
 Only a few days of controlled mechanical ventilation is associated with atrophy 
of the diaphragm (40, 41). The reduction in diaphragm force, assessed by bilateral 
magnetic stimulation of the phrenic nerves, is approximately 30% in the first 5-6 days 
of invasive mechanical ventilation, indicating the rapid development of diaphragm 
weakness (42). In spite of the growing evidence that diaphragm weakness develops 
in critically ill patients and contributes to weaning failure and thus prolonged 
ventilation (42-44), respiratory muscle function is poorly monitored in these patients. 
Importantly, current state of the art techniques for monitoring, such as EAdi and Pdi, 
are invasive, not widely available and interpretation may be rather complex (7). An 
ideal assessment of diaphragm function must be available at bedside, fast and easy 
to acquire and allow standardized quantification. Guiding of ventilator weaning, 
assessing diaphragm contractile force during spontaneous breathing trials and/or 
pressure support ventilation might allow to adapt ventilation and weaning protocols 
individually. Both sufficient loading and prevention of excessive loading are decisive 
for weaning success. ST of the diaphragm might serve as diagnostic tool that can 
provide direct inside in diaphragm activity and force generation.
In conclusion, speckle tracking ultrasound as a non-invasive technique can be used 
to detect stepwise increases of diaphragmatic effort. Deformation (strain) and 
deformation velocity (strain rate) were highly correlated with transdiaphragmatic 
pressure and electric activity of the diaphragm. Speckle tracking ultrasound might 
serve as reliable tool to guide weaning at the bedside in the future.
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Abstract
Introduction: Delivering synchronous assist during non-invasive ventilation (NIV) is 
challenging with flow or pressure controlled ventilators, especially in patients with 
chronic obstructive pulmonary disease (COPD). Neurally adjusted ventilatory assist 
(NAVA) uses diaphragm electrical activity (EAdi) to control the ventilator. We evaluated 
patient-ventilator interaction in patients with COPD during NIV with pressure support 
ventilation (PSV) and NAVA using an recently introduced  automated analysis. 
Methods: Twelve COPD patients underwent three 30-min trials: 1) PSV with 
dedicated NIV ventilator (NIV-PSV
Vision
), 2) PSV with ICU ventilator (NIV-PSV
Servo-I
), and 
3) with NIV-NAVA. EAdi, flow, and airway pressure were recorded. Patient-ventilator 
interaction was evaluated by comparing airway pressure and EAdi waveforms 
with automated computer algorithms. The NeuroSync index was calculated as the 
percentage of timing errors between airway pressure and EAdi.
Results: The NeuroSync index was higher (larger error) for NIV-PSV
Vision
 (24 [15-30] 
%) and NIV-PSV
Servo-I
 (21 [15-26] %) compared to NIV-NAVA (5 [4-7] %; p <0.001). 
Wasted efforts, trigger delays and cycling-off errors were less with NAVA (p <0.05 for 
all). The NeuroSync index and the number of wasted efforts were strongly correlated 
(r2=0.84), with a drastic increase in wasted efforts after timing errors reach 20%. 
Conclusions: In COPD patients, non-invasive NAVA improves patient-ventilator 
interaction compared to PSV, delivered either by a dedicated or ICU ventilator. 
The automated analysis of patient-ventilator interaction allowed for an objective 
detection of  patient-ventilator interaction during NIV. In addition, we found that 
progressive mismatch between neural effort and pneumatic timing is associated with 
wasted efforts. 
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Introduction
Non-invasive ventilation (NIV) plays an important role in managing patients with 
acute respiratory failure, in particular in patients with chronic obstructive pulmonary 
disease (COPD). In patients with acute hypercapnic exacerbation of COPD, NIV 
improves outcome (1-3). Accordingly, NIV utilization has increased over time among 
patients hospitalized for acute exacerbation of COPD, whereas the need for intubation 
has declined (2). Despite these positive reports, some patients treated with NIV fail 
and require invasive mechanical ventilation (3, 4). Poor patient-ventilator interaction 
may contribute to NIV failure (5, 6). Delivering synchronous non-invasive assist is 
challenging with flow or pressure controlled systems (7), especially when using 
excessively leaky or highly compliant interfaces (8). Using ventilators not dedicated 
to NIV, up to 46% of patients exhibit severe asynchrony (9). The introduction of 
dedicated NIV ventilators and NIV algorithms in ICU ventilators improved patient-
ventilator interaction, yet their performance varies and the inherent limitations of 
using flow or pressure to control assist remain (10). 
 As recommended (11, 12), patient-ventilator interaction can be evaluated by using 
the diaphragm electrical activity (EAdi) (13). Besides its monitoring capabilities, EAdi 
is used during neurally adjusted ventilatory assist (NAVA) as a controller signal for 
ventilatory assist (14). Recent studies in heterogeneous groups of critically ill patients 
show that non-invasive NAVA (NIV-NAVA) improves patient-ventilator interaction 
relative to non-invasive pressure support ventilation (NIV-PSV) (15-18). 
 To our knowledge, there are no studies of patient-ventilator interaction strictly in 
COPD patients receiving NIV-NAVA, while these patients are more likely to exhibit 
severe patient ventilator asynchrony (19). In addition, no study has used the EAdi 
signal to evaluate patient-ventilator interaction with dedicated NIV ventilators. 
Moreover, a new automated analysis method has recently been introduced in this 
journal for quantifying patient-ventilator interaction in a standardized fashion (20). 
This automated analysis allows detection of asynchronies, such as wasted efforts, 
but also makes it easy to detect the more subtle dyssynchronies, such as trigger 
delays and cycling-off errors. The present study is the first to use this analysis method 
to quantify patient-ventilator interaction during non-invasive ventilation.
 For the above-stated reasons, the aim of present study was to evaluate patient-
ventilator interaction, using an automated analysis, in COPD patients with NIV-PSV 
delivered by a dedicated NIV ventilator, and NIV-PSV and NIV-NAVA delivered by an 
ICU ventilator.
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Materials and methods
Study subjects
Adult patients with acute respiratory failure and a medical history of COPD, admitted 
to the ICU for non-invasive ventilation were eligible for inclusion in the study. 
Patients with a known neuromuscular disorder,  severe hypoxemic failure (PaO
2
/FiO
2
 
<100 mmHg), or hemodynamic instability requiring high dose norepinephrine (>0.5 
µg/kg/min) were excluded. The study was approved by the ethical committee of 
the Radboud University Medical Center (NL33351.091.11) and is in accordance with 
the ethical standards laid down in the 1964 Declaration of Helsinki and its later 
amendments. All patients gave their informed consent prior to the study.
Study design
All patients undergoing NIV in our hospital receive a nasogastric tube to allow 
adequate feeding and prevent gastric hyperinflation. COPD patients undergoing 
NIV receive a nasogastric tube with a multiple array of electrodes placed at the 
distal end (NAVA catheter, 12 French; Maquet Critical Care, Solna, Sweden). Correct 
positioning was established by use of dedicated software. After enrollment and 
clinical stabilization, each patient received three 30-min ventilation protocols in the 
following order:
(1) Pressure support ventilation with the BiPAP Vision (Philips Respironics, Best, The 
Netherlands), a dedicated NIV ventilator, with pressure support and positive end 
expiratory pressure (PEEP) levels set by the treating physician (NIV-PSV
Vision
).
(2) Pressure support ventilation with the Servo-I (Maquet Critical Care, Solna, Sweden, 
NIV software v3.0), an ICU ventilator with NIV algorithm, with similar PEEP and 
pressure support levels (NIV-PSV
Servo-I
). 
(3) NAVA with the Servo-I (Maquet Critical Care, Solna, Sweden, NIV software 
v3.0), where NAVA level was adjusted to match peak pressure of NIV-PSV, using 
manufacturer supplied software (NIV-NAVA). 
BiPAP Vision uses the Auto-Trak Sensitivity algorithm to trigger and cycle off the 
ventilator and cannot be set individually. With NAVA, the back-up mode for triggering 
was set at flow triggering. In order to reduce the amount of leak on ventilator 
performance, we chose to use a tightly-fitted oro-nasal mask (Respironics PerforMax, 
Philips, Best, The Netherlands), a frequently used interface (21). Switching between 
ventilators required modifications in measurement setup and short disconnection of 
the patient from the ventilatory circuit. In order to minimize discontinuation of assist, 
the order of interventions were not randomized.
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 At the end of each ventilator mode, respiratory discomfort was scored by use of 
a Visual Analog Scale (from 0 mm [no discomfort] to 100 mm [maximal imaginable 
discomfort]) and arterial blood gas analysis was performed from an indwelling 
arterial line.
Data acquisition 
Flow, airway pressure (Paw) and EAdi were acquired from the serial port of the Servo-I 
at a sampling rate of 62.5 Hz and recorded using dedicated acquisition software 
(Neurovent Research Inc., Toronto, Canada). The BiPAP Vision does not have a data 
output port. Therefore, flow was acquired by placing a pneumotachograph (Fleisch 
no. 3, Phipps & Bird, Virginia, USA) between the airflow port of the ventilator and 
its tubing, and Paw was acquired by placing a connection piece between the end of 
tubing (after the leakage port) and face mask, connected to a pressure transducer 
(range ± 50 kPa, Freescale, Tempe, AR). Both Paw and flow were recorded at a 
sampling rate of 62.5 Hz and synchronized with the EAdi using dedicated acquisition 
software (Neurovent Research Inc., Toronto, Canada). 
Data analysis
Study parameters were calculated from a stable 5 minute period at the end of each 
mode on a breath-by-breath basis using a software routine developed for Matlab 
(Mathworks, Natick, MA). Measuring tidal volume by expiratory flow integration is 
not precise in the presence of leaks, therefore tidal volumes are not presented in the 
manscript. Neural respiratory rate was calculated as the number of EAdi peaks/min.
 Patient-ventilator interaction was evaluated by comparing Paw and EAdi 
waveforms with automated computer algorithms (20). Trigger and cycle-off error (i.e. 
dyssynchrony) were calculated as percentages of neural inspiratory and expiratory 
time periods, respectively. Events where EAdi and Paw were completely dissociated 
(i.e. asynchrony), such as wasted efforts, auto-triggering, multiple assist during EAdi 
peak (double triggering) and multiple EAdi peaks during assist, were assigned 100% 
error. To estimate the overall extent of asynchrony and dyssynchrony we calculated 
the NeuroSync index by averaging the percentage errors for all breaths.
 
Statistical analysis
The D’Agostino & Pearson test was used to test the normality of distribution. NIV-
PSV
Vision
, NIV-PSV
Servo-I
 and NIV-NAVA were compared using the Friedman test with 
Dunn’s post-hoc testing. Exponential regression analysis using an least squares fit was 
performed to test the relationship between the NeuroSync index and wasted efforts. 
A p value <0.05 was considered significant. Statistical analyses were performed with 
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Graphpad Prism 5 (Graphpad software, San Diego, CA, USA). Results are reported as 
median with interquartile ranges.
Results
Twelve patients (1 female / 11 male) were enrolled. One patient was excluded from 
the offline analysis due to an EAdi signal with a too low amplitude for automated 
patient-ventilator interaction analysis (20). Patient characteristics and ventilator 
settings are shown in Table 1 and 2, respectively. After study completion NIV failed 
in two patients and invasive ventilation was required.  From these two patients, one 
deceased. 
Breathing pattern and respiratory drive
Results for breathing pattern and respiratory drive are presented in Table 3. EAdi 
amplitude was higher with NIV-PSV
Servo-I
 compared to NIV-PSV
Vision 
(p <0.05). Peak 
airway pressure and peak flow were higher with NIV-PSV
Vision 
( p<0.05) compared to 
NIV-NAVA and NIV-PSV
Servo-I
. 
Patient - ventilator interaction
Figure 1 depicts median values for trigger delays and cycling-off error during each 
mode for all individual patients. NIV-NAVA showed lowest trigger delay compared 
to NIV-PSV
Vision 
and NIV-PSV
Servo-I
 (p <0.0001). NIV-PSV
Vision 
and NIV-PSV
Servo-I
 had 
comparable trigger delays, but NIV-PSV
Servo-I
 showed more early cycling-off (p <0.05). 
In absolute values, NIV-PSV
Vision 
(95 ± 22 ms)
 
and NIV-PSV
Servo-I
 (91 ± 19 ms) showed 
more cycling-off error compared to NIV-NAVA (12 ± 6 ms); p <0.05.
 Patient-ventilator interaction, calculated with the NeuroSync index, was 
significantly higher (larger error) with NIV-PSV
Vision
 (24 [IQR 15-30] %) and NIV-
PSV
Servo-I
 (21 [IQR 15-26] %) compared to NIV-NAVA (5 [IQR 4-7] %; p <0.001).
 Figure 2 depicts the correlation between the number of wasted efforts and the 
NeuroSync index. The relationship shows as timing errors progressively increased 
with NIV-PSV
Servo-I
 and NIV-PSV
Vision
a positive association with the number of wasted 
efforts, which was certainly more pronounced above 20% error. 
 For all three modes of NIV studied, Figure 3 shows a plot of the relative timing-
errors of triggering (Y-axis) versus the relative timing error for cycling-off (X-axis), for 
every breath, in all patients. Based on the data from Figure 2, we have inserted a box 
suggesting “acceptable” synchrony to be <20% of neural timings, whereas larger 
errors (> 20%) represent dyssynchrony. 
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In the form of a pie chart, Figure 4 plots the distribution of synchrony (<20% error, 
i.e. inside the box in Figure 3), dyssynchrony (>20% error, i.e. outside the box in 
Figure 3), and asynchronies for each mode. Wasted efforts were the most prevalent 
type of asynchrony and differed between ventilator modes (p <0.001). Post-hoc 
analysis indicated significantly more wasted efforts with NIV-PSV
Vision
 compared to 
NIV-NAVA. Other asynchronies, such as multiple EAdi during assist, double triggering 
and auto-triggering were uncommon. 
Blood gas values and respiratory discomfort
There were no differences in blood gas values (Table 4) and respiratory discomfort 
with NIV-PSV
Vision
 (45 [IQR 31-69] mm), NIV-PSV
Servo-I
 (60 [IQR 41-65] mm), and NIV-
NAVA (45 [IQR 33-75] mm). 
Table 1. Patient characteristics at study inclusion
# Age
(y)
BMI 
(kg/m2)
FEV1
(% pred.)
FVC
 (% pred.)
FEV1
/FVC
GOLD
class.
PF
 ratio
Reason for 
admission
Total NIV 
duration (days)
1 37 25 I 316 haemoptysis 5
2 74 23 I 308 exacerbation COPD 3
3 68 38 45 79 42 III 185 exacerbation COPD 3
4 67 34 69 98 70 II 176 pneumonia 4
5 67 27 72 100 53 II 180 exacerbation COPD 5
6 64 26 31 52 43 III 220 trauma 3
7 58 26 II 143 exacerbation COPD 6
8 70 28 67 90 55 II 215 post-op lobectomy 2
9 78 22 77 88 64 II 110 exacerbation COPD 3
10 75 17 23 61 28 IV 219 exacerbation COPD 1
11 76 25 62 101 45 II 246 exacerbation COPD 5
Recent lung function tests for patient 1, 2 and 7 were unavailable in our hospital, but 
clinical picture of these patients were consistent with COPD and patient correspondence 
stated a history of COPD . BMI = body mass index; FVC = forced vital capacity; FEV1 = forced 
expired volume in 1 second; GOLD class.= Global Initiative for Chronic Obstructive Lung 
Disease classification; PF ratio = PaO
2
/FiO
2
.
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Table 2. Ventilator settings 
Patient PS level
(cmH2O)
PS rise-
time (s)
PS cycle-off
(% peak flow)
NAVA level
(cmH2O/µV)
NAVA
trigger (µV)
PEEP 
(cmH2O)
FiO2
(%)
1 6 0.20 30 0.1 0.5 6 70
2 10 0.20 50 0.8 0.5 8 50
3 8 0.20 70 0.4 0.5 8 50
4 5 0.20 50 0.1 1.0 7 60
5 6 0.20 50 0.1 0.5 4 40
6 5 0.05 50 5.0 0.5 5 30
7 10 0.00 50 0.2 0.5 6 55
8 6 0.20 50 0.2 0.5 6 45
9 6 0.20 50 0.2 0.5 6 70
10 8 0.00 60 0.1 0.5 5 35
11 6 0.20 50 0.2 0.5 6 40
Pressure support (PS) levels and rise time hold for both ventilators, whereas cycle-off crite-
ria is only set for NIV-PSV
Servo-I
. The BiPAP Vision uses the Auto-Trak Sensitivity algorithm to 
trigger and cycle off the ventilator and cannot be set individually. PEEP and FiO
2
 were similar 
for all three ventilatory modes. FiO
2 
= inspired oxygen fraction; NAVA = neurally adjusted 
ventilatory assist; PEEP = positive end-expiratory pressure. 
Table 3. Breathing pattern and respiratory drive
NIV-PSVVision NIV-PSVServo-I NIV-NAVA
Peak EAdi (μV) 25.6 (18.6 - 43.5)* 34.7 (18.8 – 49.0) 23.8 (17.1 - 48.0) 
Peak airway pressure (cmH2O) 15.3 (13.0 - 18.5)*
# 12.5 (10.4 - 15.2) 12.9 (11.7 - 16.0) 
Inspiratory peak flow (L/min) 92.5 (72.1 - 110.0)*# 54.1 (46.8 - 63.2) 45.6 (38.7 - 61.1)
Neural resp. rate (breaths/min) 22.7 (17.6 - 27.0) 25.2 (18.5 - 28.2) 25.1 (18.3 - 31.7)
EAdi = electrical activity of the diaphragm; NAVA = neurally adjusted ventilatory assist; NIV 
= non-invasive ventilation; PSV = pressure support ventilation. * NIV-PSV
Vision
 vs. NIV-PSV
Servo-I
 
(p < 0.05), # NIV-PSV
Vision
 vs. NIV-NAVA (p < 0.05).
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Figure 1. Trigger delay (left) and cycling-off error (right) for the different ventilator modes. 
Y-axis for cycle-off error: positive values indicates late cycling-off, and negative values indi-
cate early cycling-off. * p < 0.05. NAVA = neurally adjusted ventilatory assist; NIV = non-in-
vasive ventilation; PSV = pressure support ventilation.
Figure 2. Correlation between the number of wasted efforts and the NeuroSync index. 
Note that for this regression analysis, the NeuroSync index was recalculated without wast-
ed efforts to avoid mathematically coupled variables, and is thus consequently primarily a 
measure of dyssynchrony (trigger and cycle-off errors). Accordingly this correlation shows 
that progressive dyssynchrony, increases the number of wasted efforts. NAVA = neurally ad-
justed ventilatory assist; NIV = non-invasive ventilation; PSV = pressure support ventilation.
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Figure 3. Breath density graph for relative trigger (Y-axis) and cycling-off (X-axis) errors, for 
all breaths in all patients, during each ventilator mode. The small white “box” in the center 
of each graph indicates the limit between synchrony (neural efforts matched to assist deliv-
ery with less than 20% error - inside the box) and dyssynchrony (neural efforts poorly relat-
ed to assist delivery, > 20% error - outside the box). These breath-density graphs show for 
NIV-NAVA a concentrated breath density in the center, which should be anticipated since 
it is driven by EAdi. With NIV-PSV
Vision
 and NIV-PSV
Servo-I
 breaths are more spread-out and 
have considerable proportions of dyssynchronous breaths compared to NIV-NAVA. NAVA = 
neurally adjusted ventilatory assist; NIV = non-invasive ventilation; PSV = pressure support 
ventilation.
Figure 4. Percentage of synchronous, dyssynchronous and asynchronous (wasted efforts, 
auto-triggering, multiple EAdi during assist, and multiple assist during EAdi) breaths for the 
different ventilator modes. NAVA = neurally adjusted ventilatory assist; NIV = non-invasive 
ventilation; PSV = pressure support ventilation. 
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Table 4. Blood gas values
NIV-PSVVision NIV-PSVServo-I NIV-NAVA
pH 7.38 (7.36 - 7.46) 7.38 (7.36 - 7.45) 7.38 (7.36 - 7.45)
PaO2 (mmHg) 92 (77 - 106) 105 (84 - 113) 95 (77 - 98)
PaCO2 (mmHg) 44 (39 - 64) 44 (33 - 59) 41 (32 - 60)
HCO3
-
 (mmol/L) 27 (23 - 32) 26 (21 - 31) 27 (22 - 30)
NAVA = neurally adjusted ventilatory assist; NIV = non-invasive ventilation; PSV = pressure 
support ventilation. 
Discussion
This study provides insight into the interaction between patient and ventilator during 
noninvasive ventilation with different types of ventilators and modes in patients with 
COPD. First, we show that neurally adjusted non-invasive ventilation synchronizes 
assist to inspiratory effort in patients with COPD, whereas dedicated NIV ventilator 
or ICU ventilator pressure support modes do not ensure acceptable patient-ventilator 
interaction in individual patients. Second, wasted efforts increase drastically after 
timing errors between EAdi and airway pressure reach 20%. Third, automated analysis 
of patient-ventilator interaction using computer algorithms allows objective detection 
of  patient-ventilator interaction during NIV. 
Patient-ventilator interaction
For effective unloading of the respiratory muscles with NIV, the ventilator should cycle 
in synchrony with the patient’s neural respiratory drive(5). Our results are consistent 
with previous studies that showed improved patient-ventilator interaction with neurally 
compared to pneumatically controlled mechanical ventilation(15-18), however several 
differences between these and the current study should be noted. First, we included 
only patients with COPD, which are more likely to exhibit poor patient-ventilator 
interaction (19). Second, dedicated NIV-NAVA and NIV-PSV software was used instead 
of software for invasive ventilation in the previous studies (16, 17). This is important 
as the software for invasive ventilation lacks leakage compensation thereby allowing 
auto-triggering at high leakage. Indeed, auto-triggering up to 6 breaths/min was 
found with NIV-NAVA using the invasive software (16), whereas we found only up 
to 1 breath/min. Third, a dedicated NIV ventilator was evaluated in the present study. 
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In bench-test comparisons, including the ventilator used in our study, PSV delivered 
by dedicated NIV ventilators allowed better patient-ventilator interaction than ICU 
ventilators with NIV algorithms (10, 22). Lastly, an automated analysis method for 
quantifying patient-ventilator asynchronies and the more subtle dyssynchronies was 
used (20), allowing a more objective detection of patient-ventilator interaction. 
 The present study showed a small trigger delay with NIV-NAVA, which substantially 
increased with NIV-PSV
Servo-I
 and NIV-PSV
Vision
. These findings agrees with previous work 
comparing NIV-PSV
Servo-I
 and NIV-NAVA (15), but was opposing previous bench-test 
showing longer trigger delay for NIV-PSV
Servo-I
 compared to NIV-PSV
Vision 
(22). NAVA 
triggers on the increase in EAdi and thus represents the duration to increase EAdi, 
to process the signal and to open the inspiratory valve. Our average trigger delay of 
about 50 ms with NIV-NAVA is in the range of previously reported for NIV-NAVA (15, 
16, 18). In contrast, pneumatic triggering is more complex and considerably affected 
by leakage, which can only partly compensated for by dedicated NIV algorithms (7). 
 Synchronized termination of assist is another key component to maintain good 
patient-ventilator interaction. As depicted in Figure 1, NIV-PSV
Vision
 showed large 
inter-subject variability in early and late cycling off, whereas NIV-PSV
Servo-I
 showed 
primarily early cycling-off. Cycling-off error in NIV-NAVA was negligible, which could 
be anticipated since its definition for cycling-off is similar to the algorithm used to 
quantify cycling-off error (70% of peak EAdi). These findings agree with previous 
suggestions that NIV-algorithms for ICU-ventilators tend to increase the incidence of 
premature cycling-off (7). 
 Wasted efforts are inspiratory efforts not rewarded by ventilatory assist, which can 
increase work of breathing (5, 6). In the present study, 4.3 % and 2.5 % of inspiratory 
efforts were unnoticed by the ventilator for NIV-PSV
Vision
 and NIV-PSV
Servo-I
, respectively. 
In contrast, NIV-NAVA effectively prevented wasted efforts, confirming previous 
studies (15, 16, 18). Furthermore, as depicted in Figure 2, we found that wasted 
efforts increase drastically after timing errors reach 20%. This  suggests that the limits 
of the NeuroSync index and the definition of  “acceptable” synchrony should be kept 
below 20%, as indicated by the centered boxes in Figure 3. 
Breathing pattern and respiratory drive
EAdi in the present study was higher with NIV-PSV
Servo-I
 compared to NIV-PSV
Vision
, which 
is difficult to explain. Lack of difference in blood-gases or respiratory rates contradict 
that increased EAdi with NIV-PSV was ventilation related. Premature cycling-off with 
NIV-PSV
Servo-I
 could be a probable cause for increased EAdi, since this results in unassisted 
inspiration in the last part of inspiration. It should also be noted that the design of the 
respiratory circuit and assist delivery of the BiPAP Vision is fundamentally different 
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from the Servo-I. For example, the BiPAP Vision system has a large intentional leakage. 
Consequently, from Ohm’s law it follows that higher flow is required to maintain the 
preset pressure level (Table 3). Higher flow might have resulted in higher CO
2
 clearance 
in the interface and upper airways and a consequent reduction in dead space leading 
to reduced respiratory drive.
Clinical implications
Good patient-ventilator interaction is one of the key factors for clinical success of 
NIV, thus solving poor patient-ventilator interaction in COPD patients is of potential 
clinical value. In our study, we demonstrate that progressive mismatch between 
timing of the patient’s neural drive and the response of the ventilator is associated 
with increased number of wasted efforts. It is tempting to speculate that improving 
synchrony between patient neural effort and ventilator assist improves outcome in 
COPD patients, but it should be noted that our study is a short-term physiological 
study performed in a centre with extensive experience in NIV, both with PSV and 
NAVA. In addition, an limitation of the present study is the limited number of patients 
which hamper drawing generalized conclusions.
 Differences in patient-ventilator interaction between ventilator modes did not affect 
blood gas values, in particular pH, and respiratory discomfort. In part, this results from 
the timing of study inclusion, after initial stabilization on NIV. At inclusion in the study, 
blood pH (around 7.38) already increased, making it more difficult to detect changes 
in pH and respiratory discomfort caused by different ventilator modes. In this context 
it should also be mentioned that NIV modes were not performed in a random order. 
Nevertheless, we performed our measurement after initial stabilization on NIV making 
it unlikely that the patients’ respiratory status was worse at the beginning of the study 
than at the end. Future studies, that randomize between NAVA and PSV at admission, 
are necessary to ascertain whether or not improved patient-ventilator interaction in 
the acute phase of NIV translates to better NIV outcomes.
Conclusions
Automated analysis of patient-ventilator interaction showed that non-invasive NAVA 
improves patient-ventilator interaction compared to PSV in COPD patients. Moreover, 
this is not different when PSV is delivered by a dedicated NIV ventilator. In addition, 
progressive mismatch between neural effort and pneumatic timing is strongly 
associated with the number of wasted efforts. Whether NAVA is more successful in 
correcting pH in patients with acute hypercapnic exacerbation of COPD should be 
addressed in future studies that randomize between NAVA and PSV at admission. 
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Abstract
Background: In ARDS patients, the use of assisted mechanical ventilation is subject 
of debate. Assisted ventilation has benefits over controlled ventilation, such as 
preserved diaphragm function and improved oxygenation. Therefore, higher 
level of ‘patient control’ of ventilator assist may be preferable in ARDS. However, 
assisted modes may also increase the risk of high tidal volumes and lung-distending 
pressures. The present study aims to quantify how differences in freedom to control 
the ventilator, affect lung protective ventilation, breathing pattern variability, and 
patient ventilator-interaction. 
Methods: Twelve ARDS patients were ventilated in randomized order with assist 
pressure control ventilation (PCV), pressure support ventilation (PSV) and neurally 
adjusted ventilatory assist (NAVA). Transpulmonary pressure, tidal volume, diaphragm 
electrical activity and patient-ventilator interaction were measured. Respiratory 
variability was assessed using the coefficient of variation of tidal volume.
Results: During inspiration, transpulmonary pressure was slightly lower with NAVA 
(10.3±0.7, 11.2±0.7, and 9.4±0.7 cmH
2
O for PCV, PSV, and NAVA; P<0.01). Tidal 
volume was similar between modes (6.6 [5.7-7.0], 6.4 [5.8-7.0] and 6.0 [5.6-7.3] ml/
kg for PCV, PSV, and NAVA), but respiratory variability was higher with NAVA (8.0 
[6.4-10.0], 7.1 [5.9-9.0], and 17.0 [12.0-36.1] % for PCV, PSV, and NAVA; P<0.001). 
Patient-ventilator interaction improved with NAVA (6 [5-8] % error) compared to PCV 
(29 [14-52] % error) and PSV (12 [9-27] % error); P<0.0001.
Conclusions: In patients with mild to moderate ARDS, increasing freedom to control 
the ventilator maintains lung protective ventilation in terms of tidal volume and 
lung-distending pressure, but improves patient-ventilator interaction and preserves 
respiratory variability.
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Introduction
In patients with acute respiratory distress syndrome (ARDS), mechanical ventilation 
with positive-end expiratory pressure (PEEP), limited plateau airway pressure and 
low tidal volume is widely accepted as the ventilation strategy of choice to limit 
ventilator induced lung injury (1, 2). The use of assisted mechanical ventilation 
in ARDS is a subject of debate (3-5). Among other beneficial effects, assisted 
ventilation preserves diaphragm function and better resembles natural respiratory 
variability when compared to controlled mechanical ventilation (3, 4). This may be 
important, as increased variation in breathing pattern improves oxygenation, lung 
mechanics and enhances tidal distribution to the dependent lung regions (6, 7). 
However, during assisted ventilation, spontaneous breathing contributes to the 
transpulmonary pressure, (Ptp) potentially increasing the risk of ventilator-induced 
lung injury if either is excessive (4).
 Neurally adjusted ventilatory assist (NAVA) is a ventilator mode that uses 
diaphragm electrical activity (EAdi) to control timing and level of support during 
inspiration, thereby introducing inherent feedback loops between patient and 
ventilator (8). It has been shown in patients with acute respiratory failure that 
increasing levels of support with NAVA unloads the respiratory muscles, but limits 
pressure increases due to down-regulation of EAdi (9-11). This suggests that intrinsic 
lung-protective feedback mechanisms may limit tidal volume and lung distending 
pressure. Recently, it has been shown in an animal model that not only the magnitude, 
but also the duration of mechanical stress within the respiratory cycle (inspiratory to 
expiratory time ratio) determines the severity of lung injury (12). This emphasizes the 
importance of synchrony between neural and mechanical inspiration. 
 Overall, it is rational to investigate the effects of increased patient freedom to 
control the ventilator on respiratory mechanics in patients with ARDS. Up to now 
data related to these effects are scarce in patients with ARDS (10, 13). Therefore, 
the aim of the current study was to investigate the effects of three modes of assisted 
ventilation on lung distending pressures, tidal volume, breathing variability and 
patient-ventilator interaction in ARDS patients. The selected ventilator modes cover 
a wide spectrum of patient freedom to control ventilator assist: 1) pressure control 
ventilation (PCV): a pressure limited mode of both mandatory and triggered assist of 
fixed duration; 2) pressure support ventilation (PSV): a pressure limited mode with 
flow-trigger and variable cycling-off, allowing the patient more freedom to time 
assist delivery to inspiratory effort; and 3) NAVA: a mode where the patient regulates 
both timing and magnitude of assist via neural inspiratory effort. We reasoned that 
intrinsic lung-protective feedback mechanisms maintain lung-protective ventilation 
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when patient freedom to control the ventilator is increased. Accordingly, the first 
hypothesis of our study was that with NAVA (maximal ‘patient freedom’) tidal volume 
and lung-distending pressure remain within clinically acceptable limits. The second 
hypothesis was that breathing pattern variability and patient-ventilator interaction in 
ARDS patients improve with increased freedom to control the ventilator.
Materials and methods
Study design and population
Twelve adult patients, fulfilling the Berlin definition of ARDS (14), were studied in 
a physiological study on the intensive care unit of the Radboud university medical 
center. Exclusion criteria were hemodynamic instability, contra-indications to 
changing a naso-gastric tube (i.e. recent nasal bleeding, upper airway/esophageal 
pathology or surgery) and previously known neuromuscular disorders.
 The protocol was approved by the institutional review board (CMO regio Arnhem-
Nijmegen, NL31557.091.10) and is in accordance with the ethical standards laid 
down in the 1964 Declaration of Helsinki and its later amendments. Patient surrogate 
decision makers gave informed consent before study inclusion.
Ventilator and esophageal catheter
Patients were ventilated with a Servo-I ventilator (Maquet Critical Care, Sölna, 
Sweden). EAdi and esophageal pressure (Pes) were obtained with a multi-electrode 
esophageal catheter with balloon (Neurovent Research Inc., Toronto, Canada), as 
described previously (15, 16). Care was taken with correct positioning and inflation of 
the balloon using the Baydur method (17). Additional details on catheter positioning 
are provided in the supplemental material.
Study protocol
Initially, patients were ventilated in PSV mode for 30 minutes to verify feasibility of 
assisted ventilation. Subsequently, in a cross-over design, PCV, PSV, and NAVA were 
randomly applied for 30 minutes each. PSV and PCV level were matched to target a 
Vt of 6 ml/kg predicted bodyweight. With PCV, mechanical respiratory rate was set 
just below patient’s respiratory rate to allow patient-triggered breaths. NAVA level 
(cmH2O/µV) was set by the use of a dedicated window on the Servo-I ventilator. 
Briefly, in either PSV or PCV, the actual airway pressure is presented with an overlay 
of the predicted airway pressure (as if the patient were in the NAVA mode). The NAVA 
level was adjusted manually to try to match the predicted peak pressure to the actual 
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peak airway pressure. PEEP was maintained constant throughout the study period 
and set according to the higher PEEP/lower FiO
2
 arm of the ARDSnet consensus (18). 
Additional details on ventilator settings are provided in the supplemental material. 
At the end of each mode, arterial blood was sampled for analysis. Drugs, including 
sedatives and fluids, were unchanged during the entire study. 
Data acquisition 
Flow, Paw and EAdi were acquired (sampling rate 100Hz) from the serial port of the 
Servo-I and resampled to 2kHz. Pes was acquired (sampling rate 2kHz) by connecting 
the balloon to a pressure transducer (range ±50 kPa, Freescale, Tempe, AR, USA) 
and A/D converter (DT3004, Data Translation, Marlboro, MA, USA). All signals were 
acquired synchronously using dedicated software (Neurovent Research Inc., Toronto, 
Canada). 
Data analysis
Data were analyzed offline. All variables were calculated from a stable 5-min period 
at the end of each mode on a breath-by-breath basis using a software routine 
developed for Matlab (Mathworks, Natick, MA). For each breath, we defined the 
following variables during the inspiratory phase (as shown in Figure 1):
• Tidal volume, as the integral of the inspiratory flow over time.
• Peak EAdi.
• Mean, peak and end-inflation airway pressure (Paw
mean
, Paw
peak
, Paw
end inflation
).
•  Mean, peak inspiratory deflection and end-inflation esophageal pressure, as 
change from baseline (ΔPes
mean
, ΔPes
peak
, ΔPes
end inflation
). Baseline was defined as 
esophageal pressure at start of neural inspiration.
•  Mean, peak and end-inflation transpulmonary pressure, as change from baseline 
(ΔPtp
peak
, ΔPtp
mean 
and ΔPtp
end inflation
). Transpulmonary pressure was calculated as 
the difference between Paw and Pes. Baseline was defined as transpulmonary 
pressure at start of neural inspiration.
•  Transpulmonary pressure-time product (PTP
tp
) was calculated as the integral of 
transpulmonary pressure over time. PTP
tp
 is a measure of duration of mechanical 
stress within the respiratory cycle. To determine the effect of patient-ventilator 
dyssynchrony, this variable was also calculated during the following phases of 
inspiration: A) trigger delay; B) synchronous overlap period between neural and 
mechanical inspiration; and C) cycle-off error. 
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Neural respiratory rate was calculated as the number of EAdi peaks per minute 
and mechanical respiratory rate as the number of Paw peaks per minute. Breath-
by-breath variability was assessed by calculating the coefficient of variation (CV; 
[standard deviation/mean] x 100) for Vt and EAdi.
Patient-ventilator interaction was evaluated by comparing Paw and EAdi waveforms 
with a recently validated automated computer algorithm that reports the timing error 
between Paw and EAdi (19, 20).  Briefly, automatic detection of the start of neural 
inspiration (EAdi
ON
) was obtained by detecting a 0.5 µV increase in EAdi. The end of 
neural inspiration (EAdi
OFF
) was automatically detected by finding when the EAdi had 
decreased to 70% of its peak. The onset of pressure support (P
ON
) was automatically 
detected by searching for an increase in Paw of >3 cmH
2
O. The termination of 
pressure support (P
OFF
) was automatically detected by searching for the decrease 
in Paw. See Figure 1 for an example of these timings. EAdi and Paw timings were 
used to calculate the NeuroSync index as following. The trigger error (P
ON 
- EAdi
ON
) 
and cycle-off error (P
OFF 
- EAdi
OFF
) were calculated as a percentage of the neural 
inspiratory detection period and neural expiratory detection period, respectively. 
Neural inspiratory detection periods were defined as segments from one detected 
EAdi
OFF
 to the next EAdi
OFF
. Neural expiratory detection periods were defined as 
segments from one EAdi
ON
 to the next EAdi
ON
. Thus, an early trigger error could range 
between -100% and 0% and a late trigger error could range between 0% and 100%. 
In the same fashion, an early cycle-off error could range between -100% and 0% and 
a late cycle-off error could range between 0% and 100%. Breaths with an absolute 
error of more than 33% where defined as dyssynchronous breaths, and breaths with 
an absolute error of less than 33% as synchronous breaths. Asynchronous breaths, 
defined as a complete dissociation between EAdi and Paw (wasted efforts, auto-
triggering, double-triggering), were assigned 100% error. The NeuroSync index was 
then calculated by averaging the errors for all breaths per patient per mode.
Statistical analysis
To compare modes, one-way ANOVA for repeated measures was performed or the 
Friedman test as its non-parametric equivalent. Post-hoc analysis was performed 
with the Student-Newman-Keuls (SNK) test or Dunn’s test, as its non-parametric 
equivalent, to correct for multiple comparisons. The effect of patient-ventilator 
dyssynchrony on PTP
tp
 was analyzed using two-way ANOVA for repeated measures 
with Bonferroni’s post-test. Linear regression analysis was performed to test 
associations. For all tests, a two-tailed P<0.05 was considered significant. Data are 
described as mean ± standard error for parametric data or median [interquartile 
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range] for nonparametric data. Statistical analyses were performed with Prism 5 
(Graphpad software, San Diego, CA, USA).
Figure 1. Representative ex-
ample of measurements of the 
main variables studied. The dis-
played breath is during pressure 
control ventilation. All variables 
were calculated on a breath-by-
breath basis for each mode and 
averaged over a 5 min stable 
respiratory pattern. Vertical dot-
ted lines represent neural and 
mechanical respiratory cycles. 
Arrows indicate the different 
parameters that are calculated 
from the waveforms. Tidal vol-
ume is calculated as the integral 
of inspiratory flow over time. 
Transpulmonary pressure versus 
time product (PTP
tp
) is calculated 
as the integral of transpulmo-
nary pressure (Ptp) over time. 
PTP
tp
 was calculated during the 
following phases of inspiration: 
A) trigger delay; B) synchronous 
overlap period between neural 
and mechanical inspiration; and 
C) cycle-off error. P
ON
 - EAdi
ON 
= 
trigger delay and P
OFF
 - EAdi
OFF
 
= cycle off error. Abbreviations: 
EAdi = electrical activity of the di-
aphragm; Paw = airway pressure; 
Pes = esophageal pressure.
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Results
Table 1 reports patient characteristics and Table 2 reports ventilator settings for PCV, 
PSV and NAVA during the study. 
Respiratory variables
Tidal volumes were equal between modes (Figure 2A). One patient, having lowest 
pH of 7.18 revealed excessive Vt both in PSV and NAVA (#4, solid circles Figure 2A), 
but not in PCV. There was no difference between modes for neural and ventilator 
respiratory rates, however respiratory rates varied widely between subjects (Figure 
2B). The coefficient of determination (r2) between neural and ventilator respiratory 
rates was high with NAVA (0.99, P<0.0001), 0.70 (P=0.0007) with PCV, and 0.61 
(P=0.0026) with PSV. Minute ventilation was equal between modes (Table 3). 
Peak EAdi
 
ranged from near-zero to 30 mV between patients (Figure 2C). Post-hoc 
analysis did not reveal any significant differences between modes for EAdi. Mean 
Paw (Paw
mean
) during inspiration was lower with NAVA compared to both PCV and 
PSV (Figure 2D). Changes in pleural pressure during inspiration are expressed by 
ΔPes
mean
, and ranged from positive to high negative values. Group mean values for 
ΔPes
mean
 were higher during PCV, i.e. less negative swing, compared to PSV and 
NAVA (Figure 2E). Lung distending pressure, expressed by ΔPtp
mean
, was highest 
during PSV, lower during PCV and lowest during NAVA (Figure 2F). Peak and end-
inflation ΔPes and ΔPtp during inspiration were slightly lower during PCV compared 
to PSV and NAVA, whereas these values were equal for Paw (Table 3). 
The CV of EAdi was equal between modes, whereas the CV of Vt was higher with 
NAVA (Table 3). Linear regression analysis between CVs of EAdi and Vt are presented 
in Figure 3, which shows no relationship with PCV, a poor relationship with PSV and 
a good relationship with NAVA.
 There was a significant difference in PTP
tp
 between modes (one-way ANOVA, 
P = 0.0018). Post hoc analysis showed that PTP
tp
 was significantly lower (P < 0.05) 
with NAVA (6.9 ± 0.8 cmH2O∙s) compared to PSV (8.3 ± 0.7 cmH2O∙s) and PCV 
(9.5 ± 0.8 cmH2O∙s). 
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Table 1. Patient characteristics at study inclusion. 
Patient Age (y) Sex BMI (kg/m2) RASS Days on MV P/F ratio (mmHg) ARDS etiology
1 72 M 25 -3 13 242 Pneumonia
2 71 M 27 -5 4 146 Pneumonia
3 61 F 48 -1 1 116 Urosepsis
4 49 M 26 -1 21 75 Acute pancreatitis
5 64 M 23 -4 1 150 Pneumonia
6 76 M 32 0 4 108 Pneumonia
7 48 M 27 -4 7 143 Acute pancreatitis
8 71 F 32 -4 6 175 Acute pancreatitis
9 68 M 24 -4 32 177 Pneumonia and mediastinitis
10 78 M 18 -3 5 115 Pneumonia
11 45 M 24 -4 11 165 Pneumonia
12 66 M 23 -5 10 120 Pneumonia
Abbreviations: ARDS = acute respiratory distress syndrome; F = female; M = male; MV = 
mechanical ventilation; RASS = Richmond Agitation Sedation Scale.
Table 2. Ventilator settings.
Patient PCV level
(cmH2O)
PSV level
(cmH2O)
NAVA level
(cmH2O/μV)
PEEP
(cmH2O)
FiO2 Insp. time 
in PCV (s)
Cycle-off
in PSV (%)
1 17 17 1.3 14 0.40 0.8 50
2 14 14 1.4 14 0.45 0.5 50
3 12 12 1.0 16 0.65 1.0 50
4 12 10 2.2 16 0.55 0.9 30
5 8 8 1.7 14 0.60 0.7 50
6 12 12 2.5 12 0.60 1.2 30
7 6 6 1.6 16 0.50 0.8 50
8 14 16 4.0 10 0.55 0.9 50
9 16 16 4.1 14 0.43 0.5 30
10 11 11 0.5 16 0.50 0.7 30
11 9 9 2.0 14 0.40 0.8 50
12 12 12 0.8 18 0.80 0.7 30
Abbreviations: I:E ratio = ratio between inspiratory and expiratory time; NAVA = neurally ad-
justed ventilatory assist; PCV = pressure control ventilation; PEEP = positive end-expiratory 
pressure; PSV = pressure support ventilation
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Figure 2. A) Tidal volume (Vt), B) ventilator and neural respiratory rate, C) electrical activity 
of the diaphragm (EAdi), D) mean airway pressure (Pawmean), E) mean esophageal pressure 
(ΔPesmean), and F) mean transpulmonary pressure (ΔPtpmean) for each ventilation mode. 
Filled circle symbol in panel A represents patient #4. Horizontal bars represent mean values 
(B, D-F) or median values (A, C). P-values in each panel represent result of one-way ANOVA 
for repeated measures (B, D-F) or Friedman test (A, C). Asterisks represent significant differ-
ence (P < 0.05) between indicated modes following post-hoc analysis with SNK’s test. Ab-
breviations: NAVA = neurally adjusted ventilatory assist; PCV = pressure control ventilation; 
PSV = pressure support ventilation.
135
Assisted ventilation in patients with ARDS
7
Table 3. Breath parameters and variability. 
PCV PSV NAVA P-value
Minute Ventilation (L/min) 10.8 [7.2 - 13.2] 9.9 [8.7 - 12.9] 10.3 [9.0 - 12.6] 0.779
Pawpeak (cmH2O) 28 ± 1 27 ± 1 29 ± 1 0.170
Pawend inflation (cmH2O) 24 ± 1 25 ± 1 25 ± 1 0.684
∆Pespeak (cmH2O) -5 ± 1
 a, b -6 ± 1 -7 ± 1 0.027
∆Pesend inflation (cmH2O) 3 [2 - 4] 
a 1 [-5 - 2] 0 [-2 - 2] 0.039
∆Ptppeak (cmH2O) 16 ± 1 
a, b 17 ± 1 17 ± 1 0.016
∆Ptpend inflation (cmH2O) 8 ± 1 
a, b 11 ± 1 11 ± 1 0.014
CV of Vt (%) 8.0 [6.4 - 10.0] b 7.1 [5.9 - 9.0] c 17.0 [12.0 - 36.1]  0.0005
CV of EAdi (%) 27.7 [22.5 - 40.5] 28.2 [23.8 - 38.6] 29.3 [22.7 - 39.5] 0.920
Data are described as mean ± standard error for parametric or median [interquartile range] 
for non-parametric data. P-values represent result of one-way ANOVA for repeated mea-
sures for parametric data or the Friedman test as its non-parametric equivalent. Annota-
tions represent significant difference (P < 0.05) between indicated modes following post-
hoc analysis with SNK’s (parametric data) or Dunn’s (non-parametric data)  test, where a 
= PCV vs. PSV, b = PCV vs. NAVA, and c = PSV vs. NAVA. Abbreviations: CV = coefficient of 
variation; EAdi = electrical activity of the diaphragm; NAVA = neurally adjusted ventilatory 
assist; Paw
peak
 = peak airway pressure; PCV = pressure control ventilation; Pes
peak
 = peak 
esophageal pressure; PSV = pressure support ventilation; Ptp
peak
 = delta peak transpulmo-
nary pressure; Vt = tidal volume.
Figure 3. Linear regression 
analysis between coefficient 
of variation of electrical ac-
tivity of the diaphragm (CV 
of EAdi) and coefficient of 
variation of tidal volume (CV 
of Vt) for each ventilation 
mode. Abbreviations: NAVA 
= neurally adjusted ventila-
tory assist; PCV = pressure 
control ventilation; PSV = 
pressure support ventilation. 
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Patient-ventilator interaction 
The percentage of synchronous breaths was higher and trigger delay shorter with 
NAVA compared to PCV and PSV (Table 4). Cycle-off error was higher with PCV 
compared to PSV and NAVA (Table 4). Wasted efforts and double triggering were 
overall uncommon and equal between modes, whereas the rate of auto-triggering 
was different between modes (Table 4). The latter is explained by the fact that during 
PCV, 87.6 ± 16.8 % of the breaths were patient-triggered and 12.4 ± 16.8 % were 
ventilator controlled. The NeuroSync index, depicted in Figure 4A (0% error = perfect 
patient-ventilator interaction and 100% error = zero patient-ventilator interaction), 
indicated more than 20% error in seven patients during PCV, which improved during 
PSV and was below 20 % in all patients during NAVA. The higher cycle-off error with 
PCV resulted in an increased PTP
tp
, as depicted in Figure 4B. 
Blood gases
Table 5 shows arterial blood gas values at the end of each 30 minute interval. PaO
2
 
and PaCO
2
 were significantly higher with NAVA compared to PCV (Table 5).
Table 4. Effect of different ventilation modes on patient-ventilator interaction. 
PCV PSV NAVA P-value
Synchrony (% breaths) 60 [15 - 89] a, b 89 [71 - 99] 93 [79 - 99] 0.005
Dyssynchrony (%breaths) 16 [6 - 36] a, b 2 [0 - 14] 4 [0 - 14] 0.004
 Trigger delay (ms) 107 ± 20 b 96 ± 16 c 48 ± 11 0.0005
 Cycle off error (ms) 265 [143 - 401] a, b 36 [18 - 134] 8 [2 - 16] <0.0001
Wasted efforts (% breaths) 0 [0 - 2] 0 [0 - 1] 0 [0 - 0] 0.093
Auto-triggering (% breaths) 2 [0 - 16] 1 [0 - 12] 0 [0 - 4] 0.046
Double triggering (% breaths) 0 [0 - 1] 0 [0 - 0] 1 [0 - 2] 0.065
Data are described as mean ± standard error for parametric or median [interquartile range] for 
non-parametric data. P-value represents result of one-way ANOVA for repeated measures for 
parametric data or the Friedman test as its non-parametric equivalent. Annotations represent 
significant difference (P < 0.05) between indicated modes following post-hoc analysis with 
SNK’s (parametric data) or Dunn’s (non-parametric data)  test, where a = PCV vs. PSV, b = PCV 
vs. NAVA, and c = PSV vs. NAVA. Abbreviations: EAdi = electrical activity of the diaphragm; 
NAVA = neurally adjusted ventilatory assist; PCV = pressure control ventilation; PSV = pressure 
support ventilation. Values are given as median and interquartile range.
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Figure 4. A) NeuroSync index (19) of each ventilation mode. The NeuroSync index is an 
overall indicator of patient-ventilator interaction, where 0% error = perfect and 100% error 
= zero patient-ventilator interaction. Horizontal bar represent median value and P-value in 
panel represent result of Friedman test. Asterisk represents significant difference (P < 0.05) 
between indicated modes following post-hoc analysis with Dunn’s test. B) Transpulmonary 
pressure-time product (PTPtp) during different phases of patient-ventilation interaction. 
Bars represent mean ± standard error. P-value in panel represent result of two-way ANO-
VA for repeated measures. Asterisk represents significant difference (P < 0.05) between 
indicated modes following post-hoc analysis with Bonferroni’s test. Abbreviations: NAVA 
= neurally adjusted ventilatory assist; PCV = pressure control ventilation; PSV = pressure 
support ventilation.
Table 5. Effect of different ventilation modes on blood gas values
PCV PSV NAVA P-value
pH 7.40 [7.33 - 7.44] 7.40 [7.33 - 7.44] 7.39 [7.31 - 7.44] 0.378
PaO2 (mmHg) 78[68 - 84] 
* 80 [69 - 97] 81 [69 - 91] 0.022
PaO2/FiO2 mmHg) 153 ± 12 163 ± 16 163 ± 13 0.341
PaCO2 (mmHg) 46 ± 3 
* 48 ± 3 49 ± 3 0.008
HCO3
-
 (mmol/L) 27.4 ± 2.1 27.5 ± 2.0 27.8 ± 2.0 0.235
Data are described as mean ± standard error for parametric or median [interquartile range] 
for non-parametric data. P-value represents result of one-way ANOVA for repeated mea-
sures for parametric data or the Friedman test as its non-parametric equivalent. Asterisks 
represent significant difference (P < 0.05) between PCV and NAVA following post-hoc anal-
ysis with SNK’s (parametric data) or Dunn’s (non-parametric data) test. Abbreviations: NAVA 
= neurally adjusted ventilatory assist; PCV = pressure control ventilation; PSV = pressure 
support ventilation. Values are given as mean ± standard error. a PCV vs. NAVA (P < 0.05).
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Discussion
The present study reports the effects of different modes of assisted ventilation on 
lung-distending pressure, tidal volume, breathing pattern variability, and patient-
ventilator interaction in ARDS patients. The three selected modes allow for different 
degrees of patient freedom to control the ventilator. The main findings of this study 
were that with increasing freedom to control the ventilator (1) tidal volume remains 
within the limits of lung-protective ventilation; and (2) lung distending pressures 
remain similar between modes. Even with NAVA, when the patient has a high degree 
of freedom to control the amount of support, tidal volume and lung distending 
pressures were similar to assist control ventilation, whereas breathing pattern 
variability and patient-ventilator interaction improved compared to PCV and PSV. 
Furthermore, prolonged inspiratory time during PCV resulted in a longer duration of 
mechanical stress.
Tidal volume and lung distending pressures
In the present study, Vt could be considered lung-protective in the majority of 
patients and was not affected by ventilator mode. Peak and end-inflation airway 
pressures (Table 3) were equal between modes, whereas mean airway pressures were 
lower during NAVA than during PCV and PSV (Figure 2D). Lower mean ventilator 
pressures with NAVA could be explained by the slower rate of pressurization with 
NAVA compared to a squared pressure waveform with PSV and PCV. These lower 
mean airway pressures do not necessary reflect a too low level of assistance during 
NAVA. As evidenced by the similar levels of EAdi with the three modes (Fig 2C), and 
the similar level of mean esophageal pressure compared to PSV. The lower level of 
mean esophageal pressure during PCV mainly reflects a too long inspiratory time 
during PCV. Although there were statistical differences in ΔPtp
mean
, ΔPtp
end inflation
, and 
ΔPtp
peak
 between modes, these were small in absolute values. Based on a post-hoc 
analysis of the low tidal volume ARDSnet study (1), Hager and colleagues concluded 
that no safe plateau pressure exists (21). It can be derived from the first figure in 
their manuscript that reduction in plateau pressure from 30 cmH
2
O to 25 cmH
2
O is 
associated with reduction in mortality of ~4%. In our study, differences in airway and 
transpulmonary pressures among modes were ≤3 cmH
2
O and therefore probably of 
limited clinical significance. 
 Protection against excessive Ptp and Vt is likely mediated by vagal afferents 
sensitive to lung distension (22, 23). Indeed, our data demonstrate similar Vt and 
lung-distending pressures during PCV, PSV (both delivering fixed pressure) and NAVA 
(proportional control of pressure). Prevention of high Vt and Ptp may be mediated by 
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the Hering-Breuer inspiratory inhibiting (vagal) reflex where lung inflation at critical 
volume (i.e. lung stretch) terminates inspiration (24). However, in the present study 
in one patient a tidal volume >9 mL/kg was observed during PSV and NAVA. This 
patient had the lowest blood pH (7.18), consistent with the view that acid-base 
homeostasis is the primary goal of the respiratory centers in the brain stem and may 
be achieved at the expense of high Vt or Ptp (25). Based on this observation we 
suggest to be very cautious with the use of assisted breathing modes in patients with 
a very low pH. 
Breathing pattern variability
Preservation of natural breathing variability and complexity during mechanical 
ventilation is considered important, as it may improve oxygenation, lung mechanics 
and gas distribution to the more dependent regions (6, 7). Breath-by-breath 
variability of Vt with NAVA was higher in comparison to PCV and PSV, whereas 
EAdi variability was similar. Accordingly, the ventilator output responded to the 
patient’s neural breathing effort during NAVA and not during pressure targeted 
assist (Figure 3), which is in accordance with previous findings (9, 26). By definition, 
a larger respiratory variability with NAVA increases the incidence of breaths with a 
high Vt (9). It is unknown whether this periodic delivery of breaths with a higher 
Vt during assisted mechanical ventilation is harmful. It could also be regarded as a 
type of sigh or recruitment maneuver, which have been shown to have moderate 
success for improving lung mechanics and gas exchange (27-29). In the present 
study oxygenation improved slightly with NAVA compared to PCV, but not compared 
to PSV. This might be explained by better lung recruitment of the dependent regions 
with NAVA (6). PaCO
2
 was slightly lower during PCV compared to NAVA. This might 
have resulted from small differences in tidal volume, respiratory rate, and tidal 
volume distribution, nevertheless blood pH was unaffected.
Patient-ventilator interaction
With NAVA patient-ventilator interaction was with minimal error, whereas prevalence 
of patients with poor patient-ventilator interaction increased during PSV and PCV. 
This is consistent with recent findings in ARDS patients (10, 13) and in other patients 
with acute respiratory failure (30, 31). This is of potential clinical relevance, as patient-
ventilator asynchrony has been associated with adverse clinical outcome, including 
prolonged mechanical ventilation (32, 33). For example, reversed triggering or 
breath-stacking in assist-control mode may contributing to ventilator induced lung 
injury (34, 35). See supplemental Figure 1 for an example of breath-stacking caused 
by reversed triggering in the current study. Experimental animal data suggests that 
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not only the magnitude but also the inspiratory cycle duration of lung distending 
pressure during PCV is associated with lung injury of increased severity (12, 36). 
In the present study, late cycling-off resulted in prolonged and unnecessary lung 
distending pressures with PCV, and to a lesser extent with PSV (Figure 4B). Thus, our 
results support the notion that poor patient-ventilator interaction and fixed duration 
of assist during spontaneous breathing is less lung protective than synchronized 
assist delivery in proportion to neural inspiratory effort. 
Clinical implications
The role of assisted ventilation in ARDS has been extensively debated in recent years 
(4). The most striking evidence in opposition to assisted ventilation is the effect of 
muscle paralysis in the first 48 hours in ARDS patients with Pao
2
/Fio
2
 <150 mmHg, 
which has been associated with improved outcome (37). Our findings may have 
implications for mechanical ventilation in mild to moderate ARDS following these 
first 48 hrs. First, our results suggest that it is reasonable from a physiological point 
of view to use an assisted ventilation mode with good patient-ventilator interaction 
without increasing the risk of excessive tidal volume and lung-distending pressure. 
Our data are supported by recent findings in a pig model of ARDS, that higher levels 
of spontaneous breathing reduce global stress and strain (38). Second, in terms of 
the patient’s inspiratory drive and effort, the present study revealed a high variability 
in EAdi and Pes values, ranging from over-assist to strenuous efforts (Figure 1). Also, 
a great dispersion in neural respiratory rate implies a large variety in respiratory drive 
in ARDS patients. These findings suggest that adjusting ventilator assist to target 
low tidal volumes resulted in different levels of neural drive in each study patient, 
probably due to a complex interaction between sedation, ventilatory mode and level 
of assist. Accordingly, monitoring Vt in conjunction with EAdi and/or Pes can aid to 
optimize ventilation in ARDS to prevent over-assist or insufficient assist and improve 
patient-ventilator interaction (39). The capabilities of EAdi for monitoring purposes 
were recently well demonstrated in trial to monitor dynamic intrinsic PEEP (40).
Critique of the method
Several limitations of the present study should be addressed. First, esophageal 
pressure was used as an estimate of pleural pressure. The validity of esophageal 
pressure for this purpose has been discussed before in the literature (41, 42). 
Second, the real lung distending pressure is transpulmonary pressure obtained under 
static conditions (zero-flow) to eliminate the resistive component in the equation 
of motion. Achieving and verifying static conditions in spontaneous breathing 
under assisted ventilation in critically ill patients is very cumbersome. Therefore 
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our measurements of lung distending pressures were performed during dynamic 
conditions, and cannot directly be compared to static transpulmonary pressures. As 
peak pressure is highly influenced by airway resistance and is not a reliable estimate 
of lung distending pressure, mean transpulmonary pressure during inspiration may 
be a better estimate under dynamic condition. Lastly, it should be recognized that 
our study is a single-center, physiological study, conducted in a heterogeneous group 
of ARDS patients with a wide range of sedation scores. Different conditions leading 
to ARDS, such as pulmonary versus extrapulmonary, might influence the effect on 
lung-protective ventilation while changing ventilator modes, when studied in large 
subgroups. In our study, each mode was studied for a period of 30 minutes. This 
allows for physiological comparisons and improves our understanding in the effects 
of these different modes on respiratory mechanics, patient-ventilator interaction and 
gas exchange. Large clinical trials that evaluate these different ventilator modes for 
several days in large groups of patients are needed to determine whether one mode 
is superior in outcome compared to the other modes. 
In conclusion, in patients with mild to moderate ARDS, increasing patient freedom to 
control the ventilator maintains lung protective ventilation in terms of tidal volume 
and lung-distending pressure, but improves patient-ventilator interaction and 
preserves respiratory variability.
Acknowledgments
The authors thank Norman Comtois from the Department of Critical Care Medicine, 
St. Michael’s Hospital, Toronto, Ontario, Canada, for his technical assistance.
Chapter 7
142
References
1. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung 
injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome 
Network. N Engl J Med 2000; 342: 1301-1308.
2. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, Davies AR, Hand LE, Zhou Q, 
Thabane L, Austin P, Lapinsky S, Baxter A, Russell J, Skrobik Y, Ronco JJ, Stewart TE, Lung Open 
Ventilation Study I. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high 
positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a 
randomized controlled trial. JAMA 2008; 299: 637-645.
3. Marini JJ. Spontaneously regulated vs. controlled ventilation of acute lung injury/acute respiratory 
distress syndrome. Current Opinion in Critical Care 2011; 17: 24-29.
4. Gama de Abreu M, Guldner A, Pelosi P. Spontaneous breathing activity in acute lung injury and 
acute respiratory distress syndrome. Current opinion in anaesthesiology 2012; 25: 148-155.
5. Fan E, Villar J, Slutsky AS. Novel approaches to minimize ventilator-induced lung injury. BMC 
medicine 2013; 11: 85.
6. Blankman P, Hasan D, van Mourik MS, Gommers D. Ventilation distribution measured with EIT at 
varying levels of pressure support and Neurally Adjusted Ventilatory Assist in patients with ALI. 
Intensive Care Med 2013; 39: 1057-1062.
7. Spieth PM, Carvalho AR, Guldner A, Kasper M, Schubert R, Carvalho NC, Beda A, Dassow C, Uhlig 
S, Koch T, Pelosi P, Gama de Abreu M. Pressure support improves oxygenation and lung protection 
compared to pressure-controlled ventilation and is further improved by random variation of 
pressure support. Crit Care Med 2011; 39: 746-755.
8. Sinderby CA, Navalesi P, Beck J, Skrobik Y, Comtois N, Friberg S, Gottfried SB, Lindstrom L. Neural 
control of mechanical ventilation in respiratory failure. Nat Med 1999; 5: 1433-1436.
9. Patroniti N, Bellani G, Saccavino E, Zanella A, Grasselli G, Isgro S, Milan M, Foti G, Pesenti A. 
Respiratory pattern during neurally adjusted ventilatory assist in acute respiratory failure patients. 
Intensive Care Med 2012; 38: 230-239.
10. Terzi N, Pelieu I, Guittet L, Ramakers M, Seguin A, Daubin C, Charbonneau P, du CD, Lofaso F. 
Neurally adjusted ventilatory assist in patients recovering spontaneous breathing after acute 
respiratory distress syndrome: physiological evaluation. Crit Care Med 2010; 38: 1830-1837.
11. Brander L, Leong-Poi H, Beck J, Brunet F, Hutchison SJ, Slutsky AS, Sinderby C. Titration and 
implementation of neurally adjusted ventilatory assist in critically ill patients. Chest 2009; 135: 
695-703.
12. Spieth PM, Silva PL, Garcia CS, Ornellas DS, Samary CS, Moraes L, Bentes M, Morales MM, Kasper 
M, Guldner A, Huhle R, Koch T, Pelosi P, de Abreu MG, Rocco PR. Modulation of stress versus time 
product during mechanical ventilation influences inflammation as well as alveolar epithelial and 
endothelial response in rats. Anesthesiology 2015; 122: 106-116.
143
Assisted ventilation in patients with ARDS
7
13. Mauri T, Bellani G, Grasselli G, Confalonieri A, Rona R, Patroniti N, Pesenti A. Patient-ventilator 
interaction in ARDS patients with extremely low compliance undergoing ECMO: a novel approach 
based on diaphragm electrical activity. Intensive Care Med 2013; 39: 282-291.
14. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky 
AS, Force ADT. Acute Respiratory Distress Syndrome The Berlin Definition. Jama-J Am Med Assoc 
2012; 307: 2526-2533.
15. Doorduin J, Sinderby CA, Beck J, Stegeman DF, van Hees HW, van der Hoeven JG, Heunks LM. The 
calcium sensitizer levosimendan improves human diaphragm function. Am J Respir Crit Care Med 
2012; 185: 90-95.
16. Sinderby C, Beck J, Spahija J, de Marchie M, Lacroix J, Navalesi P, Slutsky AS. Inspiratory muscle 
unloading by neurally adjusted ventilatory assist during maximal inspiratory efforts in healthy 
subjects. Chest 2007; 131: 711-717.
17. Baydur A, Behrakis PK, Zin WA, Jaeger M, Milic-Emili J. A simple method for assessing the validity 
of the esophageal balloon technique. Am Rev Respir Dis 1982; 126: 788-791.
18. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, 
Thompson BT, National Heart L, Blood Institute ACTN. Higher versus lower positive end-expiratory 
pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351: 327-336.
19. Sinderby C, Liu S, Colombo D, Camarotta G, Slutsky AS, Navalesi P, Beck J. An automated and 
standardized neural index to quantify patient-ventilator interaction. Crit Care 2013; 17: R239.
20. Doorduin J, Sinderby CA, Beck J, van der Hoeven JG, Heunks L. Automated patient-ventilator 
interaction analysis during neurally adjusted non-invasive ventilation and pressure support 
ventilation in chronic obstructive pulmonary disease. Crit Care 2014; 18: 550.
21. Hager DN, Krishnan JA, Hayden DL, Brower RG, Network ACT. Tidal volume reduction in patients 
with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 2005; 172: 
1241-1245.
22. Allo JC, Beck JC, Brander L, Brunet F, Slutsky AS, Sinderby CA. Influence of neurally adjusted 
ventilatory assist and positive end-expiratory pressure on breathing pattern in rabbits with acute 
lung injury. Crit Care Med 2006; 34: 2997-3004.
23. Lecomte F, Brander L, Jalde F, Beck J, Qui H, Elie C, Slutsky AS, Brunet F, Sinderby C. Physiological 
response to increasing levels of neurally adjusted ventilatory assist (NAVA). Respir Physiol Neurobiol 
2009; 166: 117-124.
24. Hering E, Breuer J. Self-steering of respiration through the nervus vagus. Breathing: Hering-Breuer 
Centenary Symposium Ciba Found, Churchill, London; 1868. p. 359-364.
25. Karagiannidis C, Lubnow M, Philipp A, Riegger GA, Schmid C, Pfeifer M, Mueller T. Autoregulation 
of ventilation with neurally adjusted ventilatory assist on extracorporeal lung support. Intensive 
Care Med 2010; 36: 2038-2044.
Chapter 7
144
26. Schmidt M, Demoule A, Cracco C, Gharbi A, Fiamma MN, Straus C, Duguet A, Gottfried SB, 
Similowski T. Neurally adjusted ventilatory assist increases respiratory variability and complexity in 
acute respiratory failure. Anesthesiology 2010; 112: 670-681.
27. Patroniti N, Foti G, Cortinovis B, Maggioni E, Bigatello LM, Cereda M, Pesenti A. Sigh improves 
gas exchange and lung volume in patients with acute respiratory distress syndrome undergoing 
pressure support ventilation. Anesthesiology 2002; 96: 788-794.
28. Pelosi P, Cadringher P, Bottino N, Panigada M, Carrieri F, Riva E, Lissoni A, Gattinoni L. Sigh in acute 
respiratory distress syndrome. Am J Respir Crit Care Med 1999; 159: 872-880.
29. Pelosi P, Bottino N, Chiumello D, Caironi P, Panigada M, Gamberoni C, Colombo G, Bigatello LM, 
Gattinoni L. Sigh in supine and prone position during acute respiratory distress syndrome. Am J 
Respir Crit Care Med 2003; 167: 521-527.
30. Spahija J, de MM, Albert M, Bellemare P, Delisle S, Beck J, Sinderby C. Patient-ventilator interaction 
during pressure support ventilation and neurally adjusted ventilatory assist. Crit Care Med 2010; 
38: 518-526.
31. Bertrand PM, Futier E, Coisel Y, Matecki S, Jaber S, Constantin JM. Neurally adjusted ventilatory 
assist vs pressure support ventilation for noninvasive ventilation during acute respiratory failure: a 
crossover physiologic study. Chest 2013; 143: 30-36.
32. Thille AW, Rodriguez P, Cabello B, Lellouche F, Brochard L. Patient-ventilator asynchrony during 
assisted mechanical ventilation. Intensive Care Med 2006; 32: 1515-1522.
33. de Wit M, Miller KB, Green DA, Ostman HE, Gennings C, Epstein SK. Ineffective triggering predicts 
increased duration of mechanical ventilation. Crit Care Med 2009; 37: 2740-2745.
34. Chanques G, Kress JP, Pohlman A, Patel S, Poston J, Jaber S, Hall JB. Impact of ventilator adjustment 
and sedation-analgesia practices on severe asynchrony in patients ventilated in assist-control 
mode. Crit Care Med 2013; 41: 2177-2187.
35. Akoumianaki E, Lyazidi A, Rey N, Matamis D, Perez-Martinez N, Giraud R, Mancebo J, Brochard 
L, Marie Richard JC. Mechanical ventilation-induced reverse-triggered breaths: a frequently 
unrecognized form of neuromechanical coupling. Chest 2013; 143: 927-938.
36. Casetti AV, Bartlett RH, Hirschl RB. Increasing inspiratory time exacerbates ventilator-induced lung 
injury during high-pressure/high-volume mechanical ventilation. Crit Care Med 2002; 30: 2295-
2299.
37. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez 
D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guerin C, Prat G, Morange S, Roch A. 
Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363: 
1107-1116.
38. Guldner A, Braune A, Carvalho N, Beda A, Zeidler S, Wiedemann B, Wunderlich G, Andreeff M, 
Uhlig C, Spieth PM, Koch T, Pelosi P, Kotzerke J, de Abreu MG. Higher levels of spontaneous 
breathing induce lung recruitment and reduce global stress/strain in experimental lung injury. 
Anesthesiology 2014; 120: 673-682.
145
Assisted ventilation in patients with ARDS
7
39. Doorduin J, van Hees HW, van der Hoeven JG, Heunks LM. Monitoring of the respiratory muscles 
in the critically ill. Am J Respir Crit Care Med 2013; 187: 20-27.
40. Bellani G, Coppadoro A, Patroniti N, Turella M, Arrigoni Marocco S, Grasselli G, Mauri T, Pesenti 
A. Clinical assessment of auto-positive end-expiratory pressure by diaphragmatic electrical activity 
during pressure support and neurally adjusted ventilatory assist. Anesthesiology 2014; 121: 563-
571.
41. Talmor D, Sarge T, O’Donnell CR, Ritz R, Malhotra A, Lisbon A, Loring SH. Esophageal and 
transpulmonary pressures in acute respiratory failure. Crit Care Med 2006; 34: 1389-1394.
42. Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, Pelosi P, Talmor D, Grasso 
S, Chiumello D, Guerin C, Patroniti N, Ranieri VM, Gattinoni L, Nava S, Terragni PP, Pesenti A, Tobin 
M, Mancebo J, Brochard L. The application of esophageal pressure measurement in patients with 
respiratory failure. Am J Respir Crit Care Med 2014; 189: 520-531.
Chapter 7
146
Supplemental material
Supplemental materials and methods
Esophageal catheter positioning and balloon dimensions
Correct positioning of the catheter was obtained using standard software supplied 
with the ventilator by the manufacturer, which results in centering of the esophageal 
balloon about 12 cm proximal to the diaphragm. Proper esophageal balloon position 
was confirmed by the presence of proportionality between deflections in airway 
pressure (Paw) and Pes during inspiratory efforts against an occlusion (1). 
Detailed ventilator settings
Trigger sensitivity was set at 50% change of bias flow (2 L/min) and the inspiration/
expiration ratio (I:E ratio) was set to obtain optimal patient-ventilator interaction 
based upon visual inspection of ventilator pressure and flow tracings. With PSV, 
trigger sensitivity and rise time were similar as in PCV. Inspiratory cycle off was 
adjusted for each patient based on flow and pressure waveforms to obtain a level 
where premature and late cycling-off was visually minimal. With NAVA, trigger 
sensitivity was 0.5 µV above baseline and cycle-off was manufacturer set at 70% of 
peak EAdi.
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Supplemental Figure 1. Breath-stacking caused by reversed triggering in patient #4 
during pressure control ventilation. Note the increase in tidal volume during each second 
patient-triggered breath. EAdi = electrical activity of the diaphragm; Paw = airway pressure; 
Vt = tidal volume.
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Abstract
Rationale: Controlled mechanical ventilation is used to deliver lung-protective 
ventilation in patients with acute respiratory distress syndrome. Despite recognized 
benefits, such as preserved diaphragm activity, partial support ventilation modes may 
be incompatible with lung-protective ventilation due to high tidal volume and high 
transpulmonary pressure. As an alternative to high dose sedatives and controlled 
mechanical ventilation, pharmacologically induced neuromechanical uncoupling of 
the diaphragm should facilitate lung-protective ventilation under partial support 
modes.
Objectives: To investigate whether partial neuromuscular blockade can facilitate 
lung-protective ventilation while maintaining diaphragm activity under partial 
ventilatory support.
Methods: In a proof-of-concept study, we enrolled ten patients with lung injury 
and a tidal volume >8 ml/kg under pressure support ventilation (PSV) and under 
sedation. After baseline measurements, rocuronium administration was titrated to 
target tidal volume of 6 ml/kg during neurally adjusted ventilatory assist (NAVA). 
Thereafter patients were ventilated in PSV and NAVA under continuous rocuronium 
infusion for 2 hours. Respiratory parameters, hemodynamic parameters and blood 
gas values were measured.
Measurements and Main Results: Rocuronium titration resulted in significant declines 
of tidal volume (9.3±0.6 to 5.6±0.2 ml/kg; p<0.0001), transpulmonary pressure 
(26.7±2.5 to 10.7±1.2 cmH
2
O; p<0.0001) and diaphragm electrical activity (17.4±2.3 
to 4.5±0.7 µV; p<0.0001) and could be maintained under continuous rocuronium 
infusion. During titration pH (7.42±0.02 to 7.35±0.02; p<0.0001) decreased, and 
mean arterial blood pressure (84±6 to 99±6 mmHg; p=0.0004) and heart rate (83±7 
to 93±8 beats/min; p=0.0004) increased.
Conclusions: Partial neuromuscular blockade facilitates lung-protective ventilation 
during partial ventilatory support while maintaining diaphragm activity in sedated 
patients with lung injury.
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Introduction
Mechanical ventilation is the cornerstone of treatment of patients presenting with 
acute respiratory distress syndrome (ARDS). Despite being lifesaving, mechanical 
ventilation can aggravate lung injury (1-4). A lung-protective ventilation strategy 
targeting low tidal volume (V
T
) and limited plateau airway pressure under controlled 
mechanical ventilation early in the course of ICU admission has been shown to 
improve survival in ARDS patients (5, 6). However, the use of controlled modes 
generally requires high levels of sedation (7, 8), which is associated with adverse 
outcomes (9, 10). In particular, controlled mechanical ventilation is associated with 
the development of diaphragm dysfunction (11-13). For instance, in a landmark study 
Levine and colleagues demonstrated that only a few days of controlled mechanical 
ventilation results in diaphragm muscle fiber atrophy (11). In accordance with these 
data, Jaber and colleagues reported a marked reduction of in vivo diaphragmatic 
force in patients on mechanical ventilation (13). Recently, the frequent occurrence of 
diaphragm atrophy was also demonstrated in the ICU (14).
 Modes of mechanical ventilation that allow spontaneous breathing, i.e. partial 
support ventilation, have recognized benefits including lung recruitment (15-17) and 
reduced risk of ventilator-induced diaphragm dysfunction (VIDD) (18-20). Recently, 
we demonstrated that in selected patients with mild to moderate ARDS partial 
support modes can deliver support within the limits of lung-protective ventilation 
(21). However, there are also patients in whom the transition from controlled modes 
to partial support modes is difficult because control of lung protection is lost. In partial 
support modes, these patients will generate high V
T
, high transpulmonary pressures 
(P
L
) and develop excessive work of breathing (WOB). Accordingly, patient selection 
and in particular timing for initiation of partial support ventilation is still under debate 
(22-24). In patients generating high V
T
 despite low level of assist clinicians may prefer 
controlled ventilation, including high dose sedatives. As an alternative strategy, 
pharmacologically induced partial neuromechanical uncoupling of the respiratory 
muscles may facilitate a lung-protective ventilation strategy, while maintaining 
diaphragm activity. This may allow a safe compromise between the benefits and 
risks of spontaneous breathing during mechanical ventilation (25). Interestingly, 
Campbell (26) demonstrated that low dose curare, a neuromuscular blocking agent 
(NMBA) of the acetylcholine receptor, reduces maximum inspiratory pressure, while 
maintaining spontaneous breathing in awake healthy subjects. We have explored 
here the possibility to reach irreconcilable targets with partial ventilatory assist. 
The targets are on the one hand keeping the benefit of spontaneous breathing in 
patients with lung injury, which have been demonstrated quite strongly and include 
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a potential prevention against ventilator-induced diaphragm dysfunction, and on the 
other hand avoid the risk of excessive tidal volumes reached by high respiratory drive 
under partial ventilatory assist.
 Accordingly, in the current study we investigated whether low dose neuromuscular 
blockers can facilitate a lung-protective ventilation strategy without loss of 
diaphragm activity during partial ventilatory support in lung injury patients with 
high tidal volumes. We hypothesized that partial neuromuscular blockade of the 
diaphragm allows the control of V
T
 and P
L
 to traditional lung-protective values, while 
maintaining diaphragm activity.
Methods
Study design and population
This proof-of-concept study was performed at the ICU of a university hospital. 
Adult patients admitted for ARDS were eligible if they were able to pneumatically 
trigger the ventilator and developed high V
T
 (>8 ml/kg predicted bodyweight) during 
pressure support ventilation (PSV) of 12 cmH
2
O. Exclusion criteria were recent use of 
NMBAs (<3 hours), pain or agitation (RASS > 0), metabolic acidosis, hemodynamic 
instability (i.e. high dose vasopressors or inotropes), elevated intracranial pressure, 
open chest/abdomen and past medical history of neuromuscular disorders. 
 The study was approved by the local ethics review committee and conducted in 
accordance with the Declaration of Helsinki. Patient surrogate decision makers gave 
written informed consent before study inclusion.
Study protocol
All patients were ventilated with the Servo-i ventilator (Maquet Critical Care, 
Sölna, Sweden). The study protocol consisted of three phases. Phase 1: baseline 
measurements, phase 2: titration of NMBA and phase 3: continuous infusion of 
NMBA (Figure 1). In phase 1, the physiological effects of different partial support 
modes were evaluated: assist-volume control ventilation (VCV) of 6 ml/kg, PSV 
of 12 cmH
2
O (PSV-12), PSV of 6 cmH
2
O (PSV-6) and neurally adjusted ventilatory 
assist (NAVA), where assist was titrated to equal V
T
 as with PSV-12. Two levels of 
PSV were selected, where 12 cmH
2
O reflects a reasonable level of support in these 
patients and 6 cmH
2
O was selected to confirm high V
T
 under low level of assist. In 
phase 2 (titration), rocuronium bromide (Fresenius Kabi, Zeist, The Netherlands) was 
titrated to obtain V
T
 <=6 ml/kg (details in the supplemental material). Titration was 
deliberately performed in NAVA, as in this mode diaphragm activity and support are 
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tightly linked and thus preservation of diaphragm activity is guaranteed. In phase 3 
(continuous infusion), patients were ventilated with PSV and NAVA for 1 hour per 
mode to evaluate feasibility of continuous partial neuromuscular blockade. PSV was 
chosen in addition to NAVA, as the former is the most widely used partial support 
mode. During phase 3 PSV level was set to obtain equal tidal volume as with NAVA. 
Positive end-expiratory pressure (PEEP) was set according clinical protocol and not 
changed. The sedation protocol is provided in the supplemental material.
Figure 1. Study protocol. Phase 1: different modes of partial support ventilation were 
evaluated without patients receiving neuromuscular blockade. NAVA level (cmH
2
O/µV) was 
titrated to equal support under PSV-12. Phase 2: following every bolus rocuronium an aver-
age V
T
 of 10 breaths was calculated to evaluate whether the target of 6 ml/kg was reached. 
Phase 3: PSV and NAVA were applied in random order for 1 hour with continuous rocuro-
nium infusion. PSV level was set to obtain equal support as with NAVA. If required an addi-
tional bolus rocuronium was given to control V
T
. NAVA = neurally adjusted ventilatory assist; 
PSV = pressure support ventilation; VCV = volume control ventilation; V
T
 = tidal volume.
Data acquisition and analysis
Flow, ventilatory pressure (Pvent), electrical activity of the diaphragm (EAdi), 
esophageal pressure (Pes), gastric pressure (Pga), blood pressure, heart rate and 
arterial oxygen saturation (SaO
2
) were acquired. Data acquisition and analysis details 
are provide in the supplemental material.
 
The duration of phase 2 (titration) differs 
per patient, therefore data were analyzed at seven points: the first and last minute 
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and five 1-min periods taken at equal time intervals in between. Blood samples were 
taken before phase 1 (baseline) and 2, and after phase 2 and 3.
Statistical analysis
To compare between ventilator modes and/or points in time, repeated measures 
ANOVA was performed (Prism 5, Graphpad, San Diego, CA, USA). If appropriate, 
post-hoc analysis was performed. A two-tailed p <0.05 was considered significant. 
Data are described as mean ± SEM, except as stated otherwise. 
Results
All patients fulfilled the Berlin criteria for ARDS at ICU admission with a PaO
2
/FiO
2
 
ratio ranging from 86 to 205 mmHg. In all patients PaO2/FiO2 had improved at the 
time of study inclusion (Table 1). Eleven patients were initially included, but one 
patient was excluded during the study due to low EAdi signal-to-noise ratio during 
rocuronium titration; as a consequence ventilation in NAVA mode was not feasible. 
Table 1 reports patient characteristics at study inclusion and Table 2 the relevant 
ventilatory settings during study protocol. Additional ventilator settings are provided 
in supplemental Table 1.
Rocuronium administration
The number of rocuronium boluses [range: 1 - 12], cumulative dose [range: 5 - 37 mg], 
and time [range: 6 - 60 min] required to achieve a V
T
 <=6 ml/kg were highly variable 
among patients. Similarly, the dose of continuous rocuronium infusion [range: 1 - 35 
mg/hr] and requirement for additional boluses [range: 0 - 10] to maintain low V
T
 
during two hour PSV and NAVA were variable among subjects. Supplemental Table 
2 and supplemental Table 3 report the details of rocuronium administration during 
titration and continuous infusion, respectively. 
Ventilatory response
Baseline V
T
 was high in PSV-12 (9.8 ± 0.5 ml/kg) and NAVA (9.4 ± 0.6 ml/kg). Reducing 
PS level from 12 to 6 cmH
2
O resulted in a minor reduction in V
T
 (PSV-6: 8.6 ± 0.6 ml/
kg) and a non-significant change in respiratory rate (PSV-12: 17.7 ± 1.5 breaths/min vs. 
PSV-6: 20.1 ± 2.0 breaths/min; p = 0.16). The trigger occlusion pressure in the first 100 
ms (P0.1) was 3.3 ± 0.4 cmH
2
O during PSV-12 and increased to 4.3 ± 0.7 cmH
2
O during 
PSV-6 (p < 0.05). In VCV, patients developed frequent breath-stacking with an average 
number of 8.0 ± 2.1 per minute (for examples see supplemental Figure 1). 
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Table 1. Patient characteristics at study inclusion
# Sex Age
(y)
Weight
(kg)
Height
(cm)
BMI
(kg/m2)
Days
ventilation
RASS Sedation / 
analgesia *
PaO2/FiO2
(mmHg)
Admission 
diagnosis
1 M 53 73 185 21 26 -4 sufentanil, 
midazolam
143 influenza
2 M 65 83 176 27 6 -4 - 145 pneumosepsis
3 M 61 86 186 25 4 -3 sufentanil, 
midazolam
257 aspiration
4 M 70 57 174 19 48 -4 sufentanil 187 interstitial lung 
disease
5 V 31 140 160 55 8 -4 sufentanil, 
propofol
375 psittacosis
6 M 63 76 176 25 4 -3 propofol 198 legionella
7 M 62 87 175 28 0.5 -4 sufentanil, 
midazolam
188 abdominal sepsis
8 M 61 73 176 24 24 -3 propofol 247 post-op aorta 
surgery
9 M 53 97 192 26 7 -4 sufentanil, 
propofol
157 lung contusion
10 M 72 64 167 23 3 -5 propofol 115 pneumosepsis
* Type of sedation/analgesia received in past 24 hours. Patient #2 received high levels of se-
dation up to 72 hours before inclusion but maintained low RASS due to severe kidney failure. 
Patient #4 received analgesia without sedation due to an encephalopathy. 
Table 2. Ventilator settings
# FiO2 (%) PEEP (cmH2O) NAVA level (cmH2O/µV) PSV level (phase 3) (cmH2O)
1 50 10 0.7 6
2 50 10 0.6 6
3 35 6 1.0 5
4 45 6 0.5 5
5 30 12 1.5 6
6 45 12 1.5 6
7 45 10 1.0 4
8 35 12 0.6 6
9 40 14 0.8 6
10 75 14 1.8 12
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As illustrated in Figure 2A, in phase 2, rocuronium titration resulted in 38 ± 4 % 
reduction in V
T
 (from 9.3 ± 0.6 to 5.6 ± 0.2 ml/kg). During titration the percentage 
of breaths with a V
T
 > 8 ml/kg decreased from 78 ± 11 % to 4 ± 4 %, and the 
percentage of breaths with a V
T
 < 6 ml/kg increased from 1 ± 1 % to 49 ± 9 % (Figure 
3). Low V
T
 could be maintained in phase 3, during continuous rocuronium infusion 
in both NAVA and PSV (Figure 2A). There was no difference in average V
T
 between 
NAVA and PSV during continuous rocuronium infusion (6.6 ± 0.4 ml/kg vs. 6.5 ± 0.3 
ml/kg; p = 0.91). 
 Reducing PSV from 12 to 6 cmH
2
O in phase 1 resulted in an increase in EAdi (from 
17.0 ± 2.7 to 22.8 ± 3.3 µV) and patient WOB (from 0.83 ± 0.16 to 1.21 ± 0.20 J/L) 
(Figure 2C-D). P
L
, EAdi and WOB followed a similar trend compared to V
T
 in response 
to partial neuromuscular blockade during titration (Figure 2B-D) with, respectively, 
a decrease of 58 ± 5 %, 73 ± 3 % and 40 ± 9 %. During continuous rocuronium 
infusion (phase 3), there were no differences between NAVA and PSV for average P
L
 
and EAdi, but patient WOB was slightly lower with PSV. 
 Rocuronium administration had no significant effect on the coefficient of variation 
of V
T
 (baseline: 8.4 ± 1.0 % vs. end titration: 11.1 ± 0.8 %; p = 0.06) and the 
coefficient of variation of EAdi (baseline: 17.1 ± 1.7 % vs. end titration: 20.0 ± 1.5 
%; p = 0.33).
 Figure 4 shows the effects of rocuronium titration (phase 2) on Pvent, 
transdiaphragmatic pressure (Pdi), esophageal pressure (Pes), respiratory rate, and 
minute ventilation (
E
) and at the end of 1 hour NAVA and PSV (phase 3). Inspiratory 
time did not change during the titration phase (from 0.90 ± 0.14 sec in the first 
minute to 0.90 ± 0.22 sec in the last minute; p = 0.436), whereas expiratory time 
decreased from 2.58 ± 0.23 sec in the first minute to 2.14 ± 0.23 sec in the last 
Figure 2. Progress of V
T
, delta P
L
, EAdi and WOB during the different phases of the study 
protocol. Without neuromuscular blockade V
T
 and delta P
L
 were high in all three partial sup-
port modes. Note that V
T
 is lower with PSV-6 compared to PSV-12 and NAVA, but results in 
a higher EAdi and WOB. Rocuronium titration resulted in a gradual, but strong, decline of 
all parameters. A V
T 
<= 6 ml/kg was realized in all subjects with preservation of EAdi. During 
continuous rocuronium infusion more or less stable values could be obtained in both NAVA 
and PSV. Dotted lines in panel A and D represent 6 ml/kg and WOB in healthy volunteers 
(0.47 J/L) (27), respectively. Absolute P
L
 and WOB (J/min) are shown in the supplemental 
Figure 2. EAdi = electrical activity of the diaphragm; NAVA = neurally adjusted ventilatory 
assist; P
L
 = transpulmonary pressure. PSV = pressure support ventilation; VCV = volume con-
trol ventilation; V
T
 = tidal volume; WOB = work-of-breathing. * p < 0.05 for PSV-6 vs. PSV-12 
and NAVA. +
 
p < 0.05 for NAVA vs. PSV-6 and PSV-12.
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minute (p < 0.05). Dynamic lung compliance increased during phase 2 from 26 ± 2 
in the first minute to 42 ± 4.7 ml/cmH
2
O in the last minute (p < 0.0001). Expiratory 
muscle activity, measured by the increase in gastric pressure during expiration, was 
low at start of titration (1.3 ± 0.37 cmH
2
O) and did not change during the study (1.0 
± 0.47 after titration; p = 0.637).
 Figure 5 shows that short-term use (2 hrs) of partial neuromuscular blockade does 
not affect neuromechanical efficiency of the diaphragm, indicating the absence of 
the development of diaphragm fatigue.
Figure 3. Distribution of low and high V
T
 during rocuronium titration. V
T
 = tidal volume.
Cardiovascular response
Hemodynamic data from one patient was lost due to technical issues during data 
acquisition. Facilitating lung protective ventilation with NMBA did have some 
hemodynamic consequences. Mean arterial blood pressure and heart rate increased 
during rocuronium titration (phase 2) from 84 ± 6 to 99 ± 6 mmHg, and 83 ± 7 to 
93 ± 8 beats/min, respectively (supplemental Figure 3). Mean arterial blood pressure 
partially returned to baseline values in phase 3. There were no correlations between 
RASS and delta mean arterial blood pressure (Spearman r = -0.29, p = 0.437), 
and RASS and delta heart rate (Spearman r = -0.19, p = 0.613) during rocuronium 
titration. There was a significant, but clinical irrelevant, decrease in SaO
2
 from 98 ± 
0.5 to 97 ± 0.5 % during rocuronium titration (p = 0.01). There were no differences 
in hemodynamic response between NAVA and PSV during continuous rocuronium 
infusion.
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Figure 4. Pvent, Pdi, Pes, respiratory rate, and 
E
 during titration (phase 2) and at the end of 
1 hour NAVA and PSV (phase 3). Since ventilator output and diaphragm activity are coupled 
with NAVA there is a decline in Pvent during titration. In response to the decline in V
T 
(Figure 
2A) there is an increase in respiratory rate, nevertheless 
E
 drops during titration. In panel B 
the circles represent Pdi (p = 0.0001) and the squares represent Pes (p = 0.0013). p-values 
relate to the titration phase. NAVA = neurally adjusted ventilatory assist; Pdi = transdia-
phragmatic pressure; Pes = esophageal pressure; PSV = pressure support ventilation; Pvent 
= ventilatory pressure; 
E
 = minute ventilation; V
T
 = tidal volume.
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Figure 5. Neuromechanical efficiency 
(NME) of the diaphragm during continu-
ous infusion of rocuronium (phase 3). There 
were no differences in NME over time for 
NAVA and PSV, and between modes.
Figure 6. PaCO
2
 and pH at different time points. As a result of partial neuromuscular block-
ade and the consequent drop in 
E
, there is marked increase in PaCO
2
 and decrease in arterial 
pH. NAVA = neurally adjusted ventilatory assist; PaCO
2
 = partial pressure of CO
2
 in arterial 
blood; PSV = pressure support ventilation. * p < 0.05 compared to baseline. +
 
p < 0.05 com-
pared to end titration. 
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Blood gas values
Figure 6 shows the results of the arterial blood gas analysis at multiple time points. 
Briefly, there was a significant rise in PaCO
2
 after rocuronium titration (phase 2), that 
further increased during the continuous rocuronium infusion (phase 3). Consequently, 
pH decreased during phase 2 and further decreased during phase 3. PaO
2
 remained 
stable during the study (baseline: 96 ± 7 mmHg, end of NAVA (phase 3): 96 ± 6 
mmHg, end of PSV (phase 3): 100 ± 8 mmHggHg). 
Discussion
In the present proof-of-concept study we evaluated a novel strategy to deliver 
lung-protective ventilation while maintaining diaphragm activity in lung injury 
patients with high tidal volume during partial support ventilation. We found that 
neuromechanical uncoupling of the diaphragm by partial neuromuscular blockade 
1) facilitates lung-protective ventilation as indicated by low tidal volumes and low 
transpulmonary pressures and 2) reduces the work of breathing, while 3) maintaining 
diaphragm activity. Furthermore, low V
T
 and P
L
 could be maintained under continuous 
rocuronium infusion for at least 2 hours. However, this strategy is associated with 
mild hemodynamic side effects, including tachycardia and elevated blood pressure, 
and development of hypercapnic acidosis.
Before rocuronium administration, tidal volume and transpulmonary pressures were 
above the limits of lung-protective ventilation under partial support ventilation. In 
addition to high V
T, 
most patients had relatively high EAdi (± 17 µV) and delta Pes (± 
-11 cmH
2
O) compared to other studies with comparable levels of support (21, 28, 29), 
indicating strong spontaneous breathing efforts, and a moderate to high P0.1 (± 4 
cmH
2
O). Reducing pressure support level from 12 cmH
2
O to 6 cmH
2
O decreased V
T
 only 
with ±1 ml/kg (still at ± 8.6 ml/kg), but increased patient work of breathing. Further 
reducing pressure support and eventually CPAP would result in even higher work of 
breathing, which may result in the development of diaphragm injury and fatigue (30-32). 
Appropriate setting of PSV to attain both lung-protective ventilation and physiological 
levels of patient work of breathing is a clinical challenge. An assist-controlled mode 
under these conditions resulted in severe breath stacking (supplemental Figure 1), which 
is associated with high V
T
 (33). A reasonable option for the clinician would be to switch 
to controlled ventilation and increase the level of sedation to decrease respiratory drive. 
Instead, we studied the effects of partial neuromuscular blockade of the diaphragm 
using the acetylcholine receptor antagonist rocuronium.
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Tidal volume and transpulmonary pressure
The ventilatory response to rocuronium administration was rather unpredictable 
among patients (supplemental Table 2). Nevertheless, we were successful in titrating 
V
T 
<=6 ml/kg, as dictated by the protocol in all patients, supporting our hypothesis. In 
response to the decreased V
T
, respiratory rate increased, but not sufficient to maintain 
E
. The latter is in contrast to a study evaluating the respiratory effects of low dose 
NMBA in healthy subjects, where increased respiratory rate completely compensated 
for reduction of V
T
 (34). Most likely in our patients sedatives did reduce sensitivity of 
the central respiratory centers to increased PaCO
2
 and reduced pH (35-38). Although 
such pH during the continuous rocuronium administration seems to be safe from 
physiological perspective and may even be lung-protective (39), in patients with light 
sedation this may result in enhanced dyspnea sensation. 
 The transpulmonary pressure is the real distending pressure of the lung parenchyma. 
The point at which over distention of alveolar structures occurs is called the upper 
physiological limit of P
L
, which has been suggested to be around 25 cmH
2
O (40, 41). 
Even when plateau pressure of the ventilator is limited to 30 cmH
2
O, high P
L
 generated 
by strong spontaneous breathing efforts have been shown, in experimental studies, to 
worsen lung injury (4, 42, 43). In the present study, the initial high P
L
 (±27 cmH
2
O), was 
significantly reduced to lung-protective values (±11 cmH
2
O) after rocuronium titration. 
Our measurements of P
L
 were performed under dynamic conditions. Thus P
L 
consists 
of a resistive and elastic component, where only the latter is assumed to be injurious 
to the lung (29). As peak flow decreased during titration of rocuronium, part of the 
decrease in P
L
 can be attributed to the resistive component. 
 In the current study, neuromuscular blockade was titrated to achieve a V
T
 of 6 ml/
kg, although the optimal lung-protective V
T
 and P
L
 under assisted ventilation is subject 
of debate. In mild to moderate ARDS beneficial effects of spontaneous breathing 
efforts have been demonstrated in clinical studies (15-17). In particular, redistribution 
of ventilation due to alveolar recruitment of dependent lung areas may reduce lung 
injury (15). However, patient breathing efforts may promote lung injury in severe ARDS 
through different mechanisms (43, 44). First, large negative swings in P
L
 are more 
likely to occur in severe ARDS (43). Second, development of pendelluft may result 
in inhomogeneous stretch of dependent lung areas and may additionally contribute 
to lung injury (44). Accordingly, whether spontaneous breathing efforts in patients 
with injured lungs are beneficial or damaging depends on several factors, as outlined 
above. This concept has recently been elegantly reviewed by Yoshida and colleagues 
(23). Although the optimal V
T
 and P
L
 are debated in patients with ARDS under partial 
support ventilation, titration of a neuromuscular blocker facilitates precise control of 
these variables. 
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Diaphragm activity
High dose non-depolarizing NMBAs (such as rocuronium) competitively inhibit the 
postsynaptic acetylcholine receptors of the neuromuscular motor endplate, preventing 
depolarization and as such force generation (45). Using low dose rocuronium as in 
the present study allows more subtle modulation of EAdi and Pdi. In other words, 
strong spontaneous breathing efforts were abolished, but a significant degree of 
diaphragm activity was maintained. In animal studies, maintaining spontaneous 
respiratory efforts during mechanical ventilation alleviated the development of VIDD 
(18-20). As to whether the levels of diaphragm activity we obtained are sufficient 
to prevent or alleviate the development of VIDD is unknown, but after titration of 
rocuronium, near physiological levels of diaphragm activity were attained (Figure 2). 
 Administration of low dose muscle rocuronium induces acute muscle weakness. 
Therefore, a possible concern of this strategy is the development of respiratory muscle 
fatigue. Moreover, non-depolarizing neuromuscular blockers, such as rocuronium, 
tend to produce less blockade at fast-twitch (fatigue resistant) than slow-twitch 
fibers (46, 47). Throughout the 2 hours of continuous infusion the stability of V
T
, EAdi 
and P
L
 confirms it is feasible to maintain partial paralysis. EAdi represents the spatio-
temporal summation of motor unit action potentials, which in turn translates into 
muscle-tension and Pdi. Thus, the stable NME (Figure 5) contradicts that the muscle 
tension developed for a given EAdi was reduced, virtually excluding the development 
of contractile fatigue of the diaphragm. Whether prolonged administration of 
low dose rocuronium results in fatigue or injury of the diaphragm remains to be 
investigated. 
 It should be emphasized that partial neuromuscular blockade induces neuro-
mechanical uncoupling of the diaphragm and therefore the reduction in EAdi does 
not reflect a decreased neural respiratory drive, which is most likely increased. 
Studying respiratory drive under neuromuscular blockade would require measuring 
activity of the central respiratory centers or the phrenic nerve which is not feasible in 
ICU patients. 
Cardiovascular response 
Titration of rocuronium resulted in a mild increase in arterial blood pressure and heart 
rate. Supposedly, the cardiovascular response to partial neuromuscular blockade 
could be mediated through several pathways. First, direct cardiovascular effects 
of rocuronium administration (2 to 4 times the ED95) have been studied previously 
(48-50). The general conclusion from these studies in anesthetized and ventilated patients 
is that rocuronium has virtually no direct effects on hemodynamic variables. Moreover, 
we used much lower doses of rocuronium. Second, patients developed hypercapnic 
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acidosis in phase 2 and 3 of the study. The integrated hemodynamic response to 
hypercapnic acidosis during complete paralysis, as part of a lung-protective approach 
in ARDS, has been well described, and may be characterized by an increase in cardiac 
output, heart rate, and stroke volume, a decrease in systemic vascular resistance, and no 
effect on mean arterial blood pressure (51-53). This sympatheticoadrenergic activation 
by hypercapnic acidosis is supported by observations of higher perfusion to the adrenal 
glands and production of catecholamines in the state of hypercapnic acidosis (54, 
55). Previously, it was demonstrated that rapid induction of hypercapnic acidosis by 
reducing V
T
 in patients with ARDS is associated with impaired right ventricular function 
and reduced cardiac index (56). In contrast to our study, in that study MAP decreased. 
Third, physical stress in response to increased dyspnea sensation may increase heart 
rate and blood pressure. However, patients in our study were moderately to deeply 
sedated, no physical signs of stress (anxiety, agitation, diaphoresis) were observed, and 
we found no correlation between sedation depth and the changes in heart rate and 
blood pressure during rocuronium titration. In addition, both heart rate and systolic 
blood pressure decreased again during phase 3 (continuous infusion) to baseline levels. 
Fourth, increased central neural drive to the diaphragm during partial neuromuscular 
blockade may activate the cardiovascular response in parallel. This feed-forward 
neural mechanism in response to physical activity is termed ‘central command’ (57). 
Experimental studies to assess the influence of central command on the cardiovascular 
response have demonstrated that partial neuromuscular blockade during static and 
dynamic exercise leads to a concomitant increase in heart rate and mean arterial 
pressure (58-61). This was suggested to be directed by way of increased plasma 
catecholamine levels (60). To minimize hemodynamic consequences in the future, the 
increase in PaCO
2
 could be made less rapid by titrating rocuronium more slowly.
Clinical implications 
Our results may have potential future clinical implication with respect to patients 
recovering from ARDS with high tidal volume and high transpulmonary pressure during 
partial support ventilation. Recently, we have shown that partial support modes allow 
lung-protective ventilation in sedated patients with stable ARDS (PaO
2
/FiO
2
 144 ± 12 
mmHg) (21). However, in patients with strong spontaneous breathing efforts this may 
result in high V
T
 and lung distending pressures. In the present study, we demonstrated 
the feasibility of partial neuromuscular blockade to facilitate lung-protective ventilation 
during partial support ventilation while preserving diaphragm activity. Because the 
current study is only a proof of concept, it is too early for clinical application. The 
long-term effects of partial neuromuscular blockade on respiratory muscle function 
need to be studied. In addition, titration with rocuronium is complicated and requires 
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continuous observation of the patients’ respiratory muscle activity to adjust rocuronium 
dose. Several tools are available to monitor respiratory muscle function (62). All 
patients in the present study were sedated. One of the intended effects of partial 
neuromuscular blockade is to reduce the need for sedation. Future studies should 
carefully evaluate whether partial neuromuscular blockade is tolerated by patients 
under light or no sedation. As mentioned before, progressive partial paralysis has been 
studied in healthy volunteers without sedation (26, 34, 35, 63-69). 
Study limitations
This study has limitations. First, our study is a single-center, proof-of-concept study, 
conducted in a selected and small group of patients. This limits the interpretation of 
our data. Moreover, the relative short study period of 2 hours of partial neuromuscular 
blockade might not be enough to reflect the consequences for patients who are 
ventilated for longer times.
 Second, only physiological markers associated with the development of lung injury 
(V
T
 and P
L
) and diaphragm function (EAdi, Pdi) were evaluated. Future studies should 
also assess the effect of this strategy on direct markers for lung injury and diaphragm 
injury (i.e. histology, inflammation).
 Third, prior to titration of neuromuscular blockade we did not evaluate the effect of 
different PEEP levels on breathing effort. Increasing PEEP level will increase end-expiratory 
lung volume (EELV) (70), which may result in a reduction in neural respiratory drive via 
the positive effects of lung recruitment (71). Nevertheless, modulation in respiratory 
drive by increase in EELV is modest compared to the reductions in diaphragmatic force 
that were required to achieve 6 ml/kg in our study. 
 Fourth, only the diaphragm was evaluated in this study, so we are unaware of the 
effects of partial neuromuscular blockade on other respiratory and peripheral muscles. 
Previous studies demonstrated that the diaphragm is less susceptible to neuromuscular 
blockade compared to peripheral muscle, called the respiratory sparing effect (34, 67, 
68). Therefore, it is likely that peripheral muscles were at least equally affected as the 
diaphragm. 
In conclusion, the present proof-of-concept study demonstrates that partial 
neuromuscular blockade facilitates lung-protective ventilation during partial ventilatory 
support, while maintaining diaphragm activity. These findings are of potential interest 
for patients recovering from ARDS with spontaneous breathing efforts under modest 
levels of partial ventilatory assist leading to high tidal volumes. Further research should 
focus on better control of hemodynamic effects and understanding of the long-term 
consequences on muscular function and dyspnea.
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Supplemental material
Supplemental methods
Sedation protocol
Patients were sedated during the study, although not all patients received sedatives 
at the time of the study execution (see Table 1 of the main manuscript). Patient #2 
received high levels of sedation up to 72 hours before inclusion but was still sedated, 
probably due to severe kidney failure. Patient #4 received analgesics (sufentanil) 
without sedatives due to an encephalopathy. A senior critical care physician and 
nurse not involved in the study were present at the bedside to assure comfort of 
the patient. A bolus of either propofol or midazolam could be administered when 
deemed appropriate by the nurse, according to our clinical protocol for ICU sedation. 
A bolus was administered in 4 of the patients included in this study during rocuronium 
titration.
Titration protocol
The goal of rocuronium titration was to partially block diaphragmatic force to obtain 
a V
T
 of 6 ml/kg. Therefore, rocuronium was titrated on V
T
 and not guided by the 
train-of-four technique. Following every bolus of rocuronium (2 to 5 mg) an average 
tidal volume of 10 breaths was calculated to evaluate whether the target of 6 ml/kg 
was reached. If the target was not reached a subsequent bolus was given. This was 
repeated until a V
T
 of 6 ml/kg was reached.
Data acquisition 
Electrical activity of the diaphragm (EAdi), esophageal pressure (Pes) and gastric 
pressure (Pga) were measured with a multi-electrode esophageal catheter with 
double balloons (Neurovent Research Inc., Toronto, Canada). EAdi refers to a 
method using a standard electrode, acquisition, and analysis system to overcome 
signal filtering and processing effects when quantifying the electromyogram of the 
diaphragm (72). Specifically, EAdi in the present study refers to the calibration in µV 
made for the commercially available Servo-i ventilator (Maquet Critical Care, Sölna, 
Sweden). Details on catheter positioning were published previously by our group (21, 
73). Flow, ventilatory pressure (Pvent), Pes, Pga, and EAdi tracings were acquired 
synchronously and continuously during all three phases of the study protocol as 
described previously (21). Transdiaphragmatic (Pdi) and transpulmonary pressure 
(P
L
) were calculated as the difference between Pga and Pes, and Pvent and Pes, 
respectively.
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 An arterial catheter was used for continuous blood pressure monitoring and 
blood sampling. Heart rate and rhythm were monitored using a standard 5-lead 
electrocardiography system. Pulse oximetry was used to monitor arterial oxygen 
saturation (SaO
2
). Blood pressure, heart rate and SaO
2
 were sampled every 30 
seconds from a patient monitor (MP50, Philips, Eindhoven, The Netherlands) by an 
in-house developed data acquisition system. 
Data analysis 
All tracings were analyzed off-line using a software routine developed for Matlab 
(R2014b, Mathworks, Natick, MA, USA). Variables from the respiratory tracings were 
analyzed on a breath-by-breath basis. For phase 1 a 2-min period at the end of each 
mode was selected for analysis. The duration of phase 2 is different per patient, 
therefore data were analyzed at seven points in time: the first and last minute and 
five 1-min periods taken at equal time intervals in between. For phase 3 a 2-min 
period was selected for analysis every ten minutes of each mode during 1 hour. For 
each breath, we defined the following variables during the inspiratory phase:
•  V
T
, as the integral of the inspiratory flow over time.
•  Delta Pvent, as maximal change from PEEP level.
•  Delta and absolute P
L
. For delta P
L
 baseline was defined as transpulmonary 
pressure at start of inspiration.
•  Delta Pdi, as change from baseline. Baseline was defined as Pdi at start of 
inspiration.
•  P0.1 was calculated from Pes according to a previously described method (74)
•  Peak EAdi. 
•  Neuromechanical efficiency (NME), as the ratio between Pdi and EAdi.
•  Work-of-breathing (WOB), as calculated from the Campbell diagram (75).
∙•  Dynamic compliance (C
dyn
),
 
as V
T 
/ delta P
L
.
Breath-by-breath variability was assessed by calculating the coefficient of variation 
(CV; [standard deviation/mean]*100) for V
T
 and EAdi. Blood pressure, heart rate and 
SaO
2
 were averaged over the same time intervals as previously mentioned
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Supplemental Table 1. Additional ventilator settings
# Assist-volume control Pressure support NAVA
I:E
ratio
Pause time 
(% insp. time)
Insp. trigger 
(l/min)
Insp. trigger 
(l/min)
Exp. trigger
(% peak flow)
Insp. trigger 
(µV)
Tube / canule 
size (mm)
1 1:2 0 1.4 1.4 30 0.5 8
2 1:1.5 10 1.4 1.4 30 0.5 8
3 1:2 10 1.4 1.4 30 0.5 7.5
4 1:2 0 1.0 1.0 10 0.5 8
5 1:2 10 1.4 1.4 30 0.5 7
6 1:2 0 0.6 0.6 30 0.5 8
7 1:2 10 1.6 1.6 30 0.5 8
8 1:2 0 1.4 1.4 30 1.0 8
9 1:2 0 1.6 1.6 30 1.0 8
10 1:2 10 1.6 1.6 30 0.5 7
All patients were ventilate with a Servo-i ventilator (Maquet Critical Care, Sölna, Sweden) 
with a MR850 humidification device (Fisher & Paykel Healthcare Limited, Auckland, New 
Zealand). As a secondary source NAVA also employs the flow trigger, set as shown in the 
table, which operates in combination with the neural trigger on a first-come-first-served 
basis. Expiratory triggering in NAVA starts when the EAdi decreases below 70% for normal 
and high EAdi signals (40% for low EAdi signals) of the peak value.
Supplemental Table 2. Rocuronium administration (titration phase)
# Bolus (#) Total bolus (mg) Bolus (mg/#) Time (min)
1 11 34.0 3.1 33
2 1 5.0 5.0 6
3 3 15.0 5.0 12
4 2 7.5 3.8 10
5 6 31.0 5.2 42
6 6 22.0 3.7 36
7 5 14.0 2.8 14
8 5 30.0 6.0 23
9 12 37.0 3.1 60
10 4 14.0 3.5 12
mean 6 21.0 4.1 25
SEM 1 3.6 0.3 6
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Supplemental Table 3. Continuous rocuronium infusion and additional boluses (phase 3)
# Continuous * (mg/h) Bolus (#) Total bolus (mg) Bolus (mg/#)
1 35 9 27 3.0
2 14 0 0 0.0
3 5 3 10 3.3
4 8 3 6 2.0
5 26 10 24 2.4
6 10 6 19 3.2
7 1 0 0 0.0
8 18 10 39 3.9
9 33 4 12 3.0
10 11 2 4 2.0
mean 16 5 14 2.3
SEM 4 1 4 0.4
  * average value of 2 hours
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Supplemental Figure 2. Progress of absolute P
L
 and WOB (J/min) during the different 
phases of the study protocol. Without neuromuscular blockade absolute P
L
 was high in 
all three assisted modes. Rocuronium titration resulted in a gradual, but strong, decline of 
both parameters. During continuous rocuronium infusion more or less stable values could 
be obtained in both NAVA and PSV. +
 
p < 0.05 for NAVA vs. PSV-6 and PSV-12. NAVA = 
neurally adjusted ventilatory assist; P
L
 = transpulmonary pressure. PSV = pressure support 
ventilation; WOB = work of breathing.
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Supplemental Figure 3. Cardiovascular response during rocuronium titration (phase 2) 
and at the end of 1 hour NAVA and PSV (phase 3). ABP = arterial blood pressure; HR = heart 
rate; NAVA = neurally adjusted ventilatory assist; PSV = pressure support ventilation.
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Abstract
Rationale: Acquired diaphragm muscle weakness is a key feature in several chronic 
diseases including chronic obstructive pulmonary disease, congestive heart failure, 
and difficult weaning from mechanical ventilation. However, no drug is available to 
improve respiratory muscle function in these patients. Recently, we have shown that 
the calcium sensitizer levosimendan enhances force generating capacity of isolated 
diaphragm fibers.
Objectives: To investigate the effects of the calcium sensitizer levosimendan on in 
vivo human diaphragm function.
Methods: In a double-blind randomized crossover design, 30 healthy subjects 
performed two identical inspiratory loading tasks. After the first loading task, 
subjects received levosimendan (40 µg/kg bolus followed by 0.1/0.2 µg/kg/min 
continuous infusion) or placebo. Transdiaphragmatic pressure, diaphragm electrical 
activity and their relationship (neuro-mechanical efficiency) were measured during 
loading. Magnetic phrenic nerve stimulation was performed before the first loading 
task and after bolus administration to asses twitch contractility. Center frequency of 
diaphragm electrical activity was evaluated to study the effects of levosimendan on 
muscle fiber conduction velocity.
Measurements and Main results: The placebo group showed a 9% (P=0.01) loss 
of twitch contractility after loaded breathing, whereas no loss in contractility was 
observed in the levosimendan group. Neuro-mechanical efficiency of the diaphragm 
during loading improved by 21% (P<0.05) in the levosimendan group. Baseline 
center frequency of diaphragm electrical activity was reduced after levosimendan 
administration (P<0.05). 
Conclusions: The calcium sensitizer levosimendan improves both neuro-mechanical 
efficiency and contractile function of the human diaphragm. Our findings suggest a 
new therapeutic approach to improve respiratory muscle function in patients with 
respiratory failure.
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Introduction
Impaired force generation of the respiratory muscles has been recognized in a variety 
of diseases including chronic obstructive disease (COPD), congestive heart failure and 
in the critically ill (1-7). The pathophysiological substrate of diaphragm dysfunction 
in these disorders is multifactorial and includes muscle fiber atrophy and contractile 
protein dysfunction (3, 8-11). We found that diaphragm muscle fibers of patients 
with COPD display reduced sensitivity of the contractile proteins to calcium (9, 12). In 
other words more calcium is needed to develop the same amount of force as in the 
non-COPD diaphragm, resulting in impaired contractile efficiency of the diaphragm 
muscle. Subsequent studies have shown that calcium sensitivity is also reduced in the 
diaphragm of animal models for congestive heart failure and prolonged mechanical 
ventilation (2, 13). Despite a better understanding of respiratory muscle dysfunction 
in chronic diseases, currently no drug is available to improve respiratory muscle 
function in humans.
 Levosimendan is a clinically used calcium sensitizer, approved to enhance cardiac 
contractility in patients with acute heart failure. Clinical studies have shown that 
levosimendan improves cardiac function in these patients (14). Levosimendan 
enhances the binding of calcium to troponin C, thereby improving the responsiveness 
of myofilaments to calcium. Accordingly, a greater amount of force is generated 
for the same level of cytosolic calcium, resulting in enhanced contractile efficiency. 
Besides calcium sensitizing, levosimendan has vasodilatory properties mediated by 
the opening of the ATP-sensitive potassium (K
ATP
) channels (15).
 Recently, we have shown that levosimendan also enhances calcium sensitivity of 
permeabilized muscle fibers obtained from the human diaphragm, including patients 
with COPD (12). However, the effects of calcium sensitizing on the human diaphragm 
in vivo have not been studied. Based on our in vitro data (12) we hypothesize 
that levosimendan improves contractile function of the human diaphragm in vivo 
through calcium sensitizing. In addition, levosimendan would decrease muscle 
fiber conduction velocity of the diaphragm, through its effects on K
ATP 
channels in 
diaphragm fibers. We tested this hypothesis in a double-blind placebo controlled 
crossover design in healthy subjects performing inspiratory loading tasks. Some of 
the results of this study have been previously reported in the form of an abstract (16).
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Methods 
We enrolled 30 healthy volunteers in this trial. The protocol was approved by the 
ethical committee of the Radboud University Nijmegen Medical Centre and registered 
at ClinicalTrials.gov (NCT01101620). All subjects gave their informed consent.
Esophageal catheter 
Diaphragm EMG (EMGdi), esophageal (Pes) and gastric (Pga) pressure were obtained 
with a multi-electrode esophageal catheter with two balloons; see the supplemental 
material for details. Pdi was calculated as Pga-Pes.
Magnetic stimulation and maximal inspiratory effort
Cervical magnetic stimulation of the phrenic nerves was performed to measure 
twitch Pdi (Pdi
tw
) and compound muscle action potential of the diaphragm (CMAPdi). 
See the supplemental material for stimulation protocol details. 
 Maximal voluntary Pdi (Pdi
max
) was measured as mean Pdi in the first second during 
a maximal inspiratory effort against a closed valve at functional residual capacity. 
Inspiratory loading task
Each subject performed two identical loading tasks, before and after administration 
of study medication. Sitting in upright position, with uncast abdomen subjects 
breathed through a mouthpiece wearing a nose clip. Subjects performed intermittent 
inspiratory maneuvers of 10 second against a closed valve (near-isometric contractions) 
followed by 7 seconds of unloaded breathing. Duty cycle was imposed by a sound 
signal and subjects were asked to target 40% of Pdi
max
. Visual feedback of Pdi was 
provided. Total loading task duration was 10 minutes. During loading, EMGdi and 
Pdi were recorded continuously, as well as in unloaded conditions approximately 5 
minutes before and after loading. Respiratory effort sensation was scored with a 
Borg scale (range 6-20) at one, three, six, and nine minutes into loading. 
Experimental protocol
The protocol is presented in Figure 1. Pdi
tw 
and Pdi
max
 were measured and followed 
by the first loading task and 30 minutes of unloaded breathing. After randomization 
subjects received study medication, either levosimendan bolus (40 µg/kg bodyweight, 
iv) or an equal volume of placebo in 10 minutes. Pdi
tw 
and Pdi
max
 measurements 
were repeated and followed by 30 minutes of continuous levosimendan (0.1 μg/kg 
bodyweight/min, iv) or placebo infusion. A second loading task was performed while 
infusing levosimendan (0.2 μg/kg/min, iv) or placebo. 
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Heart rate, end tidal carbon dioxide (etCO
2
) and peripheral oxygen saturation (SpO
2
) 
were monitored continuously. Blood pressure was measured non-invasively every 10 
minutes and during bolus administration each minute. In six subjects cardiac output 
was determined by transthoracic echocardiography directly before and after bolus 
administration. 
Figure 1. Schematic description of the protocol. Abbreviations: Pdi
tw
 = twitch transdia-
phragmatic pressure; Pdi
max
 = maximum transdiaphragmatic pressure. 
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Data Analysis and Statistics
Measurement variables were analyzed offline in Matlab R2009b (The Mathworks, 
Natick, MA); see the supplemental material for details. The ratio of mean inspiratory 
Pdi and EMGdi amplitude was calculated as a measure of the neuro-mechanical 
efficiency of the diaphragm. Changes in muscle fiber conduction velocity were 
evaluated using the power spectrum center frequency (CFdi) of the EMGdi; see the 
supplemental material for details. Comparisons were made with
 
the appropriate 
t-test. Changes over time during loaded breathing were analyzed using repeated 
measures ANOVA. Values are means ± SEM, and P < 0.05 was considered significant. 
Statistical analyses were performed with SPSS 16.0 (SPSS, Chicago, IL, USA).
Results
Baseline characteristics of the subjects (male/female 23/7; age 22 ± 0.4 yrs; 
bodyweight 74 ± 1 kg; and body mass index 23 ± 0.4 kg/m2) were not different 
between the placebo and levosimendan group. All subjects (n=30) received study 
medication as dictated by the protocol. One subject was excluded due to technical 
problems with the esophageal catheter. Two subjects were not able to maintain 
targeted Pdi (less than 30% of Pdimax) during the first loading task and were excluded 
from data analysis. The remaining subjects (placebo n=13 and levosimendan n=14) 
were able to keep their targeted Pdi during both loading tasks (44 ± 1% and 43 ± 
2%), indicating compliance to the protocol. SpO
2
 was above 96% in all subjects 
during the study, without supplemental oxygen. There were no differences in etCO
2
 
between the placebo and levosimendan group during loaded breathing. 
 Furthermore, there were no serious adverse events during the experimental 
protocol. One subject, receiving levosimendan, experienced a mild degree of nausea 
after completion of the study. 
Diaphragm contractility
Cervical magnetic stimulation of the phrenic nerve resulted in reproducible twitch 
pressures in all subjects. Data from magnetic stimulation and maximal inspiratory 
maneuvers, as well as hemodynamic data, are given in Table 1. There was no 
significant difference in Pdi
tw
 and Pdi
max
 between the placebo and levosimendan 
group before study medication. 
 Figure 2 shows a decreased contractile response of the diaphragm after the first 
loading task in a subject receiving placebo. On average, loaded breathing in subjects 
receiving placebo resulted in significant reductions in Pdi
tw
 (-9 ± 3 %, P=0.01) and 
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Pdi
max
 (-5% ± 3, P<0.05). The group receiving levosimendan after the first period of 
loaded breathing revealed no significant decrease in Pdi
tw
 and Pdi
max
 (Figure 3 and 
Table 1).
Table 1. Effect of loading and levosimendan on the diaphragm and hemodynamics
Placebo
(n=13)
Levosimendan 
(n=14)
baseline after loading + bolus 
administration
baseline after loading + bolus 
administration
Pditw (cmH2O) 35 ± 2 32 ± 2 * 30 ± 2 31 ± 2
CMAPdi (mV) 1.3 ± 0.2 1.3 ± 0.2 1.0 ± 0.1 1.1 ± 0.1
Pdimax (cmH2O) 130 ± 8 122 ± 7 * 123 ± 11 120 ± 8
EMGdimax (μV) 76 ± 9 81 ± 10 77 ± 98 74 ± 10 
MAP (mmHg) 92 ± 2 89 ± 4 90 ± 3 86 ± 4
HR (bpm) 71 ± 3 73 ± 3 68 ± 2 83 ± 3 *
CO (l/min) 4.5 ± 1.3 4.6 ± 0.4 6.2 ± 0.7 7.0 ± 0.7 *
Diaphragm contractility and hemodynamic variables at baseline and after loading + bolus 
administration. Twitch transdiaphragmatic pressure (Pdi
tw
)
,
 compound muscle action poten-
tial of the diaphragm (CMAPdi), maximum transdiaphragmatic pressure (Pdi
max
), and maxi-
mum electromyographic activity (EMGdi
max
) were measured before the first loading task and 
after bolus administration of study medication. Mean arterial pressure (MAP), heart rate 
(HR) and cardiac output (CO) were measured directly before and after bolus administration. 
Cardiac output has only been measured in n=2 (placebo group) and n=4 (levosimendan 
group). Data are presented as mean ± SEM. Abbreviations: * Significantly different from 
before study medication (P < 0.05).
Neuro-mechanical efficiency of the diaphragm 
In Figure 4, representative tracings of EMGdi and Pdi are presented for the first loading 
task (before study medication) and the second loaded task (with study medication) 
for both groups. Neuro-mechanical efficiency of the diaphragm (Pdi/EMGdi) in the 
first loading task was not different between the placebo and levosimendan group 
(both 1.3 ± 0.2 cmH
2
O/µV) and remained stable throughout the loading task (Figure 
5). Neuro-mechanical efficiency during unloaded breathing and during the second 
loading task was improved by 21% (P<0.05, compared to the first loading task) in 
the levosimendan group, whereas neuro-mechanical efficiency was not affected in 
the placebo group (Figure 5). The improved neuro-mechanical efficiency in subjects 
receiving levosimendan sustained throughout the entire loading task. 
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Figure 2. (A) the compound muscle action potential of the diaphragm (CMAPdi) and (B) 
twitch transdiaphragmatic pressure (Pdi
tw
) elicited by cervical magnetic stimulation before 
(black solid line) and after the first loading task (blue striped line) in a subject receiving 
placebo. In response to equal diaphragm activation (i.e. equal CMAPdi), there is decreased 
contractility after loaded breathing. Note the difference in scale of the x-axis between fig-
ure A and B.
Figure 3. Percentage change in transdi-
aphragmatic twitch pressure (Pdi
tw
) from 
baseline after loading + bolus adminis-
tration in the placebo (filled squares) and 
levosimendan (open circles) group. Data 
are presented as mean ± SEM (placebo 
n=13, levosimendan n=14). *Significantly 
different from baseline (P=0.01) and le-
vosimendan group after loading + bolus 
administration (P=0.01).
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Figure 4. Diaphragm electromyography (EMGdi) and transdiaphragmatic pressure (Pdi) 
during the first (black) and second loading task (blue) in a subject receiving placebo (A and 
B) and levosimendan (C and D). Subjects were asked to target 40% of Pdi
max
. In the subject 
receiving placebo there is no change in EMGdi (i.e. neural activation), whereas the subject 
receiving levosimendan shows decreased neural activation and thus increased neurome-
chanical efficiency of the diaphragm.
Center frequency of diaphragm electrical activity
During both loaded breathing protocols, CFdi decreased over time (P<0.001; Figure 
supplemental Figure 1) in both groups. Administration of levosimendan resulted 
in a downward shift in baseline CFdi during the second loaded breathing protocol 
(P<0.05; supplemental Figure 1), whereas placebo did not affect CFdi. 
Respiratory effort sensation 
Respiratory effort sensation increased over time (P<0.001) during loaded breathing, until 
a score of 16. Neither levosimendan nor placebo affected respiratory effort sensation. 
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Discussion
The present study is the first to evaluate the effect of the calcium sensitizer 
levosimendan on human diaphragm function in vivo. In this double-blinded and 
randomized study an intervention of loaded breathing resulted in significant loss 
of diaphragm contractility in the placebo group but not in the levosimendan group, 
suggesting that levosimendan restored diaphragm contractility.  Loaded breathing 
following drug administration was associated with improved neuro-mechanical 
efficiency of the diaphragm in the levosimendan group. Furthermore, levosimendan 
reduced baseline center frequency of diaphragm electrical activity. Levosimendan 
was well tolerated with negligible side effects. 
Calcium sensitivity and muscle fiber conduction velocity: effects 
of levosimendan 
Skeletal muscle force develops as intracellular calcium rises and binds to troponin C, 
resulting in conformational changes in the troponin complex, allowing interaction 
Figure 5. Neuro-mechanical efficiency of the diaphragm (Pdi/EMGdi) before, during (at 
one, three, six, and nine minutes) and after the first and second loading task in the placebo 
(A) and levosimendan (B) group. Administration of levosimendan resulted in an increase 
in diaphragm efficiency (P<0.05) during loaded and unloaded breathing, whereas placebo 
had no effect on diaphragm efficiency. Data are presented as mean ± SEM (placebo n=13, 
levosimendan n=14).
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between actin and myosin to form force generating cross-bridges. Reuptake 
of calcium from the cytoplasm into the sarcoplasmic reticulum is a high energy 
consuming process (up to 40% of total energy expenditure). Thus, reduced sensitivity 
of the troponin complex for calcium requires higher levels of cytoplasmic calcium 
to generate the same amount of force, requiring higher energy consumption and 
elevated CO
2
 production. 
 Levosimendan belongs to a relatively new class of drugs, the calcium sensitizers 
and is approved in more than 40 countries worldwide to improve cardiac function in 
patients with acute heart failure (14). Although the loading dose of levosimendan in 
this study is higher than recommended for the treatment of acute heart failure (14), 
the total dose of levosimendan administered is lower than used in clinical practice. 
 Calcium sensitization by levosimendan occurs through stabilization of the 
interaction between calcium and the troponin complex during muscle activation 
(17). Recently, we have shown that levosimendan improves in vitro calcium 
sensitivity of human diaphragm (skeletal) muscle fibers as well (12, 18). Improvement 
in calcium sensitivity will affect contractile efficiency of the diaphragm (19). In the 
current study, loaded breathing reduced Pdi
tw
 in placebo treated subjects (Table 1 
and Figure 3), which is consistent with previous data by Laghi and colleagues (20). 
However, levosimendan reversed the development of fatigue, as Pdi
tw
 after loading 
in these subjects was not different from baseline. Neuro-mechanical efficiency of the 
diaphragm during loaded breathing, expressed as Pdi/EMGdi ratio, was enhanced 
by 21% following administration of levosimendan (Figure 5). A 21% improvement 
in the ability to generate inspiratory pressure for a given neural respiratory effort 
should be considered a clinically relevant improvement in contractility. In vitro studies 
have shown that impaired calcium sensitivity of force generation develops during 
muscle loading and may contribute to contractile failure (21). This is in line with the 
data from the current study which show that levosimendan reverses the effects of 
diaphragm force loss (Table 1 and Figure 3). 
 Administration of levosimendan resulted in a downward shift of the CFdi curve 
during loaded breathing (supplemental Figure 1). The decrease in CFdi over time 
indicates the development of reduced muscle fiber conduction velocity; see the 
supplemental material for details. Reduced muscle fiber conduction velocity is 
an increased difficulty of muscle fiber action potentials to propagate along the 
sarcolemma and into T tubuli (22). Therefore, the downward shift in baseline CFdi 
in subjects receiving levosimendan most likely reflects a baseline decrease in muscle 
fiber conduction velocity. These data are in line with the established effects of 
levosimendan on K
ATP
 channel activation (15); and that extracellular [K+] accumulation 
contributes to reduced muscle fiber conduction velocity (23, 24). Since administration 
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of levosimendan improves neuro-mechanical efficiency of the diaphragm with 21%, 
it is unlikely that extracellular [K+] accumulation results in functional impairment of 
the diaphragm. Moreover, preserving a hyperpolarized sarcolemma by activating K
ATP
 
channels might even play a myoprotective role under conditions of metabolic stress 
(25).
 All in all, enhancing calcium sensitivity with levosimendan appears a rational and 
effective approach to improve respiratory muscle function, in particular in patients 
with imminent respiratory failure.
Clinical implications
Reduced force generation of the respiratory muscles has been demonstrated in 
numerous disorders, including chronic obstructive disease (COPD), congestive heart 
failure, pulmonary hypertension and patients on mechanical ventilation (1-7). Today, 
there are no pharmacological interventions available to improve respiratory muscle 
function.
 Aubier and colleagues have previously shown that dopamine (26) and aminophylline 
(27) improve contractility of the human diaphragm, although the effects of 
aminophylline are controversial (28). Neither dopamine, nor aminophylline have been 
used in clinical practice to optimize respiratory muscle function, probably due to the 
small therapeutic window, with risk of severe side effects (aminophylline, dopamine) 
and the very short half life time (dopamine). Instead, the active levosimendan 
metabolite OR-1896 has a half life time of 70-80 hours resulting in clinical effect 
up to one week after 24 hour infusion (29). More importantly, both aminophylline 
and dopamine improve contractility by elevating intracellular calcium concentration, 
resulting in an increased ATP utilization. As discussed previously (12), inorganic 
phosphate accumulation contributes to the development of muscle fatigue and 
depresses calcium sensitivity (30). In addition, elevated energy expenditure increases 
CO
2
 production, requiring a higher level of ventilation. This limits the clinical utility 
of these drugs for the improvement of respiratory muscle function in patients with 
imminent ventilatory failure. Rather, calcium sensitizers improve muscle contractility 
without elevating energy expenditure (31). In addition, more efficient breathing may 
fasten liberation from mechanical ventilation (32). This may be important for patients 
with respiratory failure such as acute exacerbation of COPD. Of note, our previous 
in vitro work showed that the effect of levosimendan is more profound in type-1 
diaphragm fibers than in type-2 fibers (12). Because a fiber type shift towards type-1 
fibers is known to occur in the diaphragm of patients with COPD (8) and congestive 
heart failure (33), levosimendan treatment can potentially be more effective in these 
patients than in healthy subjects. Accordingly, the rationale for evaluating the effect 
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of levosimendan on respiratory muscle function in patients with respiratory failure 
appears highly appropriate.
Experimental model
The contractile performance of the diaphragm was evaluated using magnetic 
stimulation and maximal inspiratory efforts. Magnetic stimulation has a clear benefit 
over voluntary maneuvers because it is effort independent and highly reproducible 
(34). Values for Pdi
tw
 and Pdi
max 
reported in our study are similar as reported by 
other groups for healthy subjects (20, 35). Due to coincidence, baseline Pdi
tw 
as well 
as CMAPdi amplitude were lower (though insignificant) in the levosimendan group 
(Table 1), suggesting these subjects were more difficult to stimulate. Correcting for 
CMAPdi amplitude abolished the baseline difference between the groups (data not 
shown). 
 To further evaluate the function of the diaphragm we measured neuro-mechanical 
efficiency of the diaphragm (Pdi/EMGdi) during inspiratory loaded breathing. We 
found that diaphragm neuro-mechanical efficiency at 40% of Pdi
max
 was constant 
over time and that CFdi decreased over time during loaded breathing, which are in 
line with previous data from Sinderby (36). We also found that, despite evidence of 
twitch force loss, the diaphragm neuro-mechanical efficiency was not reduced in 
the placebo group during the second loaded breathing task. Thus, the reductions in 
maximal contractility were not reflected in the neuro-mechanical efficiency during 
submaximal contractions. Regardless of the reason for this inconsistency, the double-
blinded randomized design of the study should ensure that the finding of improved 
neuro-mechanical efficiency - only in the levosimendan group - was not due to bias, 
carry over effects, or other subjective influences. 
 For an accurate physiological measurement of EMGdi and CFdi during voluntary 
breathing it is necessary to control for changes in muscle-to-electrode distance, 
electrode positioning with respect to the muscle fiber direction and location, 
influence of cross-talk from other muscles (including the heart and the esophagus) 
and electrode movement-induced artifacts. The technology used to measure and 
process the EMGdi and CFdi in our study minimizes all these influences (37, 38).
 It could be postulated that improved contractile function of the diaphragm 
resulted from cardiac inotropic effects of levosimendan. However, subjects in the 
present study did not have a medical history of cardiac disease and the effect of 
levosimendan on cardiac output was modest. Development of Pdi
tw
 occurs through 
a sharp anaerobic maneuver of the diaphragm; therefore it is unlikely that an 
improved cardiac output (and oxygen delivery) would explain the restored diaphragm 
contractility with levosimendan. Moreover, levosimendan improved efficiency already 
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during unloaded breathing and immediately at the start of the loading task, which is 
unlikely the result of improved oxygen delivery to the diaphragm
 The dose of levosimendan used in the current study was derived from earlier 
studies in healthy subjects, demonstrating limited side effects (39). This is in line with 
our study. Future studies should evaluate the effects of lower doses of levosimendan 
on respiratory muscle function in humans.
In conclusion, the present study demonstrates that the calcium sensitizer 
levosimendan improves both contractile function and neuro-mechanical efficiency 
of the human diaphragm. These findings suggest a new therapeutic approach for 
patients with acute respiratory muscle dysfunction.
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Supplemental material
Supplemental methods
Randomization and masking
Healthy subjects were randomly assigned to receive either levosimendan or placebo 
(ratio 1:1). The randomization code list, with a block size of six, was generated by 
an independent investigator of the Radboud University Nijmegen Medical Centre. 
The investigator and subject were masked to treatment. Both the active compound 
(levosimendan) and the placebo were similar in appearance (yellow solution) and 
could not be distinguished from one another. Levosimendan and placebo were 
labelled and stored by the department of Clinical Pharmacology of the Radboud 
University Nijmegen Medical Centre. 
Esophageal catheter and its positioning
Diaphragm electromyogram (EMGdi) was measured via an esophageal catheter 
(NeuroVent Research Inc, Toronto, Canada) with nine stainless steel wire electrode 
rings placed 16 mm apart on 8 French polyurethane triple lumen tubing (2.5 mm 
diameter) with the tenth ring, the ground, placed 4 cm above the most proximal 
ring, creating an array of eight sequential electrode pairs. Two 4 cm long, 1.5 cm 
diameter polyurethane balloons were mounted 2.75 cm below the most distal 
ring and 1 cm above the ground ring for the measurement of gastric (Pga) and 
esophageal (Pes) pressures, respectively. The catheter was passed through the nose, 
swallowed, and the electrodes were positioned near the gastroesophageal junction 
(1, 2). The balloons were connected to two differential pressure transducers (range 
± 50 kPa, Freescale, Tempe, AR) via two PVC tubes (0.75 mm diameter) inserted in 
each pressure lumen. The balloons were filled with 1.5 ml of air in order to distend 
the walls of the balloons evenly. Following this, air was withdrawn until the desired 
amount (0.3 – 0.4 ml) remained in the balloon.
Magnetic stimulation and maximal inspiratory effort
Cervical magnetic stimulation of the phrenic nerve was performed using a 90 mm 
circular coil (P/N 9784-00) powered by a Magstim 2002 stimulator (Magstim Company 
Ltd, Whitland, UK). While seated with their neck flexed, a closed mouth and wearing 
a nose clip, magnetic stimulation was performed at functional residual capacity (FRC) 
with unbound abdomen. Stimulation position was determined and marked according 
to Similowski and colleagues (3). Subsequently, the increase in twitch Pdi (Pdi
tw
) and 
compound muscle action potential of the diaphragm (CMAPdi) were measured at 
100% Magstim output as the mean values of three twitches at least 30 seconds apart.
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 Pressure generating capacity of the diaphragm can be assessed by different 
techniques, including Pdi
sniff
 and maximal inspiratory effort against occluded airway. 
The latter technique was selected as this value was needed to calculate the load 
during the loading task (i.e, 40% maximal Pdi). 
Data acquisition
EMGdi signals were amplified and digitized (Porti 16, 22 bits, 71.5 nV/least significant 
bit, TMSi;The Netherlands) at a sampling frequency of 2 kHz. Pressure signals were 
digitized (Porti 16, 22 bits, 1.4 µV/least significant bit, TMSi; The Netherlands) at 
a sampling frequency of 100 Hz. Data were stored and buffered on a hard disk 
for offline analysis in Matlab (R2009b, The Mathworks, Natick, MA) and to provide 
visual feedback.
Signal processing
The segments of EMGdi used in the analysis were automatically selected between 
the electrocardiogram R-R intervals to avoid contamination of the QRS complex. 
The relative position of the centre of the electrical active region of the contracting 
diaphragm with respect to the electrode array was determined (1, 2). The “double 
subtraction technique” was then applied to enhance EMGdi signal quality (2). The 
double subtracted signal was converted from the time domain into the frequency 
domain by fast Fourier transform. Signal quality was evaluated from the power 
spectrum according to Sinderby and coworkers (4). For those signals deemed to be 
of acceptable quality, we calculated EMGdi (as the root mean square [RMS]) from the 
time domain and center frequency of the diaphragm (CFdi) from the EMGdi power 
spectrum. During loading, EMGdi and CFdi were calculated as means per 10 second 
isometric contraction. 
Compound muscle action potentials of the diaphragm (CMAPdi) were recorded from 
the electrode pair with the largest amplitude. Visual inspection for each individual 
CMAPdi was performed to avoid contamination of the QRS complex or motion 
artifacts. CMAPdi amplitude was calculated as the maximal displacement from 
negative to positive peak value. Mean values of three measurements were calculated.
Twitch transdiaphragmatic pressure (Pdi
tw
) and maximum transdiaphragmatic 
pressure (Pdi
max
) were calculated as the displacement from baseline to peak value. 
Mean values of three measurements were calculated. During loading, voluntary Pdi 
was calculated as means per 10 second isometric contraction. 
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Relation between center frequency and muscle fiber conduction 
velocity
As reported previously (5), there are strong reasons to assume that changes in CFdi, 
as measured in the present study, represent changes in muscle fiber conduction 
velocity. The muscle fiber conduction velocity depends on the cable properties of 
the fiber, which remain relatively stable during muscle contractions (6), and the 
membrane excitability (7, 8). The latter depends on ion gradients across the membrane 
generating the driving electric force and the properties of the proteins making up 
the gating ion channels. If the electrolyte imbalance across the sarcolemma leads up 
to a slight depolarization of the membrane, inactivation of the voltage-dependent 
sodium channels occurs, reducing membrane excitability and slowing propagation of 
the action potentials (7-9). Proportionality between APCV and the power spectrum 
frequency shift has been theoretically described in detail (1, 10), and more recently 
described in a review as a method to estimate muscle fiber conduction velocity (11).
Supplemental Figure 1. Center frequency of the diaphragm electromyogram (CFdi) at 
one, three, six, and nine minutes into the first and second loading task in the placebo (A) 
and levosimendan (B) group. CFdi decreased over time (P<0.001) in both loading tasks in 
the placebo and levosimendan group. Administration of levosimendan resulted in a down-
ward baseline shift in CFdi (P<0.05), whereas administration of placebo had no effect on 
CFdi. Data are presented as mean ± SEM (placebo n=13, levosimendan n=14).
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Abstract
Introduction: Systemic inflammation is a well-known risk factor for respiratory 
muscle weakness. Studies utilizing animal models of inflammation have shown that 
endotoxin administration induces diaphragm dysfunction. However, the effects 
of in vivo endotoxin administration on diaphragm function in humans have not 
been studied. Our aim was to evaluate diaphragm function in a model of systemic 
inflammation in healthy subjects.
Methods: Two groups of 12 male volunteers received an intravenous bolus of 2 
ng/kg of E. coli lipopolysaccharide (LPS) and were monitored until 8 hours after 
LPS administration. In the first group twitch transdiaphragmatic pressure (Pdi
tw
) and 
compound muscle action potential of the diaphragm (CMAPdi) were measured. In 
addition, plasma levels of cytokines, heart rate and arterial blood pressure were 
measured. In the second group, catecholamines as well as respiratory rate and blood 
gas values were measured. Diaphragm ultrasonography was performed in four 
subjects with severe shivering. 
Results: LPS administration resulted in flu-like symptoms, hemodynamic alterations, 
and increased plasma levels of cytokines. Pdi
tw
 increased after LPS administration 
from 31.2±2.0 cmH
2
O (baseline) to 38.8±2.0 cmH
2
O (t=1 hr) and 35.4±2.0 cmH
2
O 
(t=1.5 hr). There was no correlation between cytokine plasma levels and Pdi
tw
. We 
found a trend towards a gradual decrease in CMAPdi from 0.78±0.07 mV (baseline) 
to 0.58±0.05 mV (t = 2 hr ). Respiratory rate increased after LPS administration 
from 16.8±0.5 breaths/min (baseline) to 20.3±0.6 (t=4 hr) with a resulting decrease 
in PaCO
2
 of 0.5±0.1 kPa. Plasma levels of epinephrine peaked at t=1.5 hr with an 
increase of 1.3±0.3 nmol/L from baseline. Rapid diaphragm contractions consistent 
with shivering were observed.  
Conclusions: This study shows that, in contrast to diaphragm dysfunction observed 
in animal models of inflammation, in vivo diaphragm contractility is augmented in 
the early phase following low dose endotoxin administration in humans.
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Introduction
Respiratory muscle weakness frequently occurs in the critically ill and is associated 
with prolonged weaning from mechanical ventilation and increased mortality (1, 2). 
The pathophysiology of intensive care unit-acquired respiratory muscle weakness 
is complex, but inflammation is a well-known risk factor (2-4). Moreover, sepsis is 
a major independent risk factor for diaphragm dysfunction on intensive care unit 
admission (2). Several studies utilizing different animal models have shown that 
systemic inflammation reduces force-generating capacity of the diaphragm (3, 5). 
Cytokines are proposed to play an important role in affecting contractile function 
during inflammation. For example, tumor necrosis factor (TNF)-α has been shown to 
mediate the detrimental effects of endotoxin administration on contractile function 
of the diaphragm (6). In addition, data from our lab revealed that plasma from septic 
shock patients induces atrophy in cultured skeletal muscle cells within 24 hours with 
a prominent role for interleukin (IL)-6 (7). 
 Experimental human endotoxemia is a well-characterized, validated model 
of systemic inflammation in healthy subjects, that, among other effects, results 
in subclinical end-organ dysfunction (8-12). Up till now, the effects of endotoxin 
administration on non-volitional respiratory muscle function in humans have not 
been studied. Such a study could provide valuable information as to whether human 
endotoxemia can serve as a model for early inflammation-induced diaphragm 
dysfunction. If true, this would be a suitable model to test therapeutic agents aimed 
to improve respiratory muscle function in critically ill patients. 
 The objective of the present explorative study was to investigate changes in the 
function of the diaphragm in vivo during experimental human endotoxemia. We 
hypothesized that administration of endotoxin impairs diaphragm function.
Materials and methods
Ethics statement
All participants gave written informed consent prior to the study. This study was 
performed in subgroups of 2 larger endotoxin trials (13). Both studies were approved 
by the ethical committee of the Radboud University Medical Center (NL36068.091.11 
and NL42337.091.12) and in accordance with the ethical standards laid down in the 
1964 Declaration of Helsinki and its later amendments.
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Study population
In the first group of 12 subjects, we determined diaphragm function during 
experimental endotoxemia. As a consequence of the results obtained in that 
study, respiratory rate, blood gas values and catecholamines were determined in 
12 additional subjects that underwent experimental endotoxemia in a later trial. 
Diaphragm function was not evaluated in these subjects. In both groups, no 
intervention besides endotoxin administration was applied.
Esophageal catheter
Prior to LPS administration, subjects were instrumented with an 8 French 
polyurethane esophageal catheter (NeuroVent Research Inc, Toronto, Canada). This 
catheter was equipped with two 4 cm long, 1.5 cm diameter polyurethane balloons 
for the measurement of gastric (Pga) and esophageal (Pes) pressure, and 9 electrodes 
to record diaphragm electromyography (EMGdi). The catheter was passed through 
the nose and swallowed. Proper balloon position was confirmed in all subjects by 
observing cardiac oscillations and esophageal spasms in Pes, whereas these artefacts 
were not visible in Pga. With the correct position of the catheter, the esophageal 
balloon was located in the lower third of the esophagus and the gastric balloon in 
the stomach. The balloons were connected to two differential pressure transducers 
(range ± 50 kPa, Freescale, Tempe, AR) via two PVC tubes inserted in each pressure 
lumen. The balloons were filled with 1.5 ml of air in order to distend the walls of the 
balloons evenly. Following this, air was withdrawn until the desired amount (0.3-0.4 
ml) remained in the balloon. Transdiaphragmatic pressure was calculated as gastric 
pressure minus esophageal pressure. 
Experimental human endotoxemia
The protocol for experimental human endotoxemia was identical in both groups. 
Subjects were screened by physical examination, electrocardiography, and routine 
laboratory values. Exclusion criteria were: febrile illness during the 2 weeks before 
the endotoxemia experiment, taking any prescription medication, or participation in 
a previous trial where LPS was administered.
 After local anesthesia, the radial artery of the non-dominant arm was cannulated 
for blood pressure monitoring and blood sampling. A second cannula was placed in 
a deep antecubital vein for prehydration. Subjects received an intravenous bolus of 
2 ng/kg of US Standard Reference E. coli endotoxin (Escherichia coli O:113, Clinical 
Center Reference Endotoxin, National Institute of Health, Bethesda, MD [LPS]) in 1 
minute at t=0 hr. Concentrations of TNF-α, IL-6, IL-10 and IL-1Ra in plasma were 
analyzed using a simultaneous Luminex assay (Milliplex; Millipore, Billerica, MA, USA) 
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at t=0 hr (baseline), and t=1, 1.5, 2, 4, and 8 hr after LPS administration. Respiratory 
rate was recorded and blood gas parameters were analyzed. Furthermore, blood was 
collected into chilled lithium-heparin tubes and was immediately placed on ice and 
centrifuged at 2000g for 10 minutes at 4°C after which plasma was stored at -80°C 
until analysis. Plasma norepinephrine, epinephrine, and dopamine concentrations 
were measured using routine analysis methods also used for patient samples (high-
performance liquid chromatography with fluorometric detection, as described 
previously (14)) .
Cervical magnetic stimulation
To evaluate diaphragm contractility and excitability, twitch Pdi (Pdi
tw
) and compound 
muscle action potential of the diaphragm (CMAPdi), respectively, were assessed by 
cervical magnetic stimulation of the phrenic nerves. Magnetic stimulation of the 
phrenic nerve was performed using a 90 mm circular coil (P/N 9784-00) powered 
by a Magstim 2002 stimulator (Magstim Company Ltd, Whitland, UK). Magnetic 
stimulation makes use of electromagnetic induction. The magnetic field produced 
by the circular coil penetrates the skin and induces a secondary current in the 
tissue which causes depolarisation of the phrenic nerve. Consequently, the action 
potentials travels along the phrenic nerve and elicits a short and synchronized 
response (twitch) in the diaphragm. To obtain a reproducible response we used 
the following protocol. First, cervical stimulation position was determined and 
marked according to Similowski and colleagues (15). Briefly, subject were seated 
in an upright position with the neck flexed slightly, a closed mouth and wearing a 
nose clip. The area for optimal phrenic nerve stimulation was located by moving the 
magnetic coil around the spinous process of C7. Thereby stimulating the roots of C3-
C5 from which the phrenic nerve originates. Magnetic stimulation was performed at 
the end-expiratory phase (by observing the subject, and pressure waveforms) with 
unbound abdomen. The position associated with the response of greatest amplitude 
at 70% stimulation intensity was carefully marked on the skin to ensure consistency 
in stimulation. Second, stimulation was performed at 100% Magstim output at least 
30 seconds apart to avoid diaphragm potentiation. Stimulation was performed at 
t=0 hr (baseline), and t=1, 1.5, 2, 4, and 8 hr following LPS administration.
Data acquisition and analysis 
Pressure signals were digitized (Porti 16, 22 bits, 1.4 µV/least significant bit, TMSi; 
the Netherlands) at a sampling frequency of 2 kHz. EMGdi signals were amplified and 
digitized (Porti 16, 22 bits, 71.5 nV/least significant bit, TMSi; the Netherlands) at a 
sampling frequency of 2 kHz. Data were stored on a hard disk for off-line analyses 
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in Matlab (R2012b, The Mathworks, Natick, MA). Recordings were visually inspected 
to discard recordings with contamination of the QRS complex, esophageal spasms 
or motion artefacts. CMAPdi was recorded from the electrode with the largest 
amplitude and calculated as the peak-to-peak displacement. Pdi
tw
 was calculated as 
the peak difference from baseline. See Figure 1 for examples of CMAPdi and Pdi
tw
. 
Mean values of three to five measurements were calculated.
Figure 1. Example of CMAPdi and Pdi
tw 
following magnetic phrenic nerve stimulation. Mag-
netic stimulation of the phrenic nerves elicits a compound muscle action potential of the 
diaphragm (a) with a subsequent increase in transdiaphragmatic pressure (b). Gray lines 
represent 5 individual stimulations and the black bold line is the average response. Note 
the difference in time scale between a and b. Abbreviations: CMAPdi = compound muscle 
action potential of the diaphragm; Pdi
tw
 = twitch transdiaphragmatic pressure.
Diaphragm ultrasonography
In subjects with severe shivering, and a good ultrasonographic view of the 
diaphragm, diaphragm ultrasonography was performed to examine shivering of the 
diaphragm at 1 hour following LPS administration. Ultrasonography was performed 
using two windows: (1) a linear array transducer in the zone of apposition (16, 17), 
an echogenic layer bordered by pleural and peritoneal membranes; and (2) a phased 
array transducer positioned subcostal or low intercostal between the midclavicular 
and mid-axillary lines (18).
Statistical analysis
To evaluate diaphragm function, plasma cytokines, plasma levels of catecholamines, 
respiratory rate, and blood gas values during experimental endotoxemia we 
performed repeated measures one-way ANOVA for normally distributed data, or 
the Friedman test as its non-parametric equivalent. Repeated measures testing 
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was not possible for Pdi
tw
 and CMAPdi due to missing values at different time points. 
Therefore, we used the change from baseline to correct for inter-individual differences 
and performed one-way ANOVA for normally distributed data, or the Friedman test 
as its non-parametric equivalent. Post-hoc analysis was performed with Tukey’s test 
or Dunn’s test, as its non-parametric equivalent, to correct for multiple comparisons. 
Spearman’s correlation was performed to test associations between plasma cytokines 
and diaphragm function. A level of p<0.05 (two-tailed) was considered as statistically 
significant. The normality of the distribution of the different variables was evaluated with 
the D’Agostino & Pearson test. Data are described as mean±standard error or median 
[interquartile range] depending on the distribution of the data. Statistical analysis was 
performed with Graphpad Prism 5 (Graphpad software, San Diego, CA, USA).
Results
Baseline characteristics of the subjects are presented in Table 1. Experimental 
endotoxemia resulted in the expected flu-like symptoms in all subjects. Symptoms 
started 45 to 60 min after LPS administration with a brief episode of shivering, 
followed by varying degrees of headache, nausea, general malaise and myalgia. 
Symptoms completely subsided after 5-6 hrs in all volunteers. Due to the described 
symptoms, magnetic phrenic nerve stimulation was not feasible in every subject at 
every time point. Furthermore, in two subjects the esophageal catheter was removed 
after 1 and 1.5 hr following LPS administration because of unacceptable discomfort. 
The number of subjects per time point is given in the legend of Figure 2.
 There was an expected increase in plasma concentrations of cytokines. Pro-
inflammatory cytokines TNF-α and IL-6 peaked at t = 1.5 and 2 hr, respectively 
(Figure 2a-b), while anti-inflammatory cytokines IL-10 and IL-1Ra peaked at t 
= 2 and 4 hr (Figure 2b). Pdi
tw
 increased from baseline (31.2 ± 2.0 cmH
2
O) after 
LPS administration (Figure 2c) with a significant peak at t = 1 hr. Note that only 
six and eleven patients could be evaluated 1 and 1.5 hour after LPS administration, 
respectively, due to severe malaise/shivering. Nevertheless, increases in Pdi
tw
 at 
t = 1 and t = 1.5 hr from baseline were robust and significant in this set of subjects 
(Figure 3a-b). No significant changes were found in CMAPdi over time (Figure 2d), 
however a decreasing trend was observed after LPS administration, reaching its nadir 
after 2 hours. Indeed, at t = 2 hr CMAPdi decreased in almost all analyzed subjects 
(Figure 3c). LPS administration resulted in an increase in heart rate and decrease in 
mean arterial pressure (Figure 2d). 
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Correlations between Pdi
tw
, CMAPdi and cytokine levels were explored at different 
time points (see supplemental Figure 1 and supplemental Figure 2). No consistent 
correlations between  Pdi
tw
 or CMAPdi and cytokine levels were found. 
 In addition, we found a minor, but statistically significant, increase in breathing 
frequency following LPS administration (Figure 4a). Blood gas analysis revealed an 
increase in pH due to a decrease in PaCO
2
 (Figure 4b). PaO
2 
did not change during 
endotoxemia (Figure 4b). Plasma epinephrine concentrations increased after LPS 
administration with a sharp peak at t = 1.5 hr, whereas plasma dopamine and 
norepinephrine concentrations were only slightly altered and remained within the 
reference range throughout the endotoxemia experiment (Figure 4d). 
 Diaphragm ultrasonography was performed in selected subjects with severe 
shivering (n=4). Rapid diaphragm contractions consistent with shivering were 
observed in these subjects. 
Figure 2. Cytokine levels, diaphragm function and hemodynamic measurements. Panels a 
and b depict concentrations of pro- (TNF-α, IL-6, and IL-10) and anti-inflammatory (IL-1Ra) 
cytokines after LPS administration (n=12). Panels c and d show Pdi
tw
 and CMAPdi, respec-
tively, after LPS administration. In panels c and d the number of subjects are n=12, 6, 11, 
9, 10 and 10 for time points t=0, 1.5, 2, 4 and 8 hr, respectively. Panel e depicts HR and 
MAP after LPS administration (n=12). Data are presented as median [interquartile range] 
(panels a, b and c) and mean ± standard error (panel d and e). The p-value in the panels 
represent result of the repeated measures one-way ANOVA for normally distributed data, or 
the Friedman test as its non-parametric equivalent. Asterisks represent significant changes 
per time point from baseline as evaluated by post-hoc analysis with Tukey’s test or Dunn’s 
test, as its non-parametric equivalent. Abbreviations: CMAPdi = compound muscle action 
potential of the diaphragm;  HR = heart rate; MAP = mean arterial blood pressure; Pdi
tw
 = 
twitch transdiaphragmatic pressure.
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Table 1. Subject demographic characteristics
Group 1 (original 
experiment, n=12)
Group 2 (additional 
experiments, n=12)
p-value 
Sex  (M/F) (12/0) (12/0)
Age, yrs
Height, cm
Weight, kg
BMI, kg/m2
HR, beats/min
MAP, mmHg
21 ± 0.4
183 ± 3
79 ± 2.7
23.6 ± 0.6
68 ± 2.5
95 ± 2.5
23 ± 0.8
184 ± 1
79 ± 2.1
22.9 ± 0.6
61 ± 2.8
94 ± 2.4
0.15
0.69
0.88
0.49
0.09
0.87
Parameters measured during screening visit. Data are presented as means ± standard error. 
Abbreviations: BMI = body mass index; HR = heart rate; MAP = mean arterial blood pres-
sure. P-values calculated using unpaired t test.
Figure 3. Increase in Pdi
tw
 at t=1 and t=1.5 hr and decrease in CMAPdi at t= 2 hr Panels a 
and b depict individual increases in Pdi
tw
 from baseline (t=0 hr) to t=1 and t=1.5, respective-
ly. Note that only six and eleven patients could be evaluated 1 and 1.5 hour after LPS admin-
istration, respectively, due to severe malaise/shivering. Panel c shows individual decreases in 
CMAPdi (n=8) from baseline (t=0 hr) to t=2 hr. Abbreviations: CMAPdi = compound muscle 
action potential of the diaphragm; Pdi
tw
 = twitch transdiaphragmatic pressure.
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Figure 4. Respiratory parameters and catecholamine concentrations. Panel a depicts 
breathing frequency after LPS administration (n=12). Panels b and c depicts blood gas val-
ues (pH, PaCO
2
 and PaO
2
) after LPS administration (n=12). Panel d depicts plasma cate-
cholamine concentration (dopamine, epinephrine, nor-epinephrine) after LPS administra-
tion (n=12). Data are presented as median [interquartile range]. The p-value in the panels 
represent result of the Friedman test. Asterisks represent significant changes per time point 
from baseline as evaluated by post-hoc analysis with Dunn’s test. P-values calculated using 
Friedman test for epinephrine, norepinephrine, and dopamine are p < 0.0001, p = 0.0029, 
and p = 0.0054, respectively. 
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Discussion
In the present study we used a standardized, well-validated human model to 
investigate the effects of systemic inflammation on non-volitional diaphragm 
function in vivo. In contrast to our hypothesis, experimental endotoxemia did not 
attenuate but temporarily enhanced diaphragm contractility, despite a trend towards 
gradual decrease in diaphragm muscle fiber excitability. 
Experimental model
The contractile performance of the diaphragm during experimental human 
endotoxemia was evaluated using magnetic phrenic nerve stimulation. Magnetic 
stimulation has a clear benefit over voluntary manoeuvres because it is independent 
of subject motivation, cooperation, and effort. The baseline values for Pdi
tw
 in our 
study are similar to those reported previously (19). 
To our knowledge this is the first study that describes diaphragm contractility following 
LPS administration in humans. In apparent contrast with our hypothesis and previous 
findings in animal models and sepsis patients, diaphragm force did not decrease, 
but increased during systemic inflammation induced by experimental endotoxemia. 
Animal studies describe a significant impairment of diaphragmatic force, becoming 
evident 4 hours after endotoxin administration (3, 6). It should be noted that the 
dose of LPS administered in our study is much lower (2 ng/kg) compared with animal 
experiments which typically utilize (sub)lethal LPS dosages in the order of milligrams 
per kilogram bodyweight (6). It is very well possible that the dose required to induce 
diaphragm dysfunction might be considerably higher. In critically ill patients, sepsis 
was recently identified as a major independent risk factor for diaphragm dysfunction 
on intensive care unit admission (2). In the present study, LPS administration clearly 
elicited sepsis-like responses such as flu like symptoms and hemodynamic alterations 
as well as elevated cytokine levels. Furthermore, experimental human endotoxemia 
has been shown to result in, although mild, cardiac (8), vascular (9, 10), renal (11), 
and coagulatory (12) dysfunction. Nevertheless, this model does not accurately 
represents all organ dysfunction as observed in sepsis patients (20, 21). There are 
many discrepancies (20, 21), including the fact that the inflammatory response is 
very short-lived. Previously, the effects of experimental human endotoxemia on 
quadriceps muscle function have been studied (22). A reduction in voluntary muscle 
contractile force was found (22), which likely resulted from poor volition caused 
by the malaise associated with endotoxemia, as force generation upon stimulation 
was not affected by endotoxin. Interestingly, using approximately the same dose of 
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endotoxin (4 ng/kg), Suffredini and colleagues found depression of left ventricular 
function during endotoxemia in healthy subjects (8). This might indicate that cardiac 
muscle is more susceptible to endotoxin-induced inflammation than peripheral 
skeletal muscle or the diaphragm. 
 In contrast to increased diaphragm contractility, we observed a trend towards 
gradual decrease in diaphragm membrane excitability during endotoxemia. This is 
consistent with animal studies, where it was shown that a sublethal dose of TNF-α 
reduces CMAPdi in response to phrenic nerve stimulation (23), and that contractile 
dysfunction was found to be associated with a decreased diaphragmatic resting 
membrane potential in endotoxic shock (24). The latter phenomenon could impair 
action potential generation resulting in failure of neuromuscular transmission. 
Nevertheless, in our study diaphragm contractility was not compromised, suggesting 
that other sites in the excitation-contraction coupling compensated for the minor 
decrease in CMAPdi.
 Taken together, experimental human endotoxemia does not represent an 
appropriate in vivo model for systemic inflammation-induced diaphragm dysfunction 
and can therefore not be used to test new therapeutic agents aimed to improve 
diaphragm function in critically ill patients.
Mechanisms of action
The mechanism behind the increase in Pdi
tw
 after endotoxin administration is 
unknown. We reasoned that an increased Pdi
tw
 could be the result of activation of 
beta receptors on respiratory muscle. Indeed, β2-adrenoreceptor agonist treatment 
increases calcium release from the sarcoplasmatic reticulum and improve diaphragm 
contractility in rats (25, 26). In our study endogenous epinephrine levels were higher 
compared with baseline when Pdi
tw
 increased (Figure 2d). However, Pdi
tw
 peaked 
before the peak in plasma epinephrine levels at t= 1.5 hr. 
 In the diaphragm the twitch response is affected by prior voluntary efforts, a 
phenomenon referred to as twitch potentiation. Therefore, potentiation of the 
diaphragm might cause an increase in Pdi
tw
. For example, five seconds of 25% 
of maximal voluntary diaphragm contractions may already potentiate the diaphragm 
and result in higher twitch pressures (27). Respiratory rate increased more than 
2 hours after endotoxin administration in our model, which is in accordance with 
previously published data (28), but at that time-point Pdi
tw
 already decreased, 
which makes potentiation of the diaphragm due to increased respiratory activity 
an unlikely explanation for the increase in Pdi
tw
 at 1 hour (Figure 2c and 4a). An 
alternative hypothesis is a potentiating effect of shivering thermogenesis of the 
diaphragm. Experimental studies have shown that phosphorylation of the skeletal 
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muscle ryanodine receptor 1 (a calcium release channel) occurs during shivering 
thermogenesis (29). Interestingly, phosphorylation of calcium release channels may 
play a role in twitch potentiation (30, 31). Most subjects in our study experienced 
a period of shivering starting 1 hour after LPS administration, coinciding with 
the increased Pdi
tw 
levels. Indeed, diaphragm ultrasonography 1 hour after LPS 
administration revealed shivering of the diaphragm. Thus, shivering thermogenesis 
in the early phase of endotoxemia might have had a potentiating effect on the 
diaphragm. 
 In future research, this hypothesis could be partly tested by performing voluntary 
potentiation. For voluntary potentiation, phrenic nerve stimulation is performed after 
the subject makes a maximal voluntary contraction. If no further potentiation occurs 
it is possible that previous potentiation (due to endotoxemia or hyperventilation) took 
place. In addition, measurement of work of breathing, pressure-time product, and 
neuromechanical coupling during human endotoxemia may contribute to elucidate 
our results.
Study limitations
The human endotoxemia model used in our study, and most animal endotoxemia 
models, relate to the early changes observed with systemic inflammation and is thus 
a model of short-lived systemic inflammation and not a model of sepsis. This should 
be kept in mind while interpreting our data, since different mechanism may affect 
muscle function during the early phase of systemic inflammation compared to the 
long term effects of sepsis (32).
 With increasing lung volume, there is a linear decrease in Pdi
tw 
(33). Therefore, it 
is of importance to control for lung volume when assessing diaphragm contractility. 
We were not able to measure lung volumes using spirometry prior to stimulation. 
However, we aimed to perform all stimulations at functional residual capacity. 
Functional residual capacity was ensured by performing magnetic stimulation at the 
end-expiratory phase by observing the subject, and Pes and Pga waveforms. 
 Ideally, all measurements should have been performed in one human endotoxemia 
study. However, respiratory rate, blood gas values and catecholamines were 
determined in a different group than diaphragm function. This was a consequence 
of scientific reasoning, since the results of the first experiment were in contradiction 
to our hypothesis and we wanted to further explore possible mechanisms behind the 
observed effects. The goal of the second experiment was to find the mechanism of 
action for increased diaphragm function. Due to the invasive nature of the diaphragm 
function measurements we chose not to perform these in the second experiment. 
Nonetheless, we used the same well-characterized and validated experimental 
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model of systemic inflammation with a virtually identical protocol, and subject 
characteristics were comparable as well. Therefore, we assume that performing the 
study in two separate experiments has not confounded our results.
Conclusions
In conclusion, our study shows that, in contrast to animal experiments, in vivo 
diaphragm contractility is augmented in the first hours following low dose endotoxin 
administration in humans. Therefore experimental human endotoxemia does not 
represent an appropriate in vivo model for systemic inflammation-induced diaphragm 
dysfunction.
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Supplemental material
Supplemental Figure 1.
Correlations between 
twitch transdiaphragmat-
ic pressure (Pdi
tw
) and 
cytokine levels at different 
time points. HR, hour. 
223
Effects of experimental human endotoxemia on diaphragm function
10
Supplemental Figure 2. Correlations between compound muscle action potential of the 
diaphragm (CMAPdi) and cytokine levels at t = 2 hour.
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Summary
In the last decades, evidence has accumulated that diaphragm dysfunction frequently 
develops in critically ill patients and contributes to prolonged mechanical ventilation. 
However, monitoring of diaphragm function during mechanical ventilation and 
weaning has received little attention. In fact, most clinicians do not monitor 
diaphragm function in critically ill patients at all. In addition, there are limited 
interventions available that target the diaphragm. In this thesis, techniques have 
been investigated to monitor diaphragm function, and preventive and therapeutic 
interventions to optimize diaphragm function.
The first part of this thesis focuses on monitoring of diaphragm function in critically 
ill patients. In chapter 2, a clinical perspective, we discussed the pros and cons of 
the available techniques to monitor respiratory muscle function. These techniques 
include easy to learn and non-invasive tools, such as maximal inspiratory pressure 
and diaphragm ultrasound. But also complex and sophisticated measurements, 
such as phrenic nerve stimulation, electrical activity of the diaphragm (EAdi), and 
transdiaphragmatic pressure (Pdi). Some tools have limited value (e.g. fluoroscopy, 
occlusion pressure in the first 100ms) or are not suitable for routine monitoring 
(e.g. phrenic nerve stimulation). However, promising tools that can be used today 
or in the near future for monitoring respiratory muscle function are recordings of 
Pdi and EAdi, and diaphragm ultrasound. Although there is no literature yet that 
directly demonstrates improved outcome with close monitoring (and action) of the 
respiratory muscles, in our opinion monitoring the respiratory muscles should be as 
much part of the routine as monitoring any other vital organ function.
 Weaning from mechanical ventilation is an important phase for critically ill 
patients. The transition from positive inspiratory pressure during mechanical 
ventilation to negative pleural pressure during spontaneous breathing challenges the 
patients physiological reserve. When there is an imbalance between the patients’ 
ventilatory needs and the capacity of the neural, cardiovascular and respiratory 
systems, weaning fails. In chapter 3 we reviewed the pathophysiology of difficult 
and prolonged weaning and the techniques that are most helpful in the diagnostic 
work-up. Impaired respiratory mechanics, cardiac dysfunction, respiratory muscle 
dysfunction, cognitive dysfunction and metabolic disorders are recognized causes for 
weaning failure. Currently available research has mostly focused on respiratory muscle 
dysfunction and cardiac dysfunction as a cause for weaning failure. Understanding 
the complex pathophysiology of weaning failure in combination with a systematic 
diagnostic approach allows identification of the primary cause of  weaning failure. 
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In chapter 4 we performed detailed analysis of inspiratory muscle function, expiratory 
muscle function and respiratory mechanics during a spontaneous breathing trial 
in a heterogeneous group of critically ill patients. We found that the expiratory 
muscles significantly contribute to respiratory muscle effort (i.e. up to 26% of total 
respiratory muscle effort) in patients who fail a trial of spontaneous breathing. In 
addition, neuromechanical efficiency of the diaphragm is 41% lower in weaning 
failure patients compared to patients that are successfully extubated. This confirms 
that impaired pressure-generating capacity of the diaphragm, regardless of its origin, 
plays a central role in failure to wean from mechanical ventilation. 
 Results from chapter 5 showed that in healthy subjects, strain and strain rate of 
the diaphragm, obtained by speckle tracking imaging, are highly correlated with Pdi 
and EAdi during inspiratory loading from zero to 60 cmH
2
O. Remarkably, diaphragm 
thickening during inspiratory loading was not correlated with Pdi and EAdi. These 
findings suggest that advanced ultrasound techniques, such as speckle tracking 
imaging, may be used in the future to non-invasively assess diaphragmatic effort in 
critically ill patients.
The second part of this thesis focuses on preventive and therapeutic interventions 
to optimize diaphragm function. An important preventive intervention is to minimize 
the harmful effects of mechanical ventilation on diaphragm function, for example by 
optimizing patient-ventilator interaction. Neurally adjusted ventilatory assist (NAVA) 
is a mode of mechanical ventilation that uses the electrical activity of the diaphragm 
to control timing and magnitude of assist with invasive and non-invasive mechanical 
ventilation. 
 In chapter 6, patient-ventilator interaction was quantified using an automated 
analysis in COPD patients with different modes of noninvasive ventilation, including 
NAVA. We showed that NAVA synchronizes assist to the patients inspiratory effort, 
whereas pressure support modes of a dedicated NIV ventilator or ICU ventilator 
did not ensure optimal patient-ventilator interaction. In addition, wasted efforts 
increased exponential after timing errors between electrical activity of the diaphragm 
and airway pressure reached more than 20%. Thus progressive mismatch between 
neural effort and pneumatic timing of the ventilator is strongly associated with 
severe forms of patient-ventilator asynchrony. Despite these physiological effects 
NAVA did not improve blood gas values and patient comfort.
 In ARDS patients, lung-protective ventilation is applied via controlled mechanical 
ventilation to allow strict control of tidal volume and plateau pressure. However, 
this strategy usually requires high levels of sedation and is associated with adverse 
events, in particular diaphragm dysfunction. In contrast, assisted modes that allow 
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spontaneous breathing efforts reduce the risk of diaphragm dysfunction, but may 
result in high tidal volumes and high transpulmonary pressures. In chapter 7, we 
evaluated in patients with mild to moderate ARDS how different modes of mechanical 
ventilation (assist-pressure control ventilation  [PCV], pressure support ventilation 
[PSV] and NAVA) affect lung protective ventilation, breathing pattern variability, 
and patient ventilator-interaction. The three selected modes allowed for different 
degrees of ventilator control by the patient. The main finding of this study was that 
with increasing freedom for the patient to control the ventilator, tidal volume and 
transpulmonary pressure remained within the limits of lung-protective ventilation. 
Except for one patient with severe hypercapnic acidosis where tidal volume increased 
above 10 mL/kg. Breathing pattern variability and patient-ventilator interaction 
improved with NAVA compared to PCV and PSV. These findings suggest that there 
is a role for assisted mechanical ventilation, and active diaphragm contractions, in 
patients with mild to moderate ARDS without strong inspiratory efforts.
 Based on the findings in chapter 7 we developed a ventilation strategy for 
ARDS patients that generate high tidal volumes after the transition from controlled 
mechanical ventilation to assisted ventilation. In a proof-of-concept study it was 
investigated whether low dose neuromuscular blockers can facilitate a lung-
protective ventilation strategy without loss of diaphragm activity during assisted 
mechanical ventilation in lung injury patients with high tidal volumes (chapter 8). 
Such a strategy might allow a safe compromise between the benefits and risks of 
spontaneous breathing during mechanical ventilation. The results show that partial 
neuromuscular blocking of the diaphragm can be used to titrate tidal volume from 
approximately 10 ml/kg to 6 ml/kg with preservation of diaphragm activity at 
physiological levels. However, this strategy was associated with mild hemodynamic 
side effects, including tachycardia and elevated blood pressure, and development 
of hypercapnic acidosis. Future studies should carefully evaluate whether partial 
neuromuscular blockade is tolerated by patients for longer periods of time.
 Previously, it was demonstrated in vitro that levosimendan enhances calcium 
sensitivity of permeabilized muscle fibers obtained from the human diaphragm 
resulting in a greater amount of force generated for the same level of cytosolic 
calcium. In chapter 9 we found that levosimendan also improves in vivo 
diaphragm function in healthy subjects. During isometric loading of the diaphragm, 
neuromechanical efficiency of the diaphragm improved with approximately 20%. 
Furthermore, levosimendan reversed the development of fatigue after diaphragmatic 
loading. 
 Systemic inflammation is a well-known risk factor for respiratory muscle weakness. 
In chapter 10 we aimed to develop an experimental in vivo model for diaphragm 
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dysfunction during systemic inflammation. In contrast to animal models of systemic 
inflammation, we found in healthy subjects an augmentation of in vivo diaphragm 
contractility in the early phase following low dose endotoxin administration. 
Therefore the human endotoxemia model does not seem suitable for in vivo testing 
of interventions to improve diaphragm function.
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General discussion and future perspectives
Diaphragm dysfunction frequently develops in critically ill patients and is associated 
with increased morbidity and mortality. The studies performed in this thesis 
evaluated techniques to monitor diaphragm function, and preventive and therapeutic 
interventions to optimize diaphragm function.
Monitoring diaphragm function during mechanical ventilation 
and weaning
In clinical practice the diaphragm of critically ill patients is poorly monitored, 
the limited availability and knowledge of monitoring techniques may be one of 
the reasons. In chapter 2, we identified three promising techniques to monitor 
respiratory muscle function: 1) transdiaphragmatic pressure (Pdi); 2) electrical activity 
of the diaphragm (EAdi); and 3) diaphragm ultrasound. Indeed, these monitoring 
techniques have received growing attention in recent years. 
Pdi is a specific measure of diaphragm function and requires a double balloon 
approach (gastric and esophageal balloon). Since esophageal pressure (Pes) 
represents global respiratory muscle function and only requires one balloon, this 
approach to monitor respiratory muscle functions has been described extensively 
(1-3). In mechanically ventilated patients with spontaneous breathing efforts, Pes 
monitoring can primarily be used to monitor respiratory muscle effort and patient-
ventilator asynchrony. In chapter 7 and chapter 8 swings in Pes ranged from 
low to very high values, indicating that respiratory muscle activity ranged from 
insufficient to excessive. Both insufficient and excessive inspiratory muscle activity 
may result in diaphragm dysfunction (4-9). Monitoring Pes or Pdi during mechanical 
ventilation allows to titrate support to target specific respiratory muscle effort. A 
respiratory muscle effort between 5 and 10 cmH
2
O is within a physiological range 
(10). During weaning, monitoring of Pes has been demonstrated to discriminate 
between weaning failure and weaning success (11). In chapter 4 we recorded 
Pes and gastric pressure (Pga) in patients during spontaneous breathing trials. In 
addition, we used Pes and Pga to calculate more sophisticated measures, such as 
intrinsic positive end-expiratory pressure, expiratory rise in gastric pressure, work of 
breathing and esophageal pressure-time product. From a diagnostic point of view 
these variables provide relevant information to determine the cause of weaning 
failure for an individual patient (12, 13). For routine monitoring of the respiratory 
muscles, however, this detailed analysis requires a too high level of expertise and 
monitoring of only Pes or Pdi seems more appropriate for routine clinical application. 
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Several studies have demonstrated that Pes monitoring can be used to detect 
patient-ventilator interaction (14-16). In this thesis, however, we monitored patient-
ventilator interaction using EAdi, as described in the next paragraph. 
 Another application of Pes monitoring, in addition to respiratory muscle monitoring, 
is to guide lung-protective mechanical ventilation in patients with acute respiratory 
distress syndrome (ARDS). We showed that Pes, by calculating transpulmonary 
pressure, can be used to identify safe or lung injurious lung distending pressures 
during mechanical ventilation in ARDS patients (chapter 7-8). 
Monitoring of electrical activity of the diaphragm has frequently been used to evaluate 
patient-ventilator interaction (17-22). Often asynchrony between the patient and the 
mechanical ventilator is scored manually. Instead, we evaluated patient-ventilator 
interaction using an automated algorithm, based on EAdi, in patients with chronic 
obstructive pulmonary disease (COPD) during noninvasive ventilation (chapter 6) 
 and in ARDS patients during invasive ventilation (chapter 7). This automated 
analysis allows detection of asynchronies, such as wasted efforts, but also makes 
it easy to detect the more subtle dyssynchronies (i.e. timing errors), such as trigger 
delays and cycling-off errors. Dyssynchronies are easily missed by visual inspection 
of waveforms, but may be of clinical relevance, as we found that wasted efforts 
increase drastically after timing errors reach over 20% (chapter 6). An automated 
analysis using EAdi (or Pes) may be incorporated into mechanical ventilators to 
simplify monitoring of patient-ventilator interaction. 
 Additionally, EAdi may be used to monitor neural respiratory drive during 
mechanical ventilation and weaning. We found a large variety in neural respiratory 
drive in ARDS patients ventilated with 6 ml/kg (chapter 7). These findings suggest 
that adjusting ventilator assist to target low tidal volumes resulted in different levels 
of neural drive, probably due to a complex interaction between sedation, ventilatory 
mode and level of assist. Accordingly, monitoring EAdi can aid to optimize ventilation 
in ARDS to prevent over-assist or insufficient assist. However, the difficulty with EAdi 
is that the magnitude of the signal is strongly influenced by individual anatomy and 
this makes comparisons between patients difficult. Furthermore, there is no method 
to determine the optimal EAdi for an individual patient. Recently, attempts have been 
made to estimate inspiratory muscle effort from EAdi by using an conversion index 
(23) or determine the contribution of the patient to the inspiratory tidal volume (24). 
However, the reliability of this index is poor and therefore not yet clinical applicable 
to monitor respiratory muscle function (25). Future studies are required to develop a 
method that is able to determine the optimal EAdi for an individual patient. 
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The ratio between Pdi and EAdi represents neuromechanical efficiency (NME) of the 
diaphragm, in other words the ability of the diaphragm to translate neural respiratory 
input to mechanical respiratory output. A gradual decrease in NME over days may 
indicate the development of diaphragm weakness or fatigue, whereas an increase 
suggests recovery. We showed that NME discriminates between weaning failure 
and weaning success (chapter 4). In our study we calculated NME using a double-
balloon esophageal catheter with multiple electrodes to allow continuous recording 
of Pdi and EAdi. Other groups have calculated NME of the inspiratory muscles as 
the ratio between the drop in mouth pressure during an inspiratory occlusion and 
electrical activity of the diaphragm (26-28). Using the latter method, NME was 
found to be predictive of weaning failure as well (26). In a small randomized clinical 
trial it was shown that NAVA improves NME whereas PSV does not (27). The latter 
demonstrates that monitoring of NME may be useful to detect trends in muscular 
efficiency of the inspiratory muscles during mechanical ventilation. However, another 
study demonstrated that this index nor its trend was associated with risk factors 
for diaphragmatic injury or clinical outcome (28). Further studies are required to 
determine the value of NME monitoring, and its most optimal an practical method, 
during mechanical ventilation and weaning.
Besides physiological measurements, imaging of the diaphragm using ultrasound 
is rapidly gaining popularity to monitor diaphragm function in the ICU. Diaphragm 
ultrasound can be used to evaluate thickness, thickening during inspiration and 
displacement of the diaphragm (29). Using ultrasound it has been demonstrated in 
critically ill patients that diaphragm thickness decreases during mechanical ventilation 
and that the thickening fraction of the diaphragm is related to the level of support 
provided by the mechanical ventilator (9, 30). However, correlations between 
physiological measurements, such as transdiaphragmatic pressure, and diaphragm 
thickening are low (31). Therefore, other ultrasound techniques are required. In 
healthy subjects we demonstrated that speckle tracking imaging of the diaphragm, 
an advanced ultrasound technique, is highly correlated with Pdi during a protocol 
of increased loading (chapter 5). This offers new perspectives to use diaphragm 
ultrasound to monitor diaphragmatic effort in critically ill patients. 
This thesis demonstrates that monitoring of the diaphragm is feasible in critically 
ill patients. Recordings of Pdi (or Pes), EAdi and diaphragm ultrasound provide 
complementary information about the diaphragm. Ideally all three techniques 
should be available to clinicians, like blood pressure, electrocardiography and 
echocardiography for the heart. Nevertheless, implementing one of these techniques 
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in daily clinical care for ICU patients would already be a big step forward for the 
diaphragm. In our opinion monitoring respiratory muscles in the ICU should be as 
much part of the routine as monitoring any other organ function. Close monitoring of 
diaphragm function is a prerequisite to detect deterioration of diaphragm function in 
critically ill patients, but monitoring alone is useless if no actions can be undertaken 
to prevent the development of diaphragm dysfunction or improve its function. 
Therefore, potential interventions were also investigated in this thesis.
Preventive and therapeutic interventions to optimize diaphragm 
function
Currently, limited interventions are available to optimize diaphragm function in 
critically ill patients (32). In this thesis we evaluated novel interventions aimed at 
preventing diaphragm dysfunction (chapter 6-8) and improving diaphragm function 
(chapter 9-10).
An important factor contributing to diaphragm dysfunction in critically ill patients 
is mechanical ventilation, also known as ventilator-induced diaphragm dysfunction 
(VIDD) (33, 34). Diaphragm inactivity during mechanical ventilation is the most 
important pathophysiological trigger leading to VIDD, in particular during controlled 
mechanical ventilation (34). High levels of ventilator support during assisted 
mechanical ventilation, however, may also cause diaphragm dysfunction (8). 
Therefore, preventive measures must be taken to limit diaphragm inactivity during 
mechanical ventilation. Neurally adjusted ventilatory assist (NAVA) is ventilator mode 
that uses electrical activity of the diaphragm to control ventilator support (35). In 
COPD and ARDS patients, NAVA improves patient-ventilator interaction compared 
to pressure support ventilation (PSV) (chapter 6-7). Since poor patient-ventilator 
interaction is strongly associated with prolonged mechanical ventilation (36, 37), 
NAVA may potentially decrease the duration of mechanical ventilation and improve 
patient outcome. Furthermore, the proportionality between EAdi and ventilator 
assist prevents over-assist with NAVA, as seen with PSV (38-41). Despite these 
physiological benefits of NAVA, we did not find improvements in blood gas values 
and patient comfort with NAVA (chapter 6-7). The latter may result from the short 
period of time (30 min) the different ventilator modes were studied. Recently, it was 
demonstrated in a multicenter randomized controlled trial that NAVA is safe and 
feasible over a prolonged period of time but does not decrease ICU length of stay 
or mortality (42). This randomized trial was performed in heterogeneous group of 
patients with acute respiratory failure, whereas NAVA is mostly beneficial in specific 
patients groups, such as COPD or patients receiving high levels of support. Future 
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studies are required to determine if and in which patients groups NAVA prevents 
diaphragm dysfunction and improves patients outcome.
To limit inactivity of the diaphragm, mechanically ventilated patients should be 
ventilated with assisted ventilation as soon as possible. However, in patients 
with ARDS assisted ventilation may increase the risk of high tidal volumes and 
transpulmonary pressures (P
L
) and subsequently aggravate lung injury, known as 
ventilator-induced lung  injury (43). The use and timing for initiation of assisted 
mechanical ventilation in ARDS patients is thus subject of debate (44-47). In chapter 7, 
 it was demonstrated that in selected patients with mild to moderate ARDS assisted 
mechanical ventilation (NAVA and PSV) can deliver support within the limits of 
lung-protective ventilation. But, there were also patients in this study where tidal 
volume and P
L
 increased to high levels during assisted mechanical ventilation. In 
these cases of failure of assisted ventilation clinicians will most likely switch back to 
controlled ventilation and/or administrate high dose sedatives. Alternatively, partial 
neuromuscular blockade of the diaphragm using low dose rocuronium also facilitates 
low tidal volumes and P
L 
during assisted mechanical ventilation and with preservation 
of diaphragm activity (chapter 8). This suggests a novel strategy to deliver both 
lung-protective ventilation and diaphragm-protective ventilation in ARDS patients. 
However, this strategy was also associated with mild hemodynamic side effects, 
including tachycardia and elevated blood pressure, and development of hypercapnic 
acidosis. To minimize hemodynamic consequences in the future, the increase in 
PaCO
2
 could be made less rapid by titrating rocuronium more slowly. Further studies 
should focus on understanding the long-term consequences on diaphragm function 
using partial neuromuscular blocking and its feasibility under low levels of sedation.
Currently, there are no pharmacological agents available to improve diaphragm 
function in critically ill patients. Levosimendan is a calcium sensitizer approved to 
enhance cardiac contractility in patients with acute heart failure (48). Previously, is was 
shown that levosimendan also enhances in vitro calcium sensitivity of permeabilized 
muscle fibers obtained from the human diaphragm (49). Furthermore, levosimendan 
reduced protein nitrosylation and markers of oxidative stress in endotoxemic rodents 
(50). In this thesis we demonstrated that levosimendan administration in healthy 
subjects improved contractile function and neuromechanical efficiency of the 
diaphragm during loaded breathing (chapter 9). This suggests a new therapeutic 
approach for patients with diaphragm dysfunction. Another troponin activator 
has been shown to improve calcium sensitivity permeabilized diaphragm fibers as 
well, but not yet in humans (51). Recently a large randomized controlled trial to 
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investigate whether levosimendan reduces the severity of organ dysfunction in adults 
with sepsis was performed (52). In apparent contrast to our findings, it was found 
that levosimendan was associated with a lower likelihood of successful weaning 
from mechanical ventilation (52). However, this study was not specifically designed 
to evaluate the effect of levosimendan on weaning and diaphragm function. 
Levosimendan was given in the acute phase of septic shock for its inotropic and 
anti-inflammatory effects, whereas we would propose to administer levosimendan in 
patients with prolonged weaning, beyond their acute phase, to specifically improve 
diaphragm function. Currently, we are investigating the effects of levosimendan 
on diaphragm function in a randomized controlled trial in critically ill patients 
(ClinicalTrails.gov NCT01721434).
In addition to the work presented in this thesis other interventions to counteract 
diaphragm dysfunction have been reported in the past years, in particular 
modulation of contractile activity through inspiratory muscle strength training (IMST) 
or diaphragm pacing. Three randomized trials have assessed the effects of IMST in 
mechanically ventilated critically ill patients (53-55). These trials found, with different 
training protocols, that IMST improves maximum inspiratory pressure and has no 
adverse effects. Moreover, in two trials weaning time was reduced (53, 54). Thus, 
IMST in critically ill patients with respiratory muscle weakness is tolerated and may 
facilitate weaning. Future studies are needed to determine the optimal training 
protocol, timing and patient selection. 
 Diaphragm pacing occurs through electrical stimulation of the phrenic nerve 
via an intrathoracic or intradiaphragmatic approach. Validated indications for 
implanted phrenic nerve stimulation are quadriplegia caused by high level spinal 
cord injury and permanent, or sleep-related central hypoventilation (56). The goal 
of diaphragm pacing in these patients is liberating the patients, at least during 
the day, from mechanical ventilation. In critically ill patients receiving mechanical 
ventilation, temporary diaphragm pacing via a transvenous phrenic approach may 
offer a solution to prevent diaphragm dysfunction or even improve diaphragm 
contractility. Recently, in an experimental animal study it was found that early 
transvenous phrenic nerve stimulation preserves diaphragm thickness and myofiber 
cross-sectional area in ventilated-paced pigs compared to ventilated-not paced 
pigs (57). The prevention of diaphragm atrophy with diaphragm pacing has also 
been reported in a preliminary study of three mechanically ventilated sheep (58). 
In patients undergoing elective cardiothoracic surgery, diaphragm pacing increased 
diaphragm fiber force with 30% (59). These studies suggest that diaphragm pacing 
may prevent the development of VIDD. 
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Other future developments include the modulation of inflammation, proteolytic 
pathways and oxidative stress to improve diaphragm function. The latter strategies 
have been explored in experimental animal studies and provide encouraging data 
(60-63), but first need to be confirmed in humans. 
In conclusion, this thesis demonstrates how diaphragm function can be monitored 
in critically ill patients. In addition, we set first steps towards preventive and 
therapeutic strategies to optimize diaphragm function. Now is the time to recognize 
diaphragm dysfunction in critically ill patients and implement monitoring techniques 
into ICU routines and demonstrate improved outcome with close monitoring of the 
diaphragm and interventions specifically targeted to enhance diaphragm function.
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In de afgelopen decennia is er toenemend bewijs verzameld dat diafragmadisfunctie 
zich frequent voordoet bij kritisch zieke patiënten dit bijdraagt aan langdurige 
mechanische beademing. Echter, monitoring van diafragmafunctie tijdens 
mechanische beademing en tijdens het ontwennen van de beademing heeft 
weinig aandacht gekregen. Meestal wordt  de functie van het diafragma bij 
kritisch zieke patiënten in zijn geheel niet gemonitord door artsen. Tevens zijn er 
beperkte interventies beschikbaar die zich specifiek richten op het diafragma. In dit 
proefschrift zijn ten eerste technieken onderzocht waarmee diafragmafunctie kan 
worden gemonitord en ten tweede zijn preventieve en therapeutische interventies 
onderzocht om diafragmafunctie te optimaliseren.
Het eerste deel van dit proefschrift is gericht op het monitoren van diafragmafunctie 
bij kritisch zieke patiënten. In hoofdstuk 2, een klinisch perspectief, hebben we de 
voors en tegens besproken van de beschikbare technieken waarmee ademspierfunctie 
kan worden gemonitord. Deze technieken variëren van gemakkelijk te leren en 
non-invasieve methoden, zoals het meten van maximale inspiratoire druk en 
diafragma echografie, tot complexe en geavanceerde metingen, zoals elektrische 
stimulatie van de nervus phrenicus, elektrische activiteit van het diafragma (EAdi) 
en transdiafragmale druk (Pdi). Een aantal technieken zijn van beperkte betekenis 
(zoals fluoroscopie, occlusie druk in de eerste 100 ms) of zijn niet geschikt voor 
routine monitoring (zoals nervus phrenicus stimulatie). Echter, veelbelovende 
technieken voor het monitoren van ademspierfunctie zijn registratie van Pdi en EAdi, 
en diafragma echografie. Deze technieken zijn nu of in de nabije toekomst inzetbaar. 
Hoewel er geen bewijs is dat monitoring van de ademspieren (en handelen daarop) 
leidt tot een betere uitkomst voor patiënten, moet naar onze mening het monitoren 
van de ademspieren evenzeer onderdeel van de klinisch routine zijn als het bewaken 
van alle andere vitale orgaanfuncties.
 Bij kritisch zieke patiënten is het ontwennen van de mechanische beademing 
een belangrijke fase op intensive care (IC). De overgang van positieve inspiratoire 
druk door mechanische beademing naar negatieve pleurale druk door spontane 
ademhaling vraagt veel van de fysiologische reserves van de patiënt. Ontwennen van 
de beademing faalt wanneer er een disbalans is tussen de ventilatoire behoefte van 
de patiënt en de capaciteit van het neurale, cardiovasculaire en respiratoire systeem. 
In hoofdstuk 3 hebben we daarom de pathofysiologie van moeilijke en langdurige 
ontwenning van de beademing besproken alsmede de technieken die kunnen 
worden ingezet in het diagnostische traject om de oorzaak van falende ontwenning 
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te achterhalen. Verhoogde luchtwegweerstand en verlaagde compliantie van het 
respiratoire systeem, cardiale disfunctie, ademspierdisfunctie, cognitieve disfunctie 
en metabole aandoeningen zijn de belangrijkste oorzaken voor falende ontwenning 
van de beademing. Het wetenschappelijke onderzoek richt zich voornamelijk op 
ademspierdisfunctie en cardiale disfunctie als oorzaak voor falende ontwenning van 
de beademing. Kennis van de complexe pathofysiologie van falende ontwenning in 
combinatie met een systematische diagnostische aanpak maakt het mogelijk om de 
primaire oorzaak van falende ontwenning van de beademing te identificeren. 
 In hoofdstuk 4 is bij een heterogene groep van kritisch zieke patiënten de 
inspiratoire ademspierfunctie, expiratoire ademspierfunctie en mechanica van de 
ademhaling tijdens een trial spontaan ademen in detail geanalyseerd. We hebben in 
dit onderzoek aangetoond dat de expiratoire ademspieren een significante bijdrage 
(tot 26%) leveren aan de totale arbeid van de ademspieren bij patiënten met een 
mislukte poging trial spontaan ademen. Daarnaast is de neuromechanische efficiëntie 
van het diafragma bij patiënten met een mislukte poging trial spontaan ademen 41% 
lager dan bij patiënten die met succes een trial spontaan ademen ondergingen. Dit 
bevestigt dat een verminderde capaciteit van het diafragma om inspiratoire druk 
te genereren, ongeacht de oorzaak hiervan, een belangrijke rol speelt bij falende 
ontwenning van de mechanische beademing. 
 In hoofdstuk 5 hebben we bij gezonde proefpersonen aangetoond dat strain en 
strain rate van het diafragma, berekend middels speckle tracking echografie, sterk 
gecorreleerd is aan Pdi en EAdi bij een inspiratoire belasting tot 60 cmH
2
O, terwijl 
verdikking van het diafragma niet gecorreleerd is met Pdi en EAdi. Deze bevindingen 
suggereren dat geavanceerde technieken voor echografie, zoals speckle tracking, in 
de toekomst kunnen worden ingezet als non-invasieve methode om diafragmafunctie 
te monitoren bij kritisch zieke patiënten. 
Het tweede deel van dit proefschrift is gericht op preventieve en therapeutische 
interventies voor het optimaliseren van diafragmafunctie. Het minimaliseren van 
de schadelijke effecten van mechanische beademing op het diafragma is een 
belangrijke preventieve maatregel, bijvoorbeeld door het optimaliseren van patiënt-
ventilator interactie. Neurally adjusted ventilatory assist (NAVA) is een (non-)invasieve 
beademingsmodus die de elektrische activiteit van het diafragma gebruikt om de 
timing en het niveau van drukondersteuning te reguleren. 
 In hoofdstuk 6 is bij patiënten met COPD middels een automatische analyse 
van de beademingscurves de patiënt-ventilator interactie gekwantificeerd tijdens 
verschillende modi van non-invasieve beademing, waaronder NAVA. We hebben 
aangetoond dat met NAVA beademing de mechanische drukondersteuning in 
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synchronie is met de neurale inspiratie van de patiënt, terwijl drukgestuurde 
modi van mechanische beademing geen optimale patiënt-ventilator interactie 
geven. Tevens stijgt het aantal wasted efforts (gemiste inspiratiepogingen van 
de beademingsmachine) exponentieel wanneer het verschil in timing tussen de 
elektrische activiteit van het diafragma en de beademingsmachine meer dan 20% 
van de inspiratietijd bedraagt. Oftewel, een progressieve mismatch tussen de neurale 
inspiratie van de patiënt en de mechanische inspiratie van de beademingsmachine is 
sterk geassocieerd met ernstige vormen van patiënt-ventilator asynchronie. Ondanks 
deze fysiologische voordelen verbetert NAVA niet de bloedgaswaarden en het 
comfort van de patiënt. 
 Bij ARDS patiënten is long-protectieve beademing belangrijk om te voorkómen 
dat de long nog meer beschadigt. Long-protectieve beademing wordt meestal 
toegepast door middel van gecontroleerde mechanische beademing. Bij 
gecontroleerde mechanische beademing is strikte regulatie van het teugvolume 
en de plateaudruk mogelijk. Deze beademingsmodus vereist echter een hoog 
sedatie niveau van de patiënt en gaat gepaard met bijwerkingen, in het bijzonder 
diafragmadisfunctie. Bij ondersteunende modi van mechanische beademing is 
spontane ademhaling mogelijk, waardoor het risico op diafragmadisfunctie minder 
is.  Echter, ondersteunende mechanische beademing kan weer leiden tot hoge 
teugvolumes en hoge transpulmonale drukken, waardoor longschade ontstaat. In 
hoofdstuk 7 is bij patiënten met mild tot matig ARDS het effect onderzocht van 
verschillende modi van mechanische beademing (drukgecontroleerde beademing 
[PCV], drukondersteunende beademing [PSV] en NAVA) op parameters van long-
protectieve beademing, variabiliteit van de ademhaling en patiënt-ventilator 
interactie. De hoeveelheid controle die de patiënt kan uitoefenen op de timing 
en het niveau van ondersteuning van de beademingsmachine is verschillend voor 
deze drie modi. De belangrijkste conclusie van onze studie was dat het teugvolume 
en de transpulmonale druk binnen de grenzen van long-protectieve beademing 
bleven bij een toenemende vrijheid voor de patiënt om de beademingsmachine te 
controleren. Uitzondering hierop was één patiënt met een ernstige hypercapnische 
acidose die een teugvolume boven de 10 ml/kg ontwikkelde. Zowel variabiliteit van 
de ademhaling als patiënt-ventilator interactie verbeterden met NAVA ten opzichte 
van PCV en PSV. Deze bevindingen suggereren dat er bij patiënten met mild tot matig 
ARDS het mogelijk is om drukondersteunende beademing toe te passen waarbij het 
diafragma actief is. 
 Op basis van de bevindingen in hoofdstuk 7 is een beademingsstrategie 
ontwikkeld voor ARDS patiënten die hoge teugvolumes ontwikkelen na de overgang 
van gecontroleerde mechanische beademing naar ondersteunende mechanische 
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beademing. In een proof-of-concept studie is onderzocht of een lage dosis 
neuromusculaire blokkers een long-protectieve ondersteunende beademingsstrategie 
kan faciliteren bij patiënten met longschade en hoge teugvolumes zonder volledig 
verlies van diafragma activiteit (hoofdstuk 8). Een dergelijke strategie zou mogelijk 
de voordelen van spontane ademhaling tijdens mechanische beademing kunnen 
behouden en de risico’s minimaliseren. De resultaten van ons onderzoek tonen aan 
dat het mogelijke is om partiële spierverslapping van het diafragma zo te titreren dat 
het teugvolume van 10 ml/kg daalt naar 6 ml/kg met behoud van diafragma activiteit. 
Gedurende de partiële spierverslapping ontstaan echter wel milde hemodynamisch 
bijeffecten, waaronder tachycardie en hypertensie, en een hypercapnische acidose. 
Toekomstige studies moeten zorgvuldig evalueren of partiele spierverslapping van 
het diafragma mogelijk is gedurende langere tijdsperioden. 
 In eerder in vitro onderzoek is aangetoond dat levosimendan de calciumgevoeligheid 
verhoogt van gepermeabiliseerde spiervezels van humaan diafragma. Dit heeft tot 
gevolg dat de spiervezels meer kracht kunnen genereren voor eenzelfde hoeveelheid 
intracellulair calcium. In hoofdstuk 9 is bij gezonde proefpersonen onderzocht of 
levosimendan ook in vivo diafragmafunctie verbetert. We hebben aangetoond dat 
tijdens isometrische belasting van het diafragma, de neuromechanische efficiëntie 
van het diafragma met ongeveer 20% verbetert. Daarnaast kan levosimendan de 
afname in kracht van het diafragma door vermoeidheid ongedaan maken. 
 Systemische inflammatie is een belangrijke risicofactor voor ademspierzwakte. In 
hoofdstuk 10 is gepoogd om een experimenteel in vivo model te ontwikkelen voor 
diafragmadisfunctie tijdens systemische inflammatie. In tegenstelling tot diermodellen 
van systemische inflammatie zagen wij bij gezonde proefpersonen na toediening van 
een lage dosis endotoxine een toename van de in vivo diafragma contractiliteit in 
de vroege fase. Gezien deze bevindingen lijkt het humane endotoxemie model niet 
geschikt voor het testen van interventies om diafragmafunctie verbeteren. 
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Diafragmadisfunctie komt frequent voor bij kritisch zieke patiënten en is geassocieerd 
met een verhoogde morbiditeit en mortaliteit. In de studies in dit proefschrift zijn 
technieken om diafragmafunctie te monitoren onderzocht alsmede preventieve en 
therapeutische interventies om diafragmafunctie te optimaliseren.
Monitoring van diafragmafunctie tijdens mechanische beademing 
en het ontwennen
In de klinische praktijk wordt het diafragma bij kritisch zieke patiënten nauwelijks 
gemonitord. Beperkte beschikbaarheid en kennis van technieken waarmee je het 
diafragma kunt monitoren liggen hier aan ten grondslag. In hoofdstuk 2 hebben 
wij drie technieken geïdentificeerd die veelbelovend zijn om ademspierfunctie te 
monitoren op de IC: 1) transdiafragmale druk (Pdi), 2) elektrische activiteit van het 
diafragma (EAdi), en 3) diafragma echografie. Deze technieken zijn in de afgelopen 
jaren in toenemende mate onderzocht.
Door het meten van Pdi kun je de drukopbouw van het diafragma heel specifiek 
monitoren. Deze techniek vereist het plaatsen van een dubbele ballon katheter (maag 
en oesophagus ballon). De daling van druk in de oesophagus (Pes) tijdens inspiratie 
representeert de resulterende actie van alle ademspieren en vereist slechts het 
plaatsen van één ballon. Deze benadering is voor het monitoren van ademspierfunctie 
bij kritisch zieke patiënten uitvoerig beschreven (1-3). Bij beademde patiënten met 
spontane ademhaling wordt Pes monitoring ook gebruikt om de arbeid van de 
ademspieren en patiënt-ventilator interactie te monitoren. 
 In hoofdstuk 7 en hoofdstuk 8 zien we dat de daling in Pes tijdens inspiratie kan 
variëren van laag tot zeer hoog. Dit betekent dat de activiteit van de ademspieren 
varieert van onvoldoende tot bovenmatig. Zowel onvoldoende als bovenmatige 
inspiratoire spieractiviteit kan leiden tot diafragmadisfunctie (4-9). Monitoring van 
Pes of Pdi tijdens mechanische beademing maakt het mogelijk om de ondersteuning 
van de beademingsmachine te titreren tot een gewenste activiteit van de 
ademspieren. Een door de ademspieren gegenereerde druk tussen de 5 en 10 cmH
2
O 
valt binnen het fysiologisch bereik (10). Door het monitoren van Pes tijdens een trial 
spontaan ademen kan onderscheid worden gemaakt tussen succesvolle en falende 
ontwenning (11). In hoofdstuk 4 zijn bij patiënten tijdens een trial spontaan ademen 
de veranderingen in Pes en maagdruk (Pga) gemeten. Daarnaast hebben we Pes 
en Pga gebruikt om meer geavanceerde parameters te berekenen, zoals intrinsieke 
positief eind-expiratoire druk, expiratoire stijging van de maag druk, ademarbeid en 
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pressure-time product. Vanuit een diagnostisch perspectief geven deze parameters 
relevante informatie om de oorzaak van falende ontwenning voor een individuele 
patiënt te bepalen (12, 13). Voor routine monitoring van de ademspieren vereist deze 
gedetailleerde analyse echter een te hoog niveau van deskundigheid. Monitoring van 
enkel de drukverandering van Pes of Pdi tijdens inspiratie is beter geschikt voor een 
routinematige klinische toepassing. Verschillende studies hebben aangetoond dat 
Pes monitoring kan worden gebruikt om patiënt-ventilator interactie te monitoren 
(14-16). In dit proefschrift hebben patiënt-ventilator interactie echter gemonitord 
met behulp van de EAdi, zoals beschreven in de volgende paragraaf. 
 Een andere toepassing van Pes monitoring, naast het monitoren van de 
ademspieren, is het sturen van long-protectieve mechanische beademing bij 
patiënten met acute respiratory distress syndrome (ARDS). Wij hebben laten zien dat 
Pes (in de berekening van de transpulmonale druk) kan worden gebruikt om veilige 
of schadelijk drukken voor de long te identificeren tijdens mechanische beademing 
bij ARDS patiënten (hoofdstuk 7-8). 
Monitoring van de elektrische activiteit van het diafragma (EAdi) is de standaard 
om patiënt-ventilator interactie te evalueren (17-22). Vaak wordt patiënt-ventilator 
interactie handmatig gescoord. Daarentegen hebben wij patiënt-ventilator interactie 
geëvalueerd met behulp van een geautomatiseerd algoritme (op basis van de EAdi) 
bij patiënten met chronic obstructive pulmonary disease (COPD) tijdens non-invasieve 
beademing (hoofdstuk 6) en bij ARDS patiënten tijdens invasieve beademing 
(hoofdstuk 7). Deze geautomatiseerde analyse detecteert asynchronieën, zoals 
wasted efforts, maar maakt het ook makkelijker om meer subtiele dissynchronieën 
(timing fouten), zoals trigger vertragingen en cycling-off fouten te detecteren. 
Dissynchronieën worden gemakkelijk gemist bij een visuele inspectie van de 
beademingscurven, maar kunnen zeker klinisch relevant zijn. Het aantal wasted 
efforts stijgt namelijk sterk wanneer dissynchronieën oplopen tot meer dan 20% van 
de respiratoire cyclus (hoofdstuk 6). Een geautomatiseerde analyse van EAdi (of Pes) 
zou in beademingsmachines kunnen worden ingebouwd om monitoring van patiënt-
ventilator interactie te vereenvoudigen. 
 Het EAdi signaal kan ook worden gebruikt om de neurale aansturing van de 
ademspieren te monitoren tijdens mechanische beademing en het ontwennen. 
Wij hebben aangetoond bij ARDS patiënten die werden beademd met 6 ml/
kg dat er een grote variatie kan zijn in de mate van neurale aansturing van de 
ademspieren (hoofdstuk 7). Dit suggereert dat het instellen van lage teugvolumes 
op de beademingsmachine kan leiden een groot verschil in ademprikkel tussen 
patiënten. Dit is waarschijnlijk het gevolg van de complexe interactie tussen sedatie, 
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beademingsmodus en het niveau van ondersteuning van de beademingsmachine. Het 
monitoren van EAdi kan in deze situaties helpen om beademing van ARDS patiënten 
te optimaliseren en daarmee onvoldoende of bovenmatige ondersteuning van de 
beademingsmachine te voorkómen. Een nadeel van het monitoren van EAdi is dat de 
amplitude van het signaal sterk wordt beïnvloedt door de individuele anatomie van 
de patiënt met als gevolg dat het vergelijken tussen patiënten moeilijk is. Bovendien 
is er geen methode om de optimale EAdi amplitude te bepalen voor een individuele 
patiënt. Recentelijk zijn er pogingen gedaan om ademarbeid te schatten met behulp 
van het EAdi signaal (23) en om de bijdrage van de patiënt aan het teugvolume tijdens 
mechanische beademing te berekenen (24). Echter, de betrouwbaarheid van deze 
metingen is slecht (25) en daarom nog niet klinische toepasbaar. Nieuw onderzoek 
is vereist om een betrouwbare methode te ontwikkelen die kan vaststellen wat de 
optimale EAdi amplitude is voor een individuele patiënt.
 De verhouding tussen Pdi en EAdi representeert de neuromechanische efficiëntie 
(NME) van het diafragma, oftewel het vermogen van het diafragma om neurale 
respiratoire input om te zetten naar mechanische respiratoire output. Een geleidelijke 
afname in NME over een aantal dagen kan betekenen dat het diafragma verzwakt 
of vermoeid raakt, terwijl een toename herstel suggereert. In ons onderzoek naar 
ontwenning van de beademing is aangetoond dat de NME lager is bij falende 
ontwenning dan bij succesvolle ontwenning (hoofdstuk 4). In deze studie is de NME 
berekend met behulp van een dubbele ballon katheter met meerdere elektroden 
zodat continu Pdi en EAdi kon worden berekend. In eerder onderzoek is NME van 
de ademspieren berekent als de verhouding tussen de daling in monddruk tijdens 
een inspiratoire occlusie en EAdi (26-28). Met deze methode is aangetoond dat 
NME falende ontwenning van de beademing kan voorspellen (26). In een kleine 
gerandomiseerde klinische studie werd aangetoond dat beademing met NAVA zorgt 
voor een verbetering in NME terwijl dit niet het geval is bij beademing met PSV 
(27). Dit suggereert dat het monitoren van NME zinvol kan zijn om veranderingen 
in efficiëntie van de ademspieren te detecteren tijdens mechanische beademing. 
Echter, ander onderzoek toont aan dat de (trend van) NME niet geassocieerd is met 
risicofactoren voor diafragmadisfunctie of klinische uitkomst (28). Nader onderzoek 
is nodig naar de waarde van het monitoren van NME tijdens mechanische beademing 
en ontwenning en de meest optimale en praktische werkwijze. 
Naast fysiologische metingen neemt de populariteit van beeldvorming van het 
diafragma met echografie toe om diafragmafunctie te monitoren op de IC. 
Met echografie kan de dikte, verdikking tijdens inspiratie en de verplaatsing van 
het diafragma worden bepaald (29). Eerder onderzoek heeft aangetoond dat bij 
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kritisch zieke patiënten de dikte van het diafragma afneemt tijdens een periode van 
mechanische beademing en dat de verdikking van het diafragma afhankelijk is van 
de ondersteuning die de beademingsmachine geeft (9, 30). Echter, correlaties tussen 
functionele metingen (zoals Pdi) en verdikking van het diafragma zijn laag (31). 
Daarom is er behoefte aan nieuwe echografie technieken. Speckle tracking imaging 
van het diafragma, een geavanceerde echografie techniek, laat wel een correlatie 
zien met Pdi (hoofdstuk 5) en kan mogelijk in de toekomst worden ingezet als non-
invasieve methode om ademspierfunctie te monitoren bij kritisch zieke patiënten. 
Dit proefschrift laat zien dat monitoring van het diafragma toepasbaar is bij kritisch 
zieke patiënten. Monitoring van Pdi (of Pes), EAdi en diafragma echografie geven 
complementerende informatie over het diafragma. Idealiter beschikken artsen over 
alle drie de technieken, zoals bloeddruk, elektrocardiografie en echocardiografie 
gebruikt worden voor monitoring van cardiale functie. Echter het gebruik van één 
van deze technieken bij de dagelijkse zorg voor IC patiënten zou al een grote stap 
voorwaarts zijn voor het diafragma. Het monitoren van ademspierfunctie op de IC 
zou evenzeer onderdeel van de routine moeten zijn als het monitoren van enig andere 
orgaan functie. Zorgvuldige monitoring van diafragmafunctie is een voorwaarde 
om veranderingen te kunnen detecteren, maar monitoring is zinloos wanneer er 
geen actie kan worden ondernomen om diafragmadisfunctie te voorkómen of om 
diafragmafunctie te verbeteren. Om deze reden zijn in dit proefschrift ook mogelijke 
interventies onderzocht.
Preventieve en therapeutische interventies om diafragmafunctie 
te optimaliseren
Er zijn momenteel beperkt interventies beschikbaar om diafragmafunctie te 
optimaliseren bij kritisch zieke patiënten (32). In dit proefschrift zijn nieuwe 
interventies gericht op het voorkómen van diafragmadisfunctie (hoofdstuk 6-8) en 
het verbeteren van diafragmafunctie (hoofdstuk 9-10) geëvalueerd. 
Mechanisch beademing is een belangrijke factor die bijdraagt aan diafragmadisfunctie 
bij kritisch zieke patiënten, dit wordt ook wel beademings-geïnduceerde 
diafragmadisfunctie (VIDD) genoemd (33, 34). Inactiviteit van het diafragma 
tijdens mechanische beademing is de belangrijkste pathofysiologische trigger die 
leidt tot VIDD, vooral tijdens gecontroleerde mechanische beademing (34). Hoge 
niveaus van ondersteuning tijdens ondersteunende beademing kunnen echter ook 
diafragmadisfunctie veroorzaken (8). Om diafragma inactiviteit te beperken tijdens 
mechanische beademing kunnen preventieve maatregelen worden getroffen. 
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Neurally adjusted ventilatory assist (NAVA) is een beademingsmodus die de elektrische 
activiteit van het diafragma gebruikt om de beademingsmachine aan te sturen 
(35). Bij COPD patiënten en ARDS patiënten verbetert NAVA de patiënt-ventilator 
interactie in vergelijking met drukgestuurde beademing (PSV) (hoofdstuk 6-7). Een 
slechte patiënt-ventilator interactie is sterk geassocieerd met langdurige mechanische 
beademing (36, 37). NAVA kan daardoor potentieel de duur van mechanische 
beademing verkorten en daarmee de uitkomst van beademende patiënten verbeteren. 
De proportionaliteit tussen EAdi en het niveau van ondersteuning bij NAVA voorkomt 
tevens bovenmatige ondersteuning, zoals het geval kan zijn bij PSV (38-41). 
Ondanks deze fysiologische voordelen van NAVA, zien wij in onze onderzoeken geen 
verbeteringen in bloedgaswaarden en patiënt comfort met NAVA (hoofdstuk 6-7). 
Dit laatste kan mogelijk het gevolg zijn van de korte periode (30 min) waarin wij de 
verschillende beademingsmodi hebben onderzocht. Onlangs werd in een multicenter 
gerandomiseerde gecontroleerde trial aangetoond dat NAVA een veilige en toepasbare 
beademingsmodus is over een langere periode, maar dat het niet de ligduur op de IC 
of sterfte vermindert (42). Deze trial is uitgevoerd in een heterogene groep van kritisch 
zieke patiënten met acuut respiratoir falen, terwijl voornamelijk bepaalde groepen, 
zoals COPD patiënten of patiënten met hoge niveaus van ondersteuning, fysiologisch 
baat lijken te hebben bij NAVA. Nieuwe studies zijn nodig om te bepalen of en bij 
welke patiëntengroepen NAVA diafragmadisfunctie kan voorkómen en de uitkomst 
van patiënten kan verbeteren. 
Om activiteit van het diafragma te stimuleren, moeten beademde patiënten zo 
spoedig mogelijk worden beademd met een ondersteunende beademingsmodus. 
Bij patiënten met ARDS kan ondersteunende beademing echter het risico verhogen 
op hoge teugvolumes en hoge transpulmonale drukken (P
L
) en daarmee longschade 
verergeren, dit wordt ook wel beademings-geïnduceerde longschade genoemd 
(43). Het gebruik van ondersteunende beademing en het moment waarop dit moet 
worden gestart bij ARDS patiënten staat ter discussie (44-47). In hoofdstuk 7 
is aangetoond dat bij geselecteerde patiënten met een mild tot matig ARDS 
ondersteunende mechanische beademing (NAVA en PSV) mogelijk is binnen de grenzen 
van long-protectieve beademing. Echter, er zijn ook patiënten in deze studie met een te 
hoog teugvolume en P
L
. In deze specifieke casus, waar ondersteunende mechanische 
beademing faalt, zullen artsen zeer waarschijnlijk overgaan op gecontroleerde 
beademing en/of een hoog niveau van sedatie nastreven. Als alternatief kan partiele 
spierverslapping van het diafragma met behulp van een lage dosis rocuronium ook een 
laag teugvolume en P
L
 faciliteren tijdens ondersteunde mechanische beademing en 
met behoud van diafragma activiteit (hoofdstuk 8). Deze nieuwe beademingsstrategie 
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bij ARDS patiënten combineert daardoor long-protectieve beademing en diafragma-
protectieve beademing. Een nadeel van deze beademingsstrategie is het optreden 
van milde hemodynamisch bijeffecten, waaronder tachycardie en hypertensie, en een 
hypercapnische acidose. Om hemodynamische veranderingen te minimaliseren, zou 
de snelheid van toename in PaCO
2
 kunnen worden geminimaliseerd door rocuronium 
meer geleidelijk te titreren. Nader onderzoek moet zich richten op het begrijpen van 
de gevolgen van partiële spierverslapping voor diafragmafunctie op de lange termijn 
en de haalbaarheid van deze strategie onder lage niveaus van sedatie. 
Momenteel zijn er geen farmacologische middelen beschikbaar om de functie van 
het diafragma te verbeteren bij kritisch zieke patiënten. Levosimendan is een middel 
dat de gevoeligheid voor calcium in de spiercel verhoogt en staat geregistreerd 
als middel om de contractiliteit van het hart te verhogen bij patiënten met acuut 
hartfalen (48). In eerder in vitro onderzoek is aangetoond dat levosimendan ook 
de calciumgevoeligheid van gepermeabiliseerde spiervezels van humaan diafragma 
verhoogt (49). Daarnaast reduceert levosimendan eiwit nitrosylering en markers 
van oxidatieve stress bij knaagdieren in een model van systemische inflammatie 
(50). In dit proefschrift hebben we aangetoond dat toediening van levosimendan 
aan gezonde proefpersonen de contractiliteit en neuromechanische efficiëntie van 
het diafragma verbetert tijdens ademen tegen een hoge belasting (hoofdstuk 9). 
Onze bevindingen suggereren een mogelijkheid voor nieuwe therapeutische 
behandeling van diafragmadisfunctie bij kritisch zieke patiënten. Ook bij onderzoek 
naar een alternatieve troponine activator is gebleken dat de calciumgevoeligheid 
van gepermeabiliseerde spiervezels van humaan diafragma kan worden verhoogd 
(51), maar dit is nog niet bevestigd in humane studies. Recentelijk is er in een grote 
gerandomiseerde gecontroleerde trial onderzocht of levosimendan de ernst van 
orgaandisfunctie bij volwassenen met sepsis vermindert (52). In schijnbare tegenstelling 
tot onze bevindingen, blijkt dat levosimendan is geassocieerd met een lagere kans op 
een succesvolle ontwenning van de beademing (52). Dit onderzoek was echter niet 
specifiek gericht op het evalueren van het effect van levosimendan op ontwenning 
van de beademing of het verbeteren van diafragmafunctie. In deze studie werd 
levosimendan in de acute fase van een septische shock gegeven om de inotrope en 
anti-inflammatoire effecten te onderzoeken. Om de effecten op diafragmafunctie te 
evalueren kan levosimendan beter worden toegediend aan patiënten met een moeilijke 
ontwenning van de beademing, na de acute fase. Op dit moment onderzoeken 
we de effecten van levosimendan op diafragmafunctie in een gerandomiseerde 
gecontroleerde trial bij kritisch zieke patiënten (ClinicalTrails.gov NCT01721434). 
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In aanvulling op het werk in dit proefschrift zijn er in de afgelopen jaren andere 
interventies onderzocht gericht op het diafragma. In het bijzonder zijn er studies 
verricht naar de effecten van inspiratoire spierkracht training (IMST) en pacing 
van het diafragma. Drie gerandomiseerde studies hebben de effecten van IMST bij 
beademde kritisch zieke patiënten geëvalueerd (53-55). Deze studies hebben met 
verschillende trainingsprotocollen gevonden dat IMST de maximale inspiratoire druk 
verbetert en dat er geen bijwerkingen van IMST zijn. Bovendien lieten twee studies 
zien dat de tijd tot ontwenning van de beademing werd verkort (53, 54). Dus IMST 
wordt getolereerd door kritisch zieke patiënten met ademspierzwakte en het lijkt 
de duur van de beademing te kunnen verkorten. Nieuwe studies zijn nodig om te 
bepalen wat het optimale trainingsprotocol is en wanneer en bij wie gestart kan 
worden met IMST.
 Pacing van het diafragma gebeurt door middel van elektrische stimulatie 
van de nervus phrenicus via een intrathoracale of intradiafragmale benadering. 
Diafragma pacing via implantatie van elektroden is momenteel alleen geïndiceerd bij 
tetraplegische patiënten met een hoge dwarslaesie of patiënten met permanente of 
slaap-gerelateerde centrale hypoventilatie (56). Het doel van diafragma pacing bij deze 
patiënten is het verminderen van de afhankelijkheid van (voornamelijk nachtelijke) 
mechanische beademing. Bij kritisch zieke beademde patiënten kan tijdelijke 
diafragma pacing via een transveneuze benadering mogelijk diafragmadisfunctie 
voorkómen of zelfs de contractiliteit van het diafragma verbeteren. Recent is in 
een proefdierstudie aangetoond dat bij vroege transveneuze diafragma pacing de 
dikte van het diafragma en de dwarsdoorsnede van spiervezels behouden blijft bij 
beademde varkens met diafragma pacing versus beademde varkens zonder diafragma 
pacing (57). Preventie van diafragma atrofie door middel van diafragma pacing is ook 
aangetoond in een preliminaire studie bij drie beademde schapen (58). Bij patiënten 
die electieve cardiothoracale chirurgie ondergingen verhoogde diafragma pacing de 
kracht van diafragma vezels met 30% (59). Deze studies suggereren dat diafragma 
pacing de ontwikkeling van VIDD in de toekomst kan voorkómen. 
 Andere ontwikkelingen om diafragmafunctie te verbeteren zijn de modulatie van 
inflammatie, proteolytische pathways en oxidatieve stress. In exploratief onderzoek 
bij dieren worden positieve resultaten geboekt (60-63), maar deze moeten nog 
worden bevestigd in humaan onderzoek. 
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Tot slot, dit proefschrift toont aan hoe diafragmafunctie kan worden gemonitord 
bij kritisch zieke patiënten. Daarnaast hebben we eerste stappen gezet richting 
preventieve en therapeutische strategieën om diafragmafunctie te optimaliseren. 
De tijd is daar om diafragmadisfunctie bij kritisch zieke patiënten te erkennen 
en monitoring technieken te implementeren in de routines van de IC en te 
demonstreren dat zorgvuldige monitoring van het diafragma en gerichte interventies 
om diafragmafunctie te verbeteren leiden tot een betere uitkomst voor patiënten.
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dat het een groot succes was. 
Dr. Sinderby and dr. Beck, dear Christer and Jennifer, after having read all your 
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my research. You have learned me a great deal on the physiology of breathing and 
your revisions significantly improved my manuscripts. I have had a wonderful time in 
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roads. Christer, Jennifer and Norm, you are truly an amazing team. Thank you for all 
your support and hospitality.
Prof. dr. ir. Stegeman, beste Dick, jouw expertise op het gebied van de 
elektromyografie is zeer waardevol geweest bij de start van mijn promotie. Ik vind 
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voor het vertrouwen.
Dat je onderzoek niet alleen doet blijkt uit alle ondersteuning die ik in de loop van de 
jaren heb gehad. Voor de hulp bij het includeren van de patiënten en het uitvoeren 
van de experimenten wil ik de researchverpleegkundigen Aarnout, Chantal, 
Hellen, Hetty, Marieke, Noortje en Tijn en secretaresse Yvonne bedanken. Sjef, 
bedankt voor ICWeb, onmisbaar voor onderzoekers. Joris, Wim en Geert van de 
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meetopstellingen.
Al mijn collega onderzoekers op de IC wil ik vooral bedanken voor het werkplezier 
dat ik elke dag heb gehad. In de afgelopen jaren zijn er veel promovendi gekomen en 
gegaan, maar de sfeer op de afdeling was altijd geweldig. Een ideale balans tussen 
inspanning en ontspanning. In het bijzonder wil ik een aantal collega’s bedanken. 
Matthijs en Mark, mijn kamergenoten voor het grootste deel van mijn promotie, 
bedankt voor het vele lachen, de mooie gesprekken en de fietstochtjes. Matthijs, je 
loopt altijd een paar jaar voor op mij in je carrière en privé. Bedankt voor al je adviezen 
daarin van klein tot groot. Mark, bedankt voor je aanstekelijke enthousiasme, hulp 
bij statistische vragen en culinaire tips. Lucas, je bent een ontzettend fijne en 
betrokken collega. Ik heb veel geleerd van de manier waarop jij studenten begeleid. 
Onze survivaltochten in de Duitse bossen waren fantastisch. Willem-Jan, als collega 
diafragma onderzoeker heb ik van jouw studies veel geleerd over de biochemische 
en moleculaire spierfysiologie. De congressen in de VS waar we vaak de kamer 
deelden waren altijd erg gezellig. Lisanne, bedankt voor de talloze metingen die je 
voor me hebt uitgevoerd tot ’s avonds laat. Het is mooi om te zien dat je onmisbaar 
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Naast mijn fijne collega’s wil ik mijn vrienden en familie bedanken voor de 
noodzakelijke ontspanning, relativering en steun. 
265
Dankwoord
Kevin, de verschillen tussen jouw snelle zaken en mijn trage wetenschap zijn groot, 
maar onder het genot van een biertje vinden we verassend vaak parallellen. Het 
aantal fietstochten en avonden in de kroeg zijn minder dan in Enschede, maar ik 
geniet er nog net zoveel van. Thomas en Jasper, na al die jaren hebben we nog net 
zo veel lol als vroeger. Soms met zijn drieën, maar inmiddels ook met zijn elven. Hoe 
mooi is dat. De tijd vliegt, over drie jaar is het al 2020. 
Dan mijn paranimfen, Reinoud en Martijn. Geweldig dat wij als studievrienden 
van het eerste uur elkaar hebben bijgestaan tijdens de verdediging van onze 
proefschriften. Reinoud, jouw efficiëntie en werklust zijn ongeëvenaard. Het is niet 
voor niets dat je vier jaar eerder dan Martijn en ik bent gepromoveerd. Martijn, jij 
hebt de klus drie dagen eerder dan ik geklaard. Ik gun het je enorm, je bent een 
doorzetter. Ondanks onze drukke carrières en privélevens hoop ik dat we elkaar nog 
vaak kunnen bijpraten tijdens een borrel.
Henk en Christl, jullie zijn staan altijd voor Janet en mij klaar. Bedankt voor de vele 
momenten dat jullie op Luuk hebben gepast, zodat papa nog even kon gaan werken 
aan zijn proefschrift. Anita en Jeff, bedankt voor jullie interesse in mijn onderzoek 
en de leuke momenten samen met Véronique en Elena. 
Janine, grote zus, jij bent mij voorgegaan in de wetenschap en met promoveren. Het 
is ontzettend fijn om een zus te hebben waarmee je de vreugde en frustraties van 
het onderzoek kunt delen. Laten we snel samen een artikel schrijven. Remy, bedankt 
voor je oprechte interesse. Lieve Jaslynn, mocht je geïnteresseerd zijn, ik leg het je 
ooit graag allemaal uit.
En natuurlijk mijn ouders, Piet en Thea. Onderzoek doen vereist nieuwsgierigheid, 
creativiteit en doorzettingsvermogen. Eigenschappen waarvan ik zeker weet dat 
jullie ze me hebben meegegeven. Bedankt voor jullie onvoorwaardelijk steun. Als 
ouders, maar ook als geweldige opa en oma.
Lieve Luuk, jij gaat ook elke dag op onderzoek uit en daar geniet ik volop van. Lieve 
Janet, de laatste woorden van dit dankwoord zijn voor jou. Meer dan je beseft 
ben je belangrijk geweest voor mij, als steun bij tegenslagen en bij het vieren van 
successen. Ik ben ontzettend gelukkig met jou en Luuk.
266
267
List of publications
List of publications
Molenaar JP, Voermans NC, de Jong LA, Stegeman DF, Doorduin J, van Engelen 
BG. Repeatability and reliability of muscle relaxation induced by motor cortical 
stimulation. Submitted.
Longhini F, Colombo D, Pisani L, Idone F, Chun P, Doorduin J, Ling L, Alemani M, 
Bruni A, Zhaochen J, Tao Y, Lu W, Garofalo E, Carenzo L, Maggiore SM, Qiu H, Heunks 
LMA, Antonelli M, Nava S, Navalesi P. Efficacy of ventilator waveforms observation 
for detection of patient-ventilator asynchrony during non-invasive ventilation. A 
multicenter study. Submitted.
Tilanus TBM, Groothuis JT, tenBroek-Pastoor JMC, Feuth TB, Heijdra YF, Slenders JPL, 
Doorduin J, van Engelen BG, Kampelmacher MJ, Raaphorst J. The predictive value 
of respiratory function tests for the indication of non-invasive ventilation in patients 
with ALS. Submitted.
Doorduin J, Roesthuis LH, Jansen D, van der Hoeven JG, van Hees HWH, Heunks 
LMA. Inspiratory and expiratory muscle effort during successful and failed weaning 
from mechanical ventilation. Submitted.
Oppersma E, Hatam N, Doorduin J, van der Hoeven JG, Marx G, Goetzenich A, 
Fritsch S, Heunks LMA, Bruells CB. Functional assessment of the diaphragm by 
ultrasonic deformation imaging during inspiratory loading. Accepted for publication 
in J Appl Physiol.
Doorduin J, Nollet JL, Roesthuis LH, van Hees HW, Brochard LJ, Sinderby CA, van der 
Hoeven JG, Heunks LM. Partial Neuromuscular Blockade During Partial Ventilatory 
Support in Sedated Patients with High Tidal Volumes. Am J Resp Crit Care Med. 2017 
Apr 15;195(8):1033-1042
Witteveen E, Sommers J, Wieske L, Doorduin J, van Alfen N, Schultz MJ, van 
Schaik IN, Horn J, Verhamme C. Diagnostic accuracy of quantitative neuromuscular 
ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-
sectional observational study. Ann Intensive Care. 2017 Apr 5;7(1):40.
Podnar S, Doorduin J. Safety of needle electromyography of the diaphragm: Anterior 
lung margins in quietly breathing healthy subjects. Muscle Nerve. 2016 Jun;54(1):54-7.
268
Doorduin J, Roesthuis LH, van der Hoeven JG, Heunks LMA. New type of wasted 
effort during neurally adjusted ventilatory assist: a case report. Neth J Crit Care. 2016 
Jul;24(4):18-9.
Doorduin J, Nollet JL, Vugts MP, Roesthuis LH, Akankan F, van der Hoeven JG, van 
Hees HW, Heunks LM. Assessment of dead-space ventilation in patients with acute 
respiratory distress syndrome: a prospective observational study. Crit Care. 2016 May 
5;20(1):121.
Schellekens WJ, van Hees HW, Doorduin J, Roesthuis LH, Scheffer GJ, van der 
Hoeven JG, Heunks LM. Strategies to optimize respiratory muscle function in ICU 
patients. Crit Care. 2016 Apr 19;20(1):103.
Doorduin J, van der Hoeven JG, Heunks LM. The differential diagnosis for failure to 
wean from mechanical ventilation. Curr Opin Anaesthesiol. 2016 Apr;29(2):150-7.
Doorduin J, Leentjens J, Kox M, van Hees HW, van der Hoeven JG, Pickkers P, Heunks 
LM. Effects of Experimental Human Endotoxemia on Diaphragm Function. Shock. 
2015 Oct;44(4):316-22.
Doorduin J, Sinderby CA, Beck J, van der Hoeven JG, Heunks LM. Assisted Ventilation 
in Patients with Acute Respiratory Distress Syndrome: Lung-distending Pressure and 
Patient-Ventilator Interaction. Anesthesiology. 2015 Jul;123(1):181-90.
Heunks LM, Doorduin J, van der Hoeven JG. Monitoring and preventing diaphragm 
injury. Curr Opin Crit Care. 2015 Feb;21(1):34-41.
Doorduin J, Sinderby CA, Beck J, van der Hoeven JG, Heunks LM. Automated patient-
ventilator interaction analysis during neurally adjusted non-invasive ventilation and 
pressure support ventilation in chronic obstructive pulmonary disease. Crit Care. 
2014 Oct;18(5):550.
Oppersma E, Doorduin J, van der Heijden EH, van der Hoeven JG, Heunks LM. 
Noninvasive ventilation and the upper airway: should we pay more attention? Crit 
Care. 2013 Dec 5;17(6):245.
269
Doorduin J, Haans AJC, van der Hoeven JG, Heunks LMA. Difficult weaning: 
Principles and practice of a structured diagnostic approach. Neth J Crit Care. 2013 
Oct;17(4):11-5.
Doorduin J, van Hees HW, van der Hoeven JG, Heunks LM. Monitoring of 
the respiratory muscles in the critically ill. Am J Respir Crit Care Med. 2013 Jan 
1;187(1):20-7.
Doorduin J, Heunks LM, Pickkers P. How can you mend a broken heart? Crit Care 
Med. 2012 Feb;40(2):702-703.
Doorduin J, Sinderby CA, Beck J, Stegeman DF, van Hees HW, van der Hoeven 
JG, Heunks LM. The calcium sensitizer levosimendan improves human diaphragm 
function. Am J Respir Crit Care Med. 2012 Jan 1;185(1):90-5.
Doorduin J, Pickkers P. Hemodynamische insufficiëntie en gevolgen. In Handboek 
multiorgaanfalen. Uitgeverij De Tijdstroom, Utrecht 2011;Hoofdstuk 18:217-228 
List of publications
270
271
Curriculum vitae
Curriculum vitae
Jonne Doorduin werd geboren op 14 januari 1985 te Gieten. In 2003 behaalde hij 
zijn VWO diploma aan de Winkler Prins te Veendam. Hierna volgde hij de studie 
technische geneeskunde aan de Universiteit Twente te Enschede. In het kader 
van zijn afstuderen deed hij van 2009 tot 2010 een wetenschappelijk onderzoek 
naar diafragma functie op de afdeling Intensive Care van het Radboud universitair 
medisch centrum te Nijmegen onder begeleiding van prof. dr. Leo M.A. Heunks. Na 
zijn afstuderen is hij als technisch geneeskundige gaan werken op de Intensive Care. 
Hier was hij van 2010 tot 2016 werkzaam en specialiseerde zich in ademspierfunctie 
en mechanische beademing bij kritisch zieke patiënten, hetgeen onder andere 
resulteerde in dit proefschrift. Vanaf 2014 was Jonne tevens in deeltijd werkzaam op 
de afdeling Neurologie - Klinische Neurofysiologie. Per oktober 2016 maakt Jonne 
voltijd deel uit van de staf van de afdeling Neurologie - Klinische Neurofysiologie, 
waar hij wetenschappelijke onderzoek doet naar ademspierfunctie bij patiënten 
met een neuromusculaire aandoening, intra-operatieve neuromonitoring verricht en 
verantwoordelijk is voor de kwaliteit en veiligheid van medische technologie.
Naast zijn professionele werkzaamheden is Jonne medeoprichter van de 
beroepsvereniging voor technische geneeskundigen, de Nederlandse Vereniging 
voor Technische Geneeskunde, en heeft van 2009 tot 2013 de taak van voorzitter 
vervult.
Jonne is getrouwd met Janet Doorduin - van Delden. Samen hebben zij een zoon, Luuk. 
272
